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ABSTRACT
ADDRESSING THE ISSUES OF DRUG DELIVERY VIA ADVANCED
MACROMOLECULAR DESIGN
by Brooks Allen Abel
May 2016
The work described in this dissertation focuses on the development of synthetic
approaches toward novel polymer architectures that specifically address the issues of in
vivo drug delivery. Successful implementation of the synthetic methodologies described
herein required fundamental investigations into the underlying chemistries in ways that
now provide greater insights into the nature of the these chemical reactions.
In Section I, the synthesis of tunable pH- and CO2-responsive sulfonamidecontaining polymers using reversible addition-fragmentation chain transfer (RAFT)
polymerization is described. Initially, poor polymerization control of methacryloyl
sulfonamide (MSA) monomers was observed using traditional RAFT polymerization
conditions. Ultimately, reducing the polymerization temperature to 30 °C afforded
polymers of controlled molecular weights and low dispersities. A library of sulfonamidecontaining polymers was subsequently synthesized and their tunable pH-responsive and
reversible CO2-responsive aqueous solution properties investigated.
The work in Section II provides mechanistic understanding of the limited
molecular weight control observed during the RAFT polymerization of MSAs at 70 °C
(from Section I). This work demonstrates the unique influence of N-arylmethacrylamide
substitution on trithiocarbonate chain-end degradation during RAFT polymerization at
elevated temperatures. Detailed kinetic and structural analysis of RAFT polymer small
ii

molecule analogs showed trithiocarbonate chain-end degradation occurs by N-5
nucleophilic attack on the terminal thiocarbonyl by the ultimate methacrylamide unit. Ongoing work regarding the development of a mechanistic and kinetic theory aimed at
explaining the unique influence of N-arylsubstitution on amide nucleophilicity is further
discussed in Appendix B.
In section III we investigate deleterious side reactions that occur during “one-pot”
aminolysis/thiol-maleimide end group modification of RAFT polymers. Commonly
employed thiol-ene Michael catalysts including amines, amidines, and phosphines were
demonstrated to initiate the anionic polymerization of maleimide in a range of organic
solvents, resulting in reduced RAFT polymer end group functionalization efficiency.
Additionally, thiols and thiol-maleimide adducts were shown to initiate maleimide
polymerization in polar solvents in the presence of triethylamine (TEA). Reaction
conditions which favor rapid and quantitative end group functionalization of RAFT
polymers using “one-pot” aminolysis/thiol-maleimide chemistry were ultimately
identified.
Section IV details a new “grafting through” synthetic route towards molecular
brushes capable of intracellular-induced disassembly. RAFT polymer-derived
macromonomers were synthesized using “one-pot” aminolysis/thiol reactions with
maleimide- or methanethiosulfonate-functional oxanorbornenes. Subsequent ring opening
metathesis polymerization (ROMP) of the resulting macromonomers afforded molecular
brushes with RAFT polymer side chains attached to a polyoxanorbornene backbone via
either permanent thioether linkages or reversible disulfide linkages. Molecular brushes

iii

comprised of disulfide linkages were shown to undergo reduction-induced disassembly
and show promise as a new class of stimuli-responsive polymer therapeutics.
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1
CHAPTER I
INTRODUCTION
Pharmacologically Active Polymers
Barriers to Polymer-Facilitated Drug/Gene Delivery
The “depot” model (Figure 1.1), first proposed by Helmut Ringsdorf in 1975, has
been the basis of design for many polymer therapeutics.1 According to this model,
Ringsdorf proposed the use of a modifiable polymer scaffold that would incorporate four
major components including i) a water-soluble and biocompatible polymer backbone, ii)
targeting moiety/diagnostic agent, iii) therapeutic agent, and iv) a degradable spacer for
reversible attachment of the therapeutic agent. Various interpretations of this approach to
polymer-facilitated drug delivery have since yielded many new solutions to addressing
the issues associated with drug delivery. However, successful implementation of the
idealized “depot” model has proven difficult, largely due to synthetic challenges and the
complex nature of in-vivo drug delivery.2

Figure 1.1. Ringsdorf “depot” model of idealized polymer-based therapeutic.


2
There are numerous barriers associated with polymer-facilitated cytosolic delivery
of chemo- and gene-based therapeutics that must be overcome in order for polymer-based
therapeutics to be a viable treatment option in-vivo.3–9 These barriers include i)
therapeutic agent degradation, ii) vascular circulation, iii) cell-specific targeting, iv)
cellular internalization, v) endosomal escape, vi) controlled release of the therapeutic
agent in its active form, and vii) polymer clearance/elimination from the body. The drug
delivery “vehicle” must also be simultaneously biocompatible and non-immunogenic.
Numerous polymer-based approaches have been developed to specifically address each
of these issues with regard to drug/gene delivery but with varying degrees of success
owing to the complex nature of drug delivery. Fully understanding each barrier to drug
delivery is crucial to designing successful polymer therapeutics.
Therapeutic Agent Protection and Enhanced Vascular Circulation
Small molecule drug use in-vivo is largely inefficient due to rapid renal clearance
in the kidneys and/or liver.10,11 The reduced circulation half-lives of small molecule drugs
necessitate high initial dosages and frequent administration which can result in
unintended drug-induced side effects. In-vivo drug degradation also results in reduced
therapeutic efficacy and may result in complete inhibition of therapeutic activity. For
example, the extracellular half-life of unprotected small interfering ribonucleic acid
(siRNA) is 3-5 minutes, making direct delivery of “naked” siRNA therapeutics
completely ineffective.12 It is therefore desirable to extend the circulation half-life of
small molecule and nucleotide-based therapeutics by preventing degradation and
increasing vascular retention.
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Some of the earliest polymeric delivery vehicles encapsulated or sequestered
therapeutic agents inside liposomes or micellar-like structures which simultaneously
protected the therapeutic agent from degradation while also increasing circulation time
before ultimate renal clearance.13–15 However, these approaches did not specifically target
cells, but rather relied upon non-specific cellular uptake and the enhanced permeation and
retention (EPR) effect to direct the delivery vehicle to tumoral tissues.16–20 As illustrated
in Figure 1.2, the EPR effect enhances polymeric drug accumulation in tumoral tissue
due to the combination of a leaky vascular system and poorly formed lymphatic drainage
system, which are characteristic of rapidly growing tumors. In contrast, polymer
therapeutics tend not to accumulate in healthy tissues due to tight endothelial junctions
and improved lymphatic drainage compared to tumoral tissue.

Figure 1.2. Enhanced permeation and retention (EPR) effect.21


Interpolyelectrolyte complex (IPEC) formation is a commonly used strategy to
electrostatically bind negatively charged oligonucleic acids to cationic polymers,
effectively shielding the nucleic acid from enzymatic degradation.22–24 Traditionally, an
excess of cationic charge is used to maintain water solubility of IPECs, but the overall
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positive charge results in non-specific cellular uptake and high in-vitro and in-vivo
cytotoxicity.25–27 Recently, overall neutral block ionomer complexes (BICs) comprised of
neutral-block-cationic copolymers and siRNA have shown adequate protection of siRNA
while allowing for cell-specific uptake when used with appropriate targeting methods.24,28
Other approaches, aimed at improving therapeutic agent circulation time involve
functionalization of nanoparticles or polymeric scaffolds with biocompatible watersoluble polymers such as poly(N-(2-hydroxypropyl)methacrylamide) (pHMPMA) or
poly(ethylene glycol) (PEG).29–32 This effectively shields the drug-containing core of the
delivery vehicle from eliciting a potential immune response while simultaneously
protecting the therapeutic agent from degradation.
The ultimate goal of limiting therapeutic agent degradation while increasing the
circulation half-life of the delivery vehicle is to allow for suitable time to reach the site of
intended therapeutic action. To this end, the EPR effect can be exploited as a passive
tumor targeting mechanism; however, this approach will not specifically target any cell
of interest when well-defined tumors are not present and does not facilitate cell-specific
internalization. Therefore, to improve drug delivery specificity and avoid therapeutic
accumulation in healthy tissue, a cell-specific and preferably modifiable targeting
strategy is desired.
Cell-Specific Targeting
Polymeric drug carriers can be modified to contain targeting moieties through end
group functionalization, incorporation along the polymer backbone, or side chains.33
Availability of the targeting moiety on the surface of the polymer-drug conjugate is
necessary to ensure appropriate contact with surface receptors expressed on the exteriors
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of targeted cells. Common targeting moieties include antibodies and antibody fragments,
peptides, oligosaccharides, and folate among others.34–41 Antibodies represent a versatile
targeting agent since it is possible to produce an antibody that can uniquely bind to a
corresponding antigen expressed on any cell-type. Then, by conjugating the antibody to
the polymer therapeutic, the delivery vehicle can be specifically targeted to the desired
cell-type. It is also possible to cleave and isolate the variable regions of the antibody
known as the fragment antigen binding (Fab) regions, which reduces the entire size of the
targeting moiety from ~150 kDa per antibody to ~50 kDa per Fab.42,43 Kopecek and
coworkers have shown that Fab-targeted polymer therapeutics promote a 3-fold reduction
in tumor size compared to the non-targeted therapeutics that relied exclusively upon the
EPR effect for passive tumor targeting.44 Despite their specificity, antibodies and Fab
fragments are often recognized as being foreign biological molecules and can induce an
immunological response that results in rapid elimination/degradation of the targeting
moiety and the attached polymer therapeutic.
The use of oligosaccharides represents another attractive targeting option since all
cells express saccharide-binding proteins on their surfaces called lectins.45 Due to the
large number of unique possible combinations of sugar residues in oligosaccharides,
specific cellular targeting is possible if a unique lectin-oligosaccharide binding
interaction is known for a particular cell-type. Although lectins exhibit high specificity of
recognition, not all lectins induced cellular internalization of bound oligosaccharides such
that an additional means of cellular internalization would be needed.
Folate-targeted polymer therapeutics have been used extensively in-vitro and invivo.22,46,47 Folic acid is an essential vitamin required by cells and several cancer cell-
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types are known to over-express folic acid receptors. Furthermore, folate is readily
available compared to specifically targeted antibodies and other biomacromolecules
which are more difficult to prepare and isolate. Despite the targeting method used, the
polymer therapeutic must also be internalized by the cell. In some instances, the mode of
targeting can result in cellular internalization, known as “piggy-back endocytosis,”
whereas other routes require an additional strategy to induce cell entry.
Cellular Internalization and Endosomal Escape
Cellular internalization is most often achieved via endocytosis, the process by
which a portion of the cell membrane invaginates and separates from the rest of the cell
membrane, subsequently internalizing extracelluar compounds (Figure 1.3). Endocytosis
is usually triggered in response to an external stimulus, such as binding of a biomolecule
to a particular cellular receptor.47,48 This type of cellular entry is known as receptormediated endocytosis and is a readily exploited method to internalize polymer
therapeutics that target cellular surface receptors. Following endocytosis, the internalized
polymer therapeutic and extracellular media are isolated in endosomes, accompanied by a
reduction in pH from physiological (7.4) to early endosomal (pH 6-6.5) to late endosomal
(pH 5-6).49,50 Within approximately 30 minutes of endocytosis, the endosomes fuse with
or transform into lysozomes, which contain degradative enzymes that are particularly
detrimental to most small molecule and nucleic acid-based therapeutics.51 Furthermore,
endosomes can fuse with the cell membrane via a process known as exocytosis,
subsequently releasing their contents outside of the cell. For this reason, endosomal
escape is often cited as the “bottle neck” of intracellular drug delivery thus making
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escape of polymer-based therapeutics from the endosome prior to lysozomal fusion or
exocytosis crucial for the successful application of polymer therapeutics.

Figure 1.3. Cellular internalization of polymer therapeutics by endocytosis.1


Several methods of endosomal release have been developed that disrupt the
structural integrity of the endosomal membrane, thus facilitating the release of its
contents into the cytoplasm. One approach utilizes osmotoic swelling of the endosomal
vesicle by promoting ion influx into the endosome by a process known as the proton
sponge effect.52 High buffer capacity polymers such as polyethylene imine (PEI), contain
a large number of unprotonated amines and can act as “proton sponges” when exposed to
the acidified environment of the endosome.53 The resulting influx of counterions is
further accompanied by an influx of water, subsequently swelling the endosome which
results in either compromised membrane integrity or complete endosomal rupture,
facilitating release of its contents, polymer therapeutic included. pH-responsive peptides
and polymers that become hydrophobic at endosomal pH (5.0-6.5) have also been used to
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destabilize the amphiphilic endosomal membrane facilitating the release of the
endosomal contents.54–57 Ultimately, the goal of endosomal escape is to release the
polymer therapeutic into the cytoplasm, where triggered release of the therapeutic agent
can elicit the desired pharmacological response.
Therapeutic Release and Ultimate Polymer Fate
The final role of a polymer therapeutic is to release the therapeutic agent upon
cellular internalization. This is typically desired following escape from the endosome to
avoid unwanted degradation by endosomal and lysosomal enzymes. For example, when
delivering siRNA, release is preferred in the cytoplasm where it can then directly enter
into the RNA interference (RNAi) pathway. Therefore, a number of approaches have
been developed to promote release of therapeutic agents at a desired location within the
cell.
A common strategy for intracellular-induced therapeutic release is to conjugate
the therapeutic agent to a polymer scaffold using a degradable linkage. The most
common types of degradable linkages used for intracellular drug release cleave in
response to changes in pH, redox potential, or enzymatic degradation. Acid-labile
linkages include esters, carbonates, carbamates, acetals, and hydrazones among others,58–
63

while enzymatically-degradable linkers comprised of specific ester- or peptide-

containing sequences are selectively cleaved by esterases or peptidases, respectively,
facilitating intracellular therapeutic release.64–66 Disulfide linkages are the primary
example of a chemical linkage that cleaves upon experiencing a change in redox
potential.67–69 Glutathione, the most abundant non-protein peptide in mammalian cells, is
an efficient reducing agent meant to maintain the redox potential inside of the cell by
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reducing reactive oxygen species but also has been shown to effectively reduce most
forms of disulfide bonds.70 This type of bond cleavage occurs readily and almost
exclusively inside of the cytoplasm, which would promote therapeutic release from the
polymeric carrier only after escaping the endosome. Also, higher levels of glutathione are
observed in a number of cancer cell types compared to concentrations present in healthy
tissues, which further promotes the likelihood of disulfide bond cleavage in these cancer
cells.71
After the polymer “vehicle” has delivered its therapeutic payload to the
appropriate location within the cell, it must be reabsorbed or eliminated from the body to
avoid toxic in vivo accumulation. This can be accomplished using a polymer therapeutic
in which the polymer component is partially or entirely degradable, or small enough to be
excreted whole by the body. Examples of biodegradable polymers include poly(Llactide/glycolide),72 polypeptides,73 and polysaccharides.74 These polymers are capable of
being completely degraded, or can be used as part of larger polymeric scaffolds which are
reduced in size upon partial degradation of lactide or glycolide linkages, thus facilitating
polymer clearance from the body. Polymers that are to be secreted based upon size are
removed by renal filtration in the kidneys and typically must have hydrodynamic
diameters less than ~15 nm for adequate removal without renal accumulation.75 Thus,
adequate control over the size of the delivery vehicle is necessary to avoid both rapid
clearance from the body and to prevent perpetual accumulation by being too large for
long term elimination to occur.
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Reversible Addition-Fragmentation Chain Transfer Polymerization
The development of reversible-deactivation radical polymerization (RDRP)
techniques including nitroxide-mediated polymerization (NMP),76,77 atom transfer radical
polymerization (ATRP),78–81 and reversible addition-fragmentation chain transfer
(RAFT)82–87 polymerization has made possible the synthesis of polymers with precise
compositions, predetermined molecular weights, and advanced architectures comprised
of monomers possessing a wide variety of functional groups. RAFT polymerization is
arguably the most versatile of the RDRP techniques owing to the increased tolerance of
protic functional groups and solvents allowing for the polymerization of styrenics,
(meth)acrylates, (meth)acrylamides, acrylonitriles, vinyl esters, and vinyl amides, in
organic or aqueous media under homogeneous or heterogeneous conditions. In particular,
the development of aqueous RAFT (aRAFT) polymerization has allowed for the direct
synthesis of polymers containing biologically relevant functional groups such as amines,
carboxylates, phosphates, sulfonates, and betaines among others.88–98 For these reasons,
RAFT is an ideal polymerization method for the synthesis of advanced polymer-based
therapeutics.
The RAFT Mechanism
The mechanism of RAFT polymerization is fundamentally different from the
mechanisms of NMP and ATRP in that the main active/dormant equilibrium is
established by degenerative chain transfer between active (propagating) and dormant
chain ends rather than reliance upon the persistent radical effect. Successful degenerative
chain transfer is achieved when the product of chain transfer is also a chain transfer agent
of equal or similar reactivity. Operating under these conditions, RAFT polymerization
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exhibits similarities to pseudo-living polymerizations in that narrow molecular weight
distributions can be obtained while molecular weight progresses linearly with monomer
conversion and high chain-end fidelity is maintained throughout the reaction such that
sequential monomer addition results in the formation of block copolymers.

Scheme 1.1. Proposed mechanism of RAFT polymerization.
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Like classical free radical polymerization, the first stage in the RAFT process
involves decomposition of initiator into radicals (Scheme 1.1). However, the fate of
initiator-derived radicals differs significantly during RAFT polymerization due to the
presence of a thiocarbonylthio-containing chain transfer agent (CTA). The initiation/preequilibrium stage of RAFT consists of multiple kinetically distinct chain transfer
reactions. During this period, initiator-derived radicals 1 can either initiate
polymerization by direct addition to monomer to form the propagating species 3, or add
directly to CTA 2 to afford the radical intermediate 4. Although the formation of 4 is also
reversible, eventual fragmentation of the R-group yields a new initiator-derived CTA 9
and R-group-derived radical 7 capable of adding to monomer to form the propagating
species 8. Similarly, the initiator-derived propagating species 3 can add to CTA 2 with a
rate constant kadd to yield the radical intermediate 5. This intermediate can fragment in
the reverse direction with rate constant k-add or in the forward direction with rate constant
k to form the macro-CTA 6 and the R-group-derived radical 7, which can add to
monomer forming the propagating species 8. The pre-equilibrium period is complete
when CTA 2 has been converted into the corresponding macro-CTA 6. Similar to the
initiation stage of other controlled/”living” polymerizations where Ri > Rp must be met to
achieve narrow molecular weight distributions, it is important that the duration of the preequilibrium period during RAFT be suitably short relative to the timescale of propagation
such that the majority of polymer chains start growing at the same time.
Prolonged periods of little or no monomer conversion have often been observed
during the pre-equilibrium stage of RAFT polymerizations.99 Like conventional radical
polymerizations, inhibition of RAFT is possible due to the presence of oxygen or other
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impurities (e.g. thiol impurities originating from the CTA) that consume radicals early in
the polymerization. Extended pre-equilibrium or inhibition periods in RAFT can also
occur for certain CTA-monomer combinations because of slow reinitiation by R· due to
preferred addition to the CTA thiocarbonyl (high k-) rather than addition to monomer
(low ki).90,91,100–105 The cause of this initialization phenomena was first elucidated by
McCleary, Klumperman, and coworkers using in situ 1H NMR analysis during the 2cyano-2-propyl dithiobenzoate-mediated polymerization of styrene.106 As seen in Figure
1.4, complete conversion of the initial dithiobenzoate species (AD) to the corresponding
single monomer unit adduct (ASD) was required before reaching the main RAFT
equilibrium and thus observed as a period of minimal monomer conversion. Suppression
or elimination of prolonged initialization periods can be accomplished by selection of
CTA R- and Z-groups which favor fragmentation and reinitiation by R· (i.e. R-groups
that are structurally similar to the propagating radical Pn·).
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Figure 1.4. Percentage of dithiobenzoate species present during the AIBN-initiated
polymerization of styrene in the presence of 2-cyano-2-propyl dithiobenzoate (AD).106

Propagation during the main RAFT equilibrium occurs as it does during
conventional free radical polymerization where the rate of propagation (Rp) is expected to
be first order with respect to both the concentration of monomer [M] and propagating
radicals [Pn·] while independent of [CTA] as seen in equation 1. RAFT polymerizations
often exhibit pseudo-first-order kinetic behavior when a steady state radical concentration
is reached where Ri ≈ Rt, allowing for simplification of equation 1 to equation 2 where
kapp is the apparent propagation rate constant equal to kp[Pn·].
𝑅𝑝 = 𝑘𝑝 [𝑃𝑛 ·][𝑀]

(1)
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𝑅𝑝 = 𝑘𝑎𝑝𝑝 [𝑀]

(2)

Degenerative chain transfer during RAFT polymerization allows for the total number of
polymer chains to greatly exceed the number of propagating radicals. This is a
cornerstone feature of any RDRP technique since reducing [Pn·] by a factor of 10 will
result in a 10-fold reduction in Rp but a 100-fold reduction in the rate of bimolecular
radical termination (Rt) due to the second order dependence of Rt on [Pn·] (equation 3).
𝑅𝑡 = 𝑘𝑡 [𝑃𝑛 ·]2

(3)

In theory, the introduction of CTA (RAFT agent) to a conventional free radical
polymerization should have no effect on Rp as seen in equation 1. However, in practice
Rp during RAFT polymerization is significantly reduced compared to the analogous free
radical polymerization conducted in the absence of CTA with much debate over the exact
cause of rate retardation.107–110 One possible explanation for the differences in observed
polymerization rates between conventional and RAFT polymerizations is due to extended
lifetimes of the intermediate radical 11, such that [Pn·] is lower than what would be
predicted based upon the total radical concentration resulting from initiator-derived
radicals.111 While the intermediate radical 11 has been observed by electron spin
resonance (ESR) spectroscopy, the observed concentrations were too low to completely
explain the reduction in Rp for RAFT polymerizations.112–115 Radical trapping or “sink”
theories which suggest intermittent and reversible coupling of the transient species 11
with other radical species including Pn·, I·, and 11 have also been proposed with some
spectroscopic evidence provided for the formation of these intermediates using
electrospray ionization mass spectrometry (ESI-MS) and nuclear magnetic resonance
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(NMR) spectroscopy, however, there is still much debate as to the exact cause of
propagation rate retardation in RAFT polymerizations.116–118
Molecular Weight Control in RAFT Polymerization
In RAFT polymerization, the theoretical number average degree of
polymerization (Xn,th) can be determined based upon the molar ratio of consumed
monomer to the number of polymer chains formed during polymerization such that:
𝑋𝑛,𝑡ℎ =

[𝑀]0 𝜌
[𝐶𝑇𝐴]0 + 2𝑓[𝐼]0 (1 − 𝑒 −𝑘𝑑 𝑡 )

(4)

where [M]0 is the initial monomer concentration,  is the fractional monomer conversion,
[CTA]0 is the initial CTA concentration, f is the initiator efficiency, [I]0 is the initial
initiator concentration, kd is the initiator dissociation constant, and t is the reaction time.
In a typical RAFT polymerization, the [CTA]0:[I]0 is suitably high such that the total
number of initiator-derived polymer chains is negligible allowing for omission of the
second term in the denominator of equation 4.110 The theoretical number average
molecular weight (Mn,th) can then be calculated according to:
𝑀𝑛,𝑡ℎ = 𝑋𝑛,𝑡ℎ 𝑀𝑀𝑊 + 𝐶𝑇𝐴𝑀𝑊 =

[𝑀]0 𝜌
𝑀
+ 𝐶𝑇𝐴𝑀𝑊
[𝐶𝑇𝐴]0 𝑀𝑊

(5)

where MMW and CTAMW are the molecular weights of monomer and CTA respectively. It
is worth noting that equation 5 assumes 100% of CTA results in formation of a polymer
chain and has been shown to underestimate Mn,th compared to experimentally determined
Mn (Mn,exp) during RAFT polymerizations where incomplete consumption of CTA occurs
during the pre-equilibrium period or due to CTA degradation during polymerization.119
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RAFT Agent Design
Chain transfer agents possessing thiocarbonylthio functional groups (RAFT
agents) have been utilized to mediate the polymerization of a wide variety of monomer
types including styrenics, (meth)acrylates, (meth)acrylamides, acrylonitriles, vinyl esters,
and vinyl amides among others. As shown in Figure 1.5, the RAFT agent consists of a
reactive C=S double bond capable of addition to propagating radicals, a weak S-R bond
to promote rapid fragmentation and reinitiation by the R-group, and Z-group that
influences the stability of the intermediate radical. The R-group is only involved during
the initialization period while the Z-group is present on the -terminus of dormant RAFT
chains throughout the entire polymerization. Consequently, the Z-group has the greatest
influence over polymerization control and must be chosen in accordance with monomer
type. For this reason a number of Z-groups including dithioesters,82 trithiocarbonates,120
xanthates,121 and dithiocarbamates122 have been utilized to polymerize a range of
monomers from “more activated monomers” (MAM) such as methyl methacrylate to
“less activated monomers” (LAM ) such as vinyl acetate. Furthermore, “universal” or
“switchable” RAFT agents based upon 4-pyridinyl dithiocarbamates (Figure 1.5) have
been designed to polymerize a wider range of monomers.123–125 In the presence of acid,
the pyridine ring is protonated and elelctron withdrawing, allowing for control over
polymerization of MAMs. Alternatively, use of 4-pyridinyl dithiocarbamates in the
electron donating neutral form facilitates polymerization control of LAMs. General
guides for RAFT agent R- and Z-group selection for a given monomer-type are also now
available as shown in Figure 1.6.
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Figure 1.5. General structures of commonly used RAFT agents.


Figure 1.6. Guidelines for RAFT agent Z-group, R-group, and monomer selection based
upon previously reported experimental results.87 Dashed lines indicate marginal
polymerization control.
End Group Functionalization of RAFT Polymers
It is often desirable or necessary to control polymer end group functionality.
Inherent to polymers synthesized by RAFT is retention of the RAFT agent R-group on
the -terminus and the thiocarbonylthio moiety and Z-group on the -terminus (Figure
1.7). Accordingly, preparation of functional telechelic RAFT polymers is readily
accomplished by incorporating the desired functionalities onto the RAFT agent R- and Zgroups.126–129 However, precise control over end group functionality not directly
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obtainable through R- and Z-group selection necessitates the use of post-polymerization
end group transformations. Extensive efforts have thus been made toward end group
functionalization of RAFT polymers by exploiting the latent reactivity of the
thiocarbonylthio moeity.130–137

Figure 1.7. R/Z-group approach toward the synthesis of ,-telechelic polymers by
RAFT.
While the reactive thiocarbonylthio -terminus of RAFT polymers functions as a
useful chemical “handle” for subsequent end group transformations, the instability of this
group may be undesirable depending upon the end-use of the RAFT polymer. Bulmus
and coworkers recently studied the effect of RAFT agent type on cytotoxicity of the
biocompatible polymer pHPMA. In-vitro cell viability assays showed that
dithiobenzoate-functional pHPMA was significantly more toxic than analagous
trithiocarbonate-terminated pHPMA.138 This is likely due to the hydrolytic instability of
dithiobenozoates relative to trithiocarbonates, with hydrolysis byproducts responsible for
the decreased cell viability. A number of methods now exist whereby the reactive
thiocarbonylthio moiety can be converted to a benign end group to minimize unintended
consequences of RAFT agent reactivity.139–142
Stimuli-Responsive Polymers
Of particular interest in the field of polymeric drug carriers is the ability to design
stimuli-responsive behavior into the delivery “vehicle” such that autonomous functions
can be performed in-vivo that elicit a therapeutic effect. For example, the acidic
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environment of tumoral tissue may be used as an environmental trigger for polymerbound drug release.143 Stimuli-responsive polymers in solution can exhibit changes in
chain conformation, size, or solubility in response to biologically relevant stimuli such as
changes in pH, redox potential, temperature, ionic strength, or specific molecular
interactions.144 Furthermore, externally applied stimuli such as electromagnetic radiation,
changing magnetic fields, and mechanical forces (sonication) have also been used to
elicit changes in polymer physical and chemical properties.145 Such stimuli-responsive
polymer properties can be exploited to passively/actively target polymeric drug carriers,
promote cell-specific internalization, endosomal escape, site-specific drug release, trigger
drug carrier degradation/elimination from the body, and allow polymers to function as
combined therapeutic/diagnostic (theranostic) agents. It is therefore becoming ever more
pertinent to design multipli-responsive polymeric carriers that can exhibit rapid and
reversible changes in physical and chemical properties in response to discrete changes in
orthogonal biologically relevant stimuli.
pH-Responsive Polymers
Polymers comprised of weakly acidic or basic functional groups (polyacids or
polybases) make up a class of polyelectrolytes that exhibit pH-dependent aqueous
solution properties and have been used extensively in a variety of applications including
drug delivery.97,146–157 A change in solution pH results in a corresponding change in the
degree of ionization of the polyelectrolyte and subsequently its hydration state. This can
ultimately lead to aggregation or self assembly of polyelectrolyte-containing polymers.
Polyacids exist predominantly in the ionized form when the solution pH (pHsol) is greater
than the pKa of the poly acid. Accordingly, polyacids are protonated and therefore neutral
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(or nearly neutral) in charge and less hydrophilic when pHsol < pKa. Conversely,
polybases are ionized and therefore water soluble when pHsol < pKa and neutrally charged
and less water soluble when pHsol > pKa. It is therefore possible to dictate whether
increasing or decreasing the solution pH will increase or decrease polymer solubility
depending upon whether the polymer is a weak polyacid or polybase Figure 1.8 shows
some of the more common acid- and base-functional acrylic monomers that are readily
polymerizable by RDRP techniques such as RAFT to afford the corresponding pHresponsive polymers.

Figure 1.8. Common pH-responsive monomers polymerizable by RDRP techniques.144


Temperature-Responsive Polymers
Temperature-responsive polymers are those which exhibit a volume phase
transition at a critical temperature. In solution, the influence of temperature on polymer
solubility can be explained by the mutual influences of the enthalpy (H) and entropy
(S) of mixing on the total free energy of mixing (G) according to equation 6. Polymers
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which exhibit a decrease in solubility in a given solvent upon heating possess a lower
critical solution temperature (LCST), above which polymer-solution phase separation
occurs. For these systems, S is negative and an increase in temperature results in a
corresponding increase in G with the temperature at which G = 0 defined as the LCST.
Polymers that exhibit increased solubility in a given solvent upon heating possess an
upper critical solution temperature (UCST) owing to a positive S of mixing. In aqueous
systems, entropic effects are driven by the ordering or disordering of water molecules at
the polymer-water interface whereas the enthalpy of mixing is influenced by hydrogen
bonding, dipole interactions, and hydrophobic effects.

𝐺 = 𝐻 − 𝑇𝑆

(6)

Figure 1.9 shows the more commonly used temperature-responsive monomers
that have been polymerized by RAFT. The most extensively studied temperatureresponsive polymers for biological applications are those derived from Nisopropylacrylamide (NIPAM) owing to the LCST of poly(NIPAM) (~32 °C) being near
that of physiological temperature (37 °C).158–161 A number of other N-substituted
(meth)acrylamides have also been polymerized by RAFT to afford the corresponding
temperature-responsive polymers and have seen applications in polymer-facilitated drug
delivery.146,162–166
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Figure 1.9. Common temperature-responsive monomers polymerizable by RDRP
techniques.144
Redox-Responsive Polymers
Polymers exhibiting redox-responsive chemical and physical properties are
actively being explored as stimuli-responsive drug carriers. Glutathione (GSH), the most
abundant non-protein peptide in mammalian cells, is largely responsible for the reductive
intracellular environment within cells.71,167 The intracellular concentration of GSH (5-10
mM) is significantly higher than that outside of the cell (2- 20μM) resulting in a
difference in redox potential that can be exploited as an intracellular-specific stimulus.
Redox-responsive polymers for drug delivery are almost exclusively based upon disulfide
linkages which are chemically stable in the oxidative extracellular environment while
being rapidly reduced to the corresponding thiols by GSH upon cellular
internalization.46,168–174 Consequently, redox-responsive polymers differ from pH- and
temperature-responsive polymers in that the “response” is cleavage of covalent disulfide
linkages rather than a thermodynamic change in polymer hydration/solubility. This
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makes possible the triggered release of covalently bound therapeutics such as thiolfunctional siRNA as was recently demonstrated by York et al.46 There are a number of
reviews that address the potential applications of redox-responsive disulfide-containing
polymer therapeutics.168,171,172,174–176
Advanced Macromolecular Architectures
While imparting stimuli-responsive behavior into polymer-drug conjugates
through careful selection of monomer-type and end group functionality has the potential
to address many of the barriers to drug delivery in a single delivery “vehicle,” it is
evident that multipli-responsive polymer therapeutics will likely be needed thus
necessitating the use of branched or block copolymers where discrete blocks of the
polymer are designed to respond to different stimuli. Furthermore, issues such as
therapeutic agent protection, vascular circulation, tumoral accumulation, and ultimate
polymer clearance from the body can be accomplished by controlling polymer
architecture. Upon the advent of controlled/”living” polymerization techniques, a number
of polymer architectures are now possible including
alternating/statistical/gradient/multiblock copolymers, functional telechelics, stars,
hyperbranched polymers, dendrimers, and molecular brushes (Figure 1.10).177–185
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Figure 1.10. Polymer architectures accessible through the use of controlled/”living”
polymerization techniques.
Highly branched architectures with tailorable shapes and sizes are of particular
interest for polymer therapeutics. Compared to analogous linear polymers, highly
branched polymers have been shown to exhibit increased vascular circulation and
tumoral tissue accumulation.186 While self-assembled polymer structures such as micelles
and vesicles share many of the benefits of branched polymers, in-vivo usage is limited
due to dilution-induced disassembly caused by polymer concentrations falling below the
critical micelle concentration (CMC).89,187 Consequently, branched polymer architectures
that are assembled using permanent or reversible covalent linkages are desired.
Molecular Brush Copolymers
Molecular brush or “bottle-brush” copolymers are comprised of polymeric sidechains attached to a polymer backbone and can exhibit highly branched spherical or
cylindrical morphologies with minimal intermolecular chain entanglement owing to the
volume-exclusion interactions between sterically crowded polymeric side-chains.188,189

26
Molecular brush architectures are of particular interest as drug delivery “vehicles” due to
their unique branched topology and readily tailorable dimensions. As stated previously,
large, highly branched, and cylindrical polymer architectures exhibit increased in-vivo
circulation times, enhanced accumulation in tumoral tissue due to the EPR effect, and
improved biocompatibility compared to analogous linear polymers.186 Molecular brush
copolymers therefore represent an attractive polymer architecture that has the potential to
simultaneously address numerous issues associated with drug delivery.
In general, molecular brush synthesis is accomplished by one of three routes
referred to as “grafting from,” “grafting onto,” and “grafting through” (Figure 1.11).
“Grafting from” molecular brush synthesis involves initial preparation of a
multifunctional backbone (macroinitiator) followed by side chain growth from initiator
side groups. Controlled polymerization techniques such as RAFT, ATRP, NMP, and
ROP have been used to prepare molecular brush backbones, which typically require
additional post-polymerization modification in order to attach the desired initiator groups
along the backbone.190–194 Side chain growth is most often accomplished using RDRP
techniques such as ATRP. Limited use of RAFT polymerization to afford side chain
growth is due in part to difficulties in attaching the RAFT agent to the brush backbone by
post-polymerization modification and also because of the fragmentation-chain transfer
nature of RAFT requiring that either a polymer side chain fragment from the backbone in
order to propagate or necessitating the unlikely collision of sterically restricted polymer
end groups in order for degenerate chain transfer to occur.194 While there are some
limitations regarding the synthesis of molecular brushes using “grafting from”
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approaches, purification of molecular brushes synthesized in this fashion is typically
simpler since the resulting molecular brush is the only polymeric product of the reaction.

Figure 1.11. “Grafting from,” “grafting onto,” and “grafting through” synthetic routes
toward molecular brush synthesis.
“Grafting onto” methods allow for preparation of molecular brush back bone and
side chains separately.195–197 Side chains are then grafted onto the brush backbone using
efficient coupling or “click” type reactions to ensure high side chain grafting density.
This approach makes possible the synthesis of well-defined side chains and backbones
first, such that molecular brushes with predetermined backbone and side chain lengths are
easier to prepare. In addition to covalent means of “grafting onto” molecular brush
synthesis, supramolecular brushes based upon noncovalent interactions have been
demonstrated which rely upon coordination bonding, hydrogen bonding, or ionic
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interactions between side chains and backbones.198–200 This type of supramolecular brush
assemblage occurs naturally in proteoglycan aggregates found in cartilage tissues which
are comprised of a positively charged polypeptide backbone electrostatically bound to
glycosaminoglycan side chains.201 While practical, the primary drawback to “grafting
onto” methods is the near impossibility of achieving 100 % grafting density of the
molecular brush backbone due to kinetic and thermodynamic restrictions resulting from
steric exclusion of side chains as grafting density increases.
The third and arguably most versatile molecular brush synthetic route is referred
to as “grafting through.” This method relies upon first using a controlled polymerization
technique to synthesize macromonomers (MMs) which possess polymerizable end groups
that can then be reacted by a second polymerization technique to afford the
corresponding molecular brush.202–205 “Grafting through” is the only approach that
affords molecular brushes with 100 % side chain graft density since each brush backbone
repeat unit is inherently attached to a polymer side chain. However, this method often
results in kinetically limited reactions with low MM conversions due to the steric
constraints arising from the use of MMs and the low concentration of polymerizable end
groups typically ranging from 0.01-0.1 M.
To overcome these issues, ring opening metathesis polymerization (ROMP)206–209
has recently been used to successfully synthesize molecular brushes from norbornenefunctional MMs while achieving near quantitative conversion of norbornene end groups
owing to the high reactivity and functional group tolerance of the current generation of
ruthenium-based metathesis catalysts (Figure 1.12).189,202,210–217 This approach has since
been used to synthesize a variety of molecular brushes with block-backbone and block-
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side chain subarchitectures from a wide range of MMs derived from controlled
polymerization techniques. While ROMP of MMs overcomes the previous limitations
associated with “grafting through” molecular brush synthetic routes, the facile synthesis
of norbornene-functional MMs still represents an ongoing challenge.

Figure 1.12. Ruthenium-based metathesis catalysts.


Synthesis of MMs can be accomplished by either “direct-growth” (DG-MM) or
“growth-then-coupling” (GC-MM) methods as described recently by Xia and coworkers
(Figure 1.13).218 DG-MM synthesis has been accomplished through the use of
norbornene-functional initiators during ROP, NMP, ATRP, and through the use of
norbornene-functional chain transfer agents during RAFT polymerization.202,219–226 The
use of reversible deactivation radical polymerization techniques to synthesize MMs is
particularly advantageous due to the wide variety of vinyl monomers available and ease
of controlling end group functionality. However, DG-MM synthesis by RDRP techniques
requires polymerization optimization for a given monomer to minimize radical addition
to the norbornene olefin during polymerization.214 Furthermore Xia and coworkers have
demonstrated that even trace amounts of difunctional macromonomer impurities resulting
from bimolecular radical coupling of α-norbornene-functional polymers can result in
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undesired molecular brush branching and broadened molecular weight distributions.218
Therefore, facile and efficient growth-then-coupling methods to synthesize RDRP-based
MMs are needed.

Figure 1.13. Norbornene-functional macromonomer synthesis by direct-growth (DGMM) and growth-then-coupling (GC-MM) synthetic routes.
Due to recent improvements in molecular brush synthetic methods, a number of
drug delivery applications have been developed that readily exploit the discrete sizes and
highly branched morphologies of molecular brushes. Johnson, Grubbs and coworkers
recently demonstrated the synthesis of drug-loaded, bivalent molecular brush copolymers
that were synthesized using “grafting through” ROMP methodologies developed in the
same lab (Figure 1.14).212 Molecular brushes were comprised of polynorbornene
backbones and PEG side chains with anticancer drugs doxorubicin (DOX) and
camptothecin (CT) attached to the brush backbone using a photocleavable
nitrobenzyloxycarbonyl linker. Subsequently, photolysis of the degradable linkages using
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365 nm UV light afforded rapid release of DOX and CT with 50% drug release observed
in 3.1 min and 10 min for each drug respectively. When irradiated with UV light, the
molecular brush-cancer drug conjugates were shown to have similar half-maximum
inhibitory concentrations to the free drugs whereas the PEG-based drug-bound molecular
brushes showed minimal influence on cell viability due to steric shielding of the
covalently attached anticancer drugs.

Figure 1.14. Drug-loaded, bivalent molecular brush polymers synthesized using “grafting
through” ROMP of norbornene-functional macromonomers.212
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CHAPTER II
OBJECTIVES OF RESEARCH
The original “depot” model proposed by Ringsdorf in 1975 was the first attempt
at addressing the issues of drug delivery using a single macromolecular architecture.
Initially, limitations in the available synthetic methods prevented the synthesis of well
defined polymers comprised of functionally diverse monomers and advanced
architectures such as block, star, and molecular brush copolymers. Upon the advent of
controlled/”living” polymerization techniques such as reversible-deactivation radical
polymerization (RDRP), facile preparation of (co)polymers with tailorable architectures,
predetermined molecular weights, and of narrow molecular weight distributions has made
possible the synthesis of a wide variety of interpretations of the Ringsdorf “depot” model.
However, limitations still exist regarding the facile synthesis of polymers aimed at
specifically addressing the issues of drug delivery.
The main work described in this dissertation focuses on the development of
synthetic approaches toward novel stimuli-responsive polymers and advanced polymer
architectures that specifically address the issues of in vivo drug delivery. Particular
attention is given to understanding the fundamentals of the underlying chemistry used to
synthesize the polymers discussed in this work.
The specific objectives of this research are to:
1. Synthesize a library of methacryloyl sulfonamide (MSA) monomers with pKa
values in the biologically relevant regime.
2. Develop conditions to control the RAFT polymerization of MSA monomers.
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3. Investigate the tunable pH- and CO2-responsive aqueous solution properties of
MSA RAFT polymers.
4. Investigate temperature-dependent trithiocarbonate chain-end degradation
observed during RAFT polymerization of N-arylmethacrylamides.
5. Synthesize RAFT polymer small molecule analogs by single monomer unit
insertion in order to study the byproducts of trithiocarbonate degradation.
6. Use in situ 1H NMR analysis to study the mechanism of N-arylmethacrylamide
promoted trithiocarbonate chain-end degradation.
7. Develop complimentary mechanistic and kinetic models to explain the observed
effects of N-arylmethacrylamide substitution on amide nucleophilicity.
8. Systematically investigate the effects of nucleophilic catalyst, reducing agent, and
solvent on “one-pot” aminolysis/thiol-maleimide end-group functionalization of
RAFT polymers.
9. Identify and prevent detrimental nucleophile-promoted thiol-maleimide side
reactions.
10. Elucidate the mechanism(s) of base catalyzed maelimide polymerization initiated
by thiols and thiol-maleimide adducts.
11. Optimize “one-pot” aminolysis/thiol-maleimide end-group functionalization
reaction conditions to afford selective and quantitative end group
functionalization efficiency of RAFT polymers with N-substituted maleimides.
12. Synthesize thiol-reactive maleimide- and methanethiosulfonate-functional
oxanorbornenes.
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13. Synthesize -oxanorbornenyl macromonomers by end-group modification of
RAFT polymers with thiol-reactive oxanorbornenes.
14. Develop polymerization conditions for the controlled ROMP of RAFT-polymer
derived macromonomers.
15. Demonstrate reduction-induced disassembly of disulfide-containing molecular
brushes.
The work addressing these objectives is divided into four main sections. The first
section is concerned with the synthesis of a novel class of tunable pH-responsive
polymers by RAFT polymerization. These polymers are to be synthesized using a library
of sulfadrug-based methacryloyl sulfonamide monomers possessing pKa values in the
range of the early-to-late endosomes (pH = 5-7). Future work regarding these polymers is
aimed at developing pH-responsive endolytic polymers that could be incorporated into
polymer therapeutics to aid in endosomal escape, which is often cited as the “bottle neck”
of drug delivery.
Section 2 is concerned with investigating the poor RAFT polymerization control
of methacryloyl sulfonamide monomers despite using “standard” methacrylamide
polymerization conditions. Consequently, work in this section aims to provide an
understanding of the factors influencing RAFT agent degradation during MSA
polymerization by systematically studying the effects of methacrylamide structure and
polymerization temperature on the rates and mechanisms of RAFT polymer chain-end
degradation. In addition, on-going work regarding the development of a mechanistic and
kinetic theory aimed at explaining the unique influence of N-arylsubstitution on amide
nucleophilicity is further discussed in Appendix B.
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Control over polymer end group functionality is typically necessary when
synthesizing highly branched polymer architectures such as molecular brushes. Section 3
details the identification and prevention of deleterious side reactions that we observed
during “one-pot” aminolysis/thiol-maleimide end group functionalization reactions of
RAFT polymers. The effects of solvent, nucleophilic catalyst, reducing agent, and
reagent order of addition on RAFT polymer end-group functionalization efficiency are
investigated. Particular attention is also given to finding suitable reagents and reaction
conditions that favor quantitative end group functionlization of RAFT polymers with Nsubstituted maleimides with minimal side reactions.
Section 4 is concerned with developing a facile synthetic route towards molecular
brush copolymers derived from RAFT polymers for potential use as drug delivery
“vehicles.” This work is particularly focused on synthesizing RAFT polymer-derived
macromonomers using optimized end group functionalization techniques as discussed in
Section 3. Furthermore, this work aims to develop a facile synthetic route towards
molecular brushes capable of intracellular-induced disassembly via the incorporation of
disulfide linkages between the molecular brush backbone and side chain. Macromonomer
polymerization control by ROMP and reduction-induced molecular brush disassembly
are discussed.
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CHAPTER III
EXPERIMENTAL SECTION
Materials
Methacryloyl chloride (Aldrich, 97%), N,N-dimethylacrylamide (Aldrich, 99%),
styrene (Aldrich, 99%), aniline (Aldrich, 99%), benzylamine (Aldrich, 98%), and furan
(Aldrich, 99%) were vacuum distilled and stored under N2 at -10 °C prior to use. 4,4Azobis(4-cyanovaleric acid) and azobisisobutyronitrile (AIBN) (Aldrich, 98%) were
recrystallized from methanol and stored at -10 °C. N,N’-dimethylformamide (Acros,
extra dry w/ sieves) was stirred under vacuum at room temperature for 60 min prior to
use in order to remove traces of dimethylamine. The following were used as received: 2,
2’-Azobis(4-methoxy-2-4-dimethyl valeronitrile) (V-70) (Wako, 96%); sulfacetamide
(Aldrich, >98%); sulfamethazine (Aldrich, >99%); sulfamethizole (Aldrich, >99%);
sulfadimethoxine (Aldrich, >98.5%); sulfadoxine (Aldrich, >95%); sulfabenzamide (TCI,
>98%); trimesic acid (Aldrich, 95%); 1-dodecanethiol (Aldrich, 98%); ethane thiol
(Aldrich, 97%); carbon disulfide (Aldrich, 99.9%); 2-bromoisobutyryl bromide (TCI,
98%); triethylamine (Aldrich, 99.5%); NaH (Aldrich, 95%); maleic anhydride (Aldrich,
99%); acetic anhydride (Fisher, 99.2%); sodium acetate (Fisher, anhydrous); Nmethylmaleimide (Aldrich, 97%); ethyl 2-mercaptopropionate (Aldrich, >95%); benzyl
mercaptan (Fluka, >99%); hexylamine (Aldrich, 99%); 1,8-diazabicyclo[5.4.0]undec-7ene (DBU) (Aldrich >99.0%); triethylamine (Aldrich, >99.5%); tributylphosphine
(Aldrich, 97%); trimethylphosphite (Aldrich, >99%); 2nd generation Grubbs catalyst
(Aldrich); ethylenediamine (Aldrich > 99.5%); di-tert-butyl dicarboante (Aldrich, >
99%); maleimide (Aldrich, 99%); methylchlroformate (Aldrich, 99%); 4-
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methylmorpholine (Aldrich, redist., > 99.5%); trifluoroacetic acid (Aldrich, 99%); 3bromopropylamine hydrobromide (Aldrich, 98%); sodium methane sulfinate (Alfa Aesar,
95%); 0.1 N NaOH (Alfa Aesar, standardized); and 0.05 N HCl (Alfa Aesar,
standardized); CDCl3 (Cambridge Isotopes, 99.8%); acetone-d6 (Cambridge Isotopes,
99.9%); N, N’-dimethylformamide-d7 (Cambridge Isotope, 99.5%); dimethylsulfoxide-d6
(Cambridge Isotopes, 99.9%); acetonitrile-d3 (Cambridge Isotopes, 99.8%); methylene
chloride-d2 (Cambridge Isotopes, 99.8%); Ethanol-D (Cambridge Isotopes, D 99%, <6%
D2O); and Deuterium Oxide (Aldrich, 99.9%). All other chemicals were purchased from
Aldrich in the highest available purity and used as received.
Characterization
NMR spectra for structural analysis and monomer conversions were obtained
using a Varian INOVA 300 MHz NMR spectrometer. Polymer molecular weights and
molecular weight distributions (Mw/Mn) were determined by size exclusion
chromatography (SEC) using DMF 20 mM LiBr as the eluent at a flow rate of 1.0
mL/min in combination with two Agilent PolarGel-M columns heated to 50 °C and
connected in series with a Wyatt Optilab DSP interferometric refractometer and Wyatt
DAWN EOS multiangle laser light scattering (MALLS) detector (λ = 633 nm). Absolute
molecular weights and Mw/Mn were calculated using a Wyatt ASTRA SEC/LS software
package. The dn/dc values for each polymer derivative in the above eluent at 35 °C were
determined offline using a Wyatt Optilab DSP interferometric refractometer and Wyatt
ASTRA dn/dc software.
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Chapter IV Section 1 Experimental
Dithiobenzoic acid 21

Magnesium (1.22 g, 50.0 mmol) was washed in anhydrous diethyl ether and dried
in an oven prior to addition to a 250 mL round bottomed flask equipped with stir bar. The
flask was flame dried under vacuum and backfilled with argon followed by the addition
of anhydrous THF (25 mL). Bromobenzene (5.0 mL, 47.8 mmol) was then added
dropwise via syringe over 15 min, upon which 75 mL of THF was added and the
resulting Grignard solution transferred via cannula to a flame-dried 3-neck round
bottomed flask equipped with condenser and heated to reflux (40 °C). Carbon disulfide
(2.89 mL, 47.8 mmol) was then added dropwise over 15 min and the reaction stirred at 40
°C for an additional 2 h. Ice cold 0.5 N HCl (50 mL) was then added to the reaction
followed by removal of approximately 75% of the THF/Et2O by rotary evaporation. The
pH of the aqueous solution was then adjusted to pH < 2 with 12 N HCl and transferred to
a separatory funnel and extracted with diethyl ether (2 x 100 mL). The light pink aqueous
layer was discarded and the dark pink/red ether layer kept in the separatory funnel, to
which was added ice cold 10 wt. % NaOH (100 mL). Upon formation of distinct phases,
the aqueous layer was removed and further washed with Et2O (3 x 100 mL). The aqueous
layer was again acidified (pH < 2) with 12 N HCl and the dithiobenzoic acid extracted
into ether (2 x 100 mL) while discarding the aqueous layer. The Et2O layer was dried
over MgSO4 and the solvent removed via rotary evaporation to give 21 as a purple oil
(3.47 g, 47%).
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Bis(thiobenzoyl)disulfide 22

Dithiobenzoic acid 21 (3.47 g, 22.5 mmol) was dissolved in 2 N NaOH (150 mL)
and transferred to a 1 L round bottomed flask equipped with stir bar. A solution of
K3FeCN6 (15 g, mmol) in H2o (300 mL) was added dropwise over 1 h followed by
stirring at room temperature for an additional hour. The resulting solids were removed by
filtration and the solvent removed by rotary evaporation. 22 was further purified by
recrystallization form EtOH to give deep purple crystals (1.71 g, 57%).
4-Cyanopentanoic acid dithiobenzoate 23

A solution of bis(thiobenzoyl)disulfide 22 (1.71 g, 5.6 mmol) and 4,4’-azobis(4cyanopentanoic acid) (2.35 g, 8.4 mmol) in EtOAc (100 mL) was prepared in a 3-necked
round bottomed flask equipped with stir bar and condenser. The reaction was degassed by
purging with N2 for 40 min prior to heating to reflux (77 °C) for 18 h. The reaction was
quenched by exposure to air and freezing in liquid N2 followed by solvent removal via
rotary evaporation. The crude RAFT agent was purified by column chromatography
(59:40:1 EtOAc:hexanes:AcOH). To remove residual AcOH, column fractions containing
23 were combined and transferred to a separatory funnel and washed with 0.05 N HCl (2
x 150 mL), brine (1 x 150 mL) and dried over MgSO4 followed by solvent removal by
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rotary evaporation to give 23 as a purple solid (2.22 g, 71%). 1H NMR (300 MHz,
CDCl3): δ 7.91 (d, 2H), 7.57 (t, 1H), 7.40 (t, 2H), 2.77-2.40 (m, 4H), 1.94 (s, 3H).
Sodium ethyl trithiocarbonate 24

A suspension of NaH (2.11 g, 83.5 mmol) in anhydrous diethyl ether (150 mL)
was cooled to 0 °C using an ice bath; ethane thiol (5.73 g, 92.3 mmol) was then added
dropwise over 15 min accompanied by vigorous evolution of hydrogen gas. The reaction
was stirred for an additional 15 min at 0 °C followed by dropwise addition of CS2 (7.03g,
92.3 mmol) over 5 min and the reaction mixture stirred for an additional 60 min at room
temperature and then diluted with pentane (100 mL). The resulting yellow precipitate was
isolated by vacuum filtration before drying in-vacuo yielding 24 (12.07 g, 90%) as a
hygroscopic yellow solid. 1H NMR (300 MHz, D2O): δ 3.15 (q, 2H), 1.27 (t, 3H). 13C
NMR δ: 35.36, 12.39.
Bisethyl trithiocarbonate 25

Sodium ethyl trithiocarbonate 24 (7.74 g, 48.3 mmol) was dissolved in H2O (50
mL) in a 250 mL round bottomed flask equipped with magnetic stir bar. A solution of I2
(13.49 g, 53.1 mmol) and potassium iodide (8.82 g, 53.1 mmol) in H2O (100 mL) was
subsequently added dropwise over 30 min to the stirred solution of sodium ethyl
trithiocarbonate. The reaction mixture was stirred for an additional 60 min and
transferred to a separatory funnel and extracted with ether (3 x 75 mL). The ether layers
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were combined and washed with H2O (2 x 150 mL), 5% Na2S2O3 (2 x 150 mL) and brine
(1 x 150 mL) before drying over MgSO4 followed by solvent removal by rotary
evaporation to give 25 as a yellow oil (6.29 g, 95%). 1H NMR (300 MHz, CDCl3): δ 3.30
(q, 4H), 1.35 (t, 6H).
4-cyano-4-(ethylsulfanylthiocarbonylsulfanyl)pentanoic acid 26

A solution of bisethyl trithiocarbonate 25 (5.00 g, 18.2 mmol) and 4,4’-azobis(4cyanopentanoic acid) (7.66 g, 27.3 mmol) in EtOAc (250 mL) was prepared in a 500 mL
3-necked flask equipped with stir bar and condenser. The solution was purged with N2 for
40 min prior to heating at reflux for 18 h. The reaction was then quenched via exposure to
air and cooled to room temperature. The solvent was removed by rotary evaporation and
the crude RAFT agent purified by column chromatography (60:35:5
hexanes:EtOAc:AcOH). To remove residual AcOH, column fractions containing 26 were
combined and transferred to a separatory funnel and washed with 0.05 N HCl (2 x 150
mL), brine (1 x 150 mL) and dried over MgSO4 followed by solvent removal by rotary
evaporation to give 26 as a yellow solid (7.10 g, 74%).1H NMR (300 MHz, CDCl3): δ
3.37 (q, 2H), 2.70 (t, 2H), 2.60-2.30 (m, 2H) 1.89 (s, 3H), 1.36 (t, 3H).
General Procedure for Methacryloyl Sulfonamide Synthesis
Using a modified procedure, sulfa drug (40.0 mmol) was dissolved in 160 mL of a
1:1 (v:v) mixture of acetone and 0.5 N aqueous NaOH and stirred while cooling in an ice
bath. Methacryloyl chloride (4.10 mL, 42.0 mmol) was then added dropwise over 30 min
followed by removing the ice bath and stirring the reaction at room temperature for an
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additional 60 min. The acetone was removed by rotary evaporation, followed by
adjusting the solution to pH = 2 with 6 N HCl. The resulting solids were isolated using
vacuum filtration and washed with 100 mL of dilute HCl (0.01 N) prior to drying invacuo for 48 h, yielding the desired monomers as colorless to off-white solids. The
synthesis of methacryloyl sulfadoxine 30 required the use of 240 mL of a 1:2 (v:v)
mixture of acetone and 0.5 N aqueous NaOH.
Methacryloyl sulfacetamide 27

Yield: (10.29 g, 91%); mp 203-205 °C dec. 1H NMR (300 MHz, DMSO-d6): δ 11.99 (s,
1H), 10.20 (s, 1H), 8.11 – 7.65 (m, 4H), 5.84 (s, 1H), 5.58 (s, 1H), 1.93 (s, 3H), 1.89 (s,
3H). 13C NMR (75 MHz, DMSO-d6) δ 168.69, 167.34, 143.72, 139.99, 133.13, 128.67,
121.03, 119.50, 23.22, 18.63.
Methacryloyl sulfabenzamide 28
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Yield: (12.89 g, 94%); mp 228-229 °C dec. 1H NMR (300 MHz, DMSO-d6): δ 12.46 (s,
1H), 10.22 (s, 1H), 8.02 – 7.87 (m, 4H), 7.83 (d, J = 7.2 Hz, 2H), 7.60 (t, J = 7.4 Hz, 1H),
7.47 (t, J = 7.6 Hz, 2H), 5.84 (s, 1H), 5.58 (s, 1H), 1.93 (s, 3H). 13C NMR (75 MHz,
DMSO-d6) δ 167.36, 165.38, 143.79, 139.99, 133.24, 133.15, 131.54, 128.93, 128.61,
128.40, 121.03, 119.50, 18.62.
Methacryloyl sulfamethazine 29

Yield: (13.39 g, 97%); mp 234-235 °C dec. 1H NMR (300 MHz, DMSO-d6): δ 11.47 (s,
1H), 10.10 (s, 1H), 7.86 (dd, J = 28.3, 8.6 Hz, 4H), 6.74 (s, 1H), 5.81 (s, 1H), 5.55 (s,
1H), 2.23 (s, 6H), 1.92 (s, 3H). 13C NMR (75 MHz, DMSO) δ 167.61, 156.65, 143.19,
140.43, 135.08, 129.49, 121.24, 119.42, 113.97, 23.37, 19.04.
Methacryloyl sulfamethizole 30
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Yield: (12.42 g, 91%); mp 215-217 °C dec. 1H NMR (300 MHz, DMSO-d6): δ 13.90 (s,
1H), 10.12 (s, 1H), 7.77 (dd, J = 37.4, 8.4 Hz, 4H), 5.82 (s, 1H), 5.56 (s, 1H), 2.44 (s,
3H), 1.92 (s, 3H). 13C NMR (75 MHz, DMSO-d6) δ 167.80, 167.20, 154.46, 142.65,
140.03, 136.05, 126.71, 120.83, 119.70, 18.65, 16.10.
Methacryloyl sulfadimethoxine 31

Yield: (14.72 g, 97%); mp 216-218 °C dec. 1H NMR (300 MHz, DMSO-d6): δ 11.50 (s,
1H), 10.17 (s, 1H), 7.86 (m, 4H), 5.92 (s, 1H), 5.82 (s, 1H), 5.57 (s, 1H), 3.77 (s, 3H),
3.73 (s, 3H), 1.92 (s, 3H). 13C NMR (75 MHz, DMSO-d6) δ 171.67, 167.30, 164.26,
159.90, 143.41, 139.98, 133.68, 128.30, 120.96, 119.64, 84.57, 54.54, 53.81, 18.59.
Methacryloyl sulfadoxine 32
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Yield (14.10 g, 93%); mp 198-199 °C. 1H NMR (300 MHz, DMSO-d6): δ 11.09 (s, 1H),
10.17 (s, 1H), 8.12 (s, 1H), 5.84 (s, 1H), 5.59 (s, 1H), 3.90 (s, 3H), 3.70 (s, 3H), 1.95 (s,
3H). 13C NMR (75 MHz, DMSO-d6) δ 167.32, 161.63, 150.43, 143.14, 140.06, 134.61,
129.88, 128.61, 127.21, 120.92, 119.40, 60.28, 54.08, 18.64.
General Procedure for RAFT Polymerization of Methacryloyl Sulfonamides
Briefly, methacryloylsulfonamide (5.0 x 10-3 mol, 150 equiv), CTA (23 or 26)
(3.3 x 10-5 mol, 1 equiv), initiator (V-70 or V-501) (6.7 x 10-7 mol, 0.2 equiv), and
trimesic acid (50 mg, 1H NMR internal standard) were combined in a 10 mL graduated
cylinder and DMF added to bring the final solution volume to 5.0 mL ([M]0 = 1 M) or 6.0
mL (0.83 M) depending upon monomer solubility as indicated in Table 1. The solution
was then transferred to a 10 mL test tube equipped with a magnetic stir bar and rubber
septum followed by purging with N2 for 40 mins. An initial aliquot (200 μL) was taken
prior to heating the reaction vessel at the indicated temperature with subsequent aliquots
taken at timed intervals and analyzed by 1H NMR (DMSO-d6) to determine monomer
conversion by comparing the relative integral areas of the trimesic acid aromatic protons
(8.64 ppm, 3H) to the monomer vinyl proton (5.84 ppm, 1H). SEC-MALLS (95%
DMF/5% CH3COOH, 20 mM LiBr) was used to monitor the progression of molecular
weight and molecular weight distribution (Mw/Mn) throughout each polymerization.
Polymers isolated for solubility studies were purified by precipitating the reaction
mixture into a 10-fold excess of MeOH followed by isolating the resulting solids by
ultracentrifugation. The isolated polymers were precipitated a total of three times from
DMF into MeOH before drying overnight in-vacuo.
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Methacryloyl Sulfonamide Monomer Titrations
Monomer stock solutions (1mM) were prepared by weighing each MSA (0.1
mmol) into separate 100 mL volumetric flasks, followed by the addition of 2.00 mL of
0.1 N NaOH (0.2 mmol) to each flask. Once the monomers were completely dissolved,
DI H20 (18.2 MΩ resistance) was added to each volumetric flask to achieve a final
volume of 100 mL. Twenty-five mL of each stock solution was transferred to a 100 mL
beaker containing a stir bar and titrated against 0.05 N HCl in volume increments of 5 μL
at 25 °C using a Metrohm 848 Titrino Plus autotitrator. All titrations were performed in
triplicate.
pH-dependent Polymer Solubility
Polymer solutions were first prepared by dissolving each pMSA derivative (1 eq.
sulfonamide, 2.5 x 10-5 mol sulfonamide functional groups) in 1.00 mL 0.05 N NaOH (2
eq., 5 x 10-5 mol)) followed by dilution with DI H2O (18.2 MΩ resistance) to a final
volume of 2.50 mL ([SO2NH] = 10 mM). The polymer solution was transferred into a
quartz cuvette and the solution pH adjusted incrementally by adding 1-10 μL of 0.2 N
HCl followed by measuring the % transmittance at λ = 500 nm using a UV-Vis
spectrophotometer.
CO2-dependent Polymer Solubility
In a 20 mL vial equipped with magnetic stir bar and pierceable cap, pMSA (1 eq.
sulfonamide, 2.0 x 10-5 mol sulfonamide functional groups) was dissolved in 400 μL of
0.05 N NaOH (1.25 eq., 2.5 x 10-5 mol) and subsequently diluted to a final volume of
3.00 mL ([SO2NH] = 6.7 mM) with DI H2O (18.2 MΩ resistance). CO2-dependent
polymer solubility was examined between purge cycles by transferring the solutions to a
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quartz cuvette and measuring the percent transmittance at 500 nm. Purge cycles consisted
of purging the solution with CO2 for 10 s or N2 for 25 min.
Chapter IV Section 2 Experimental
N-Phenylmethacrylamide 33

Methacryloyl chloride (11.83 mL, 121 mmol) was added dropwise over 15 min to
a stirred solution of aniline (12.00 g, 121 mmol) and triethylamine (12.86 g, 127 mmol)
in CH2Cl2 (250 mL) that was previously cooled using an ice bath. Upon complete
addition of methacryloyl chloride, the reaction was stirred at 0 °C for 30 min followed by
stirring at room temperature for an additional 60 min. The reaction mixture was then
transferred to a separatory funnel and washed with 0.1 N HCl (1 × 200 mL), saturated
NaHCO3 (1 × 200 mL), and saturated NaCl (brine) (1 × 200 mL) before drying over
MgSO4. The solvent was removed via rotary evaporation and the isolated solids
recrystallized from hot hexanes:THF (95:5) to yield 33 (17.52 g, 90%) as colorless
needle-like crystals. mp 80-81 °C. 1H NMR (300 MHz, CDCl3): δ 7.60 (s, 1H), 7.57 (d,
2H), 7.32 (t, 2H), 7.11 (t, 1H), 5.78 (s, 1H), 5.44 (s, 1H), 2.05 (s, 3H). 13C NMR (CDCl3):
δ 166.87, 141.05, 137.95, 129.15, 124.57, 120.24, 120.04, 18.96.
N-Benzylmethacrylamide 34
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A synthetic procedure analogous to that described for 33 was used to prepare Nbenzylmethacrylamide. The product was recrystallized from hot hexanes:THF (90:10) to
yield 34 (17.88 g, 91%) as colorless needle-like crystals. mp 78-79 °C. 1H NMR (300
MHz, CDCl3): δ 7.30 (m, 5H), 6.13 (s, 1H), 5.71 (s, 1H), 5.34 (s, 1H), 4.50 (d, 2H), 1.97
(s, 3H). 13C NMR (CDCl3): δ 168.43, 140.03, 138.41, 128.87, 127.97, 127.67, 119.89,
43.86, 18.89.
Sodium dodecyl trithiocarbonate 35

1-Dodecanethiol (15.0 g, 74.1 mmol) was added dropwise over 30 min to a stirred
suspension of NaH (1.68 g, 70.0 mmol) in anhydrous diethyl ether (350 mL) resulting in
slow evolution of hydrogen gas. The reaction mixture was vented and stirred overnight
(12 h) at room temperature after which carbon disulfide (5.64 g, 74.1 mmol) was added
dropwise over 10 min, followed by stirring at room temperature for 60 min. The reaction
mixture was subsequently diluted with pentane (100 mL) and the solids isolated by
vacuum filtration and further dried in-vacuo to yield 35 (18.55 g, 83%) as a yellow solid.
1

H NMR (300 MHz, DMSO-d6): δ 2.97 (t, 2H), 1.49 (m, 2H), 1.23 (b, 18H), 0.85 (t, 3H).
C NMR (DMSO-d6): δ 31.79, 29.55, 29.51, 29.27, 29.21, 29.14, 22.59, 14.45.
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Bisdodecyl trithiocarbonate 36
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To a suspension of sodium dodecyl trithiocarbonate 35 (18.55 g, 61.7 mmol) in
diethyl ether (200 mL) at room temperature was added solid I2 (8.62 g, 34.0 mmol) over
5 min. The reaction was stirred for 60 min at room temperature followed by removal of
the precipitated NaI salts by vacuum filtration. The filtrate was transferred to a separatory
funnel and washed with 5% Na2S2O4 (1 × 150 mL), H2O (1 × 150 mL), and brine (1 ×
150 mL) before drying over MgSO4. The solvent was removed via rotary evaporation to
yield 36 (16.36 g, 96%) as a yellow oil that solidified upon cooling to -10 °C. 1H NMR
(300 MHz, CDCl3): δ 3.28 (t, 4H), 1.68 (m, 4H), 1.24 (b, 36H), 0.87 (t, 6H). 13C NMR
(CDCl3): δ 221.74, 38.52, 32.13, 29.85, 29.77, 29.64, 29.57, 29.31, 29.16, 27.57, 22.91,
14.36.
2-Cyano-2-propyl dodecyl trithiocarbonate 37

Bisdodecyl trithiocarbonate 36 (7.88 g, 14.2 mmol) and AIBN (2.33 g, 14.2
mmol) were dissolved in EtOAc (250 mL) and the solution purged with N2 for 40 min
before heating to 77 °C. After 12 h, a degassed solution of AIBN (2.33 g, 14.2 mmol) in
EtOAc (100 mL) was subsequently added and the reaction stirred for an additional 12 h
at 77 °C. Purification by column chromatography (95:5 Hexanes:EtOAc) yielded 37
(7.36 g, 75%) as a yellow oil that solidified upon cooling to 0 °C. 1H NMR (300 MHz,
CDCl3): δ 3.32 (t, 2H), 1.86 (s, 6H), 1.68 (m, 2H), 1.25 (b, 18H), 0.87 (t, 3H). 13C NMR
(CDCl3): δ 217.96, 120.66, 42.54, 37.13, 32.11, 29.82, 29.74, 29.62, 29.54, 29.27, 29.12,
27.91, 27.25, 22.90, 14.35.
2-(Ethylthiocarbonylthio)-2-methylpropionic acid 38
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Ethane thiol (12.4 g, 0.200 mol), acetone (96.4 g, 1.66 mol), and
trioctylmethylammonium chloride (aliquat 336) (3.23 g, 8.00 mmol) were charged into a
500 mL round bottomed flask equipped with magnetic stir bar and the solution cooled to
0-5 °C using an ice bath. 50 wt. % NaOH (16.8 g, 0.210 mol) was then added dropwise
over 20 min, followed by the dropwise addition of a solution of carbon disulfide (15.2 g,
0.200 mol) in acetone (20.0 g, 0.344 mol) over 20 min. The reaction mixture was stirred
at 0 °C for 20 min, upon which chloroform (35.8 g, 0.300 mol) was added in a single
portion immediately followed by the dropwise addition of 50 wt. % NaOH (80.0 g, 1.00
mol) over 30 min. The ice bath was then removed and the reaction mixture stirred
overnight (18 h) at room temperature, after which the remaining acetone was removed by
rotary evaporation. The resulting viscous residue was diluted with 250 mL H2O and
cooled with an ice bath before acidification with 12 N HCl to pH = 2. Upon acidification,
the aqueous component was transferred to a separatory funnel and extracted with hexane
(4 x 250 mL) and the aqueous layer discarded. The combined hexane layers were
subsequently washed with 0.1 N HCl (1 x 250 mL), brine (1 x 250 mL), and dried over
Na2SO4 before isolating the crude product by rotary evaporation. Purification by column
chromatography (60:38:2 Hexanes:EtOAc:AcOH, Rf = 0.33) yielded a dark yellow oil
that was further purified by recrystallization from hot hexanes to give 38 (16.01 g, 36%)
as bright yellow crystals. 1H NMR (300 MHz, CDCl3) δ 3.31, 1.73, 1.34.
2-Bromoisobutyranilide 39
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2-Bromoisobutyryl bromide (15.00 mL, 124 mmol) was added dropwise over 15
min to a stirred solution of aniline (12.03 g, 124 mmol) and triethylamine (12.28 g, 124
mmol) in CH2Cl2 (500 mL) that was previously cooled using an ice bath. Upon complete
addition of 2-bromoisobutyryl bromide, the reaction was stirred at 0 °C for 30 min
followed by stirring at room temperature for an additional 60 min. The reaction mixture
was then transferred into a separatory funnel and washed with 0.1 N HCl (1 × 400 mL),
saturated NaHCO3 (1 × 400 mL), and brine (1 × 400 mL) before drying over MgSO4 and
removal of the solvent by rotary evaporation. The isolated solids were recrystallized from
hot hexanes to yield 39 (29.13 g, 97%) as colorless needle-like crystals. mp 82-23 °C. 1H
NMR (300 MHz, CDCl3): δ 8.45 (s, 1H), 7.55 (d, 2H), 7.35 (t, 2H), 7.14 (t, 1H), 2.04 (s,
6H). 13C NMR (CDCl3): δ 170.12, 137.53, 129.24, 125.06, 120.11, 63.37, 32.75.
N-phenyl-2-(ethylsulfanylthiocarbonylsulfanyl)propanamide 40

A solution of sodium ethyl trithiocarbonate 24 (1.32 g, 8.3 mmol), 2bromoisobutyrylanilide 39 (2.00 g, 8.3 mmol), and NaI (0.124 g, 0.83 mmol) in absolute
EtOH (10 mL) was prepared and stirred at 22 °C for 48 h. The reaction mixture was then
precipitated twice into water (100 mL) and the precipitate isolated by vacuum filtration
and further purified by recrystallization from absolute EtOH resulting in large needle-like
crystals. The product, isolated by recrystallization, was determined to be 5,5-dimethyl-3-
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phenyl-2-thioxothiazolidin-4-one (40).227 Conducting the reaction at 60 °C for 12 h
allowed for isolation of 40 in higher yields for use in additional studies. mp 108-110 °C.
1

H NMR (300 MHz, CDCl3): δ 7.50 (m, 3H), 7.22 (d, 2H), 1.79 (s, 6H). 13C NMR

(CDCl3) δ 199.80, 179.64, 135.43, 129.82, 129.70, 128.54, 55.59, 27.55.
Synthesis of 41

A solution of 2-cyano-2-propyl dodecyl trithiocarbonate 37 (3.41 g, 9.9 mmol),
33 (1.59 g, 9.9 mmol), and V-70 (0.609 g, 2.0 mmol) in DMF (35 mL) was prepared in a
round bottomed flask equipped with magnetic stir bar and the reaction degassed via three
freeze-pump-thaw cycles and backfilled with argon. The reaction mixture was heated at
30 °C in an oil bath for 48 h, followed by exposure to air and freezing in liquid N2. The
reaction mixture was then diluted with EtOAc (250 mL) and transferred to a separatory
funnel and washed with 75% brine (1 × 200 mL), H2O (1 × 200 mL), brine (1 × 200 mL),
and dried over MgSO4. The crude product was then purified by column chromatography
(8:2 Hexanes:EtOAc, Rf = 0.30) yielding 41 (0.511 g, 10%) as a yellow solid. 1H NMR
(300 MHz, CDCl3): δ 8.44 (s, 1H), 7.45 (d, 2H), 7.32 (t, 2H), 7.12 (t, 1H), 3.26 (t, 2H),
2.55 (q, 2H), 2.02 (s, 3H), 1.64 (m, 2H), 1.47 (s, 3H), 1.46 (s, 3H), 1.23 (b, 18H), 0.87 (t,
3H). 13C NMR (CDCl3): δ 219.02, 169.43, 137.45, 129.02, 124.83, 120.51, 60.48, 45.13,
37.33, 31.91, 30.45, 29.62, 29.54, 29.42, 29.35, 29.10, 29.07, 28.90, 28.69, 27.62, 23.81,
22.70, 14.15.
Synthesis of 42
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A solution of 2-cyano-2-propyl dodecyl trithiocarbonate 37 (2.00 g, 5.8 mmol),
34 (1.01 g, 5.8 mmol), and AIBN (0.190 g, 1.2 mmol) in DMF (20 mL) was prepared in a
round bottomed flask equipped with magnetic stir bar and degassed via three freezepump-thaw cycles and backfilled with argon. The reaction mixture was heated at 60 °C in
an oil bath for 24 h, followed by exposure to air and freezing in liquid N2. The reaction
mixture was then diluted with EtOAc (150 mL) and transferred to a separatory funnel and
washed with 75% brine (1 × 150 mL), H2O (1 × 150 mL), brine (1 × 150 mL), and dried
over MgSO4. The crude product was first purified by column chromatography (8:2
Hexanes:EtOAc, Rf = 0.25) followed by recrystallization from MeOH:H2O (98:2) at -10
°C yielding 42 (0.475 g, 16%) as yellow crystals. 1H NMR (300 MHz, CDCl3): δ 7.31
(m, 5H), 6.79 (t, 1H), 4.42 (q, 2H), 3.25 (t, 2H), 2.56 (q, 2H), 1.96 (s, 3H), 1.64 (m, 2H),
1.47 (s, 3H), 1.45 (s, 3H), 1.27 (b, 18H), 0.89 (t, 3H). 13C NMR (CDCl3): δ 219.32,
171.33, 137.62, 128.87, 128.38, 127.84, 125.04, 60.16, 45.04, 37.28, 32.12, 30.66, 29.84,
29.76, 29.64, 29.55, 29.47, 29.29, 29.14, 28.72, 27.87, 24.16, 22.90, 14.35.
RAFT Polymerization of 33 and 34
Briefly, monomer (33 or 34) (10.0 mmol, 200 equiv), 37 (5.0 × 10-5 mol, 1 equiv),
initiator (V-70 or V501) (1.0 × 10-5 mol, 0.2 equiv), and trimesic acid (50 mg, 1H NMR
internal standard) were combined in a 10 mL graduated cylinder and DMF added to bring
the final solution volume to 5.0 mL ([M]0 = 2 M). The solution was then transferred to a
10 mL test tube equipped with a magnetic stir bar and rubber septum, degassed via three
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freeze-pump-thaw cycles, and backfilled with argon. An initial aliquot (200 μL) was
taken prior to heating the reaction vessel at the indicated temperature with subsequent
aliquots taken at timed intervals and analyzed by 1H NMR (DMSO-d6) to determine
monomer conversion by comparing the relative integral areas of the trimesic acid
aromatic protons (8.64 ppm, 3H) to the vinyl proton of 33 (5.86 ppm, 1H) or 34 (5.79
ppm, 1H). SEC-MALLS (DMF 20 mM LiBr) analysis of aliquots was used to monitor
molecular weight and molecular weight distribution progression throughout each
polymerization.
Trithiocarbonate Degradation Analysis by UV-Vis Spectroscopy
Reactions (final volume = 2500 μL) were performed using [37]0 = 5 × 10-3 M and
[M]0:[37]0:[V501]0 = 10:1:0.2 in DMF. A typical procedure was as follows: 34 (250 μL
of an 87.6 mg/mL stock soln. in DMF, 10 equiv), 37 (250 μL of a 17.3 mg/mL stock soln.
in DMF, 1 equiv), V501 (25 μL of a 28.0 mg/mL stock soln. in DMF, 0.2 equiv), and
DMF (1975 μL) were combined in a 4 mL test tube equipped with magnetic stir bar and
rubber septum. The reaction was then degassed via 4 freeze-pump-thaw cycles and
backfilled under argon. An initial aliquot (50 μL) was taken using an argon-purged gastight syringe and subsequently diluted into a quartz cuvette containing 2500 μL of
acetonitrile before measuring the absorbance at λ = 320 nm using a Lambda 35 UV-vis
spectrometer. Subsequent aliquots (50 μL) were taken and analyzed in the same manner.
In situ 1H NMR Analysis
Samples of 41 and 42 (2 × 10-2 M) in DMF-d7 were prepared immediately prior to
analysis by first adding DMF-d7 (0.60 mL) into an NMR tube equipped with pierceable
rubber septum and the solvent degassed by two freeze-pump-thaw cycles to remove
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possible traces of dimethyl amine. The appropriate amount of 41 or 42 was then added as
a solid directly into the NMR tube containing the previously degassed DMF-d7 and the
resulting solution degassed by two additional freeze-pump-thaw cycles and backfilled
with argon. 1H NMR spectra were acquired at 70 °C using a Bruker Ascend™ 600 MHz
spectrometer.
Chapter IV Section 3 Experimental
Reactions of N- and P-based Nucleophiles with N-Methylmaleimide
A solution of N-methylmaleimide (25.0 mg, 2.23 × 10-4 mol, 10 eq.) and CH2Cl2
(10 μL, 1H NMR internal standard) in DMSO-d6 (1.00 mL) was prepared in an NMR
tube in the presence of air. An initial 1H NMR spectrum was taken upon which the
appropriate nucleophile (2.23 × 10-5 mol, 1 eq.) was added to the NMR tube and the
solution mixed by inverting three times. Subsequent spectra were taken at timed intervals
and the fractional change in maleimide concentration measured by comparing the relative
integrated peak areas of the maleimide olefin protons (DMSO-d6, 7.02 ppm, 2H) to the
CH2Cl2 protons (DMSO-d6, 5.76 ppm, 2H).
Reaction of Ethyl 2-Mercaptopropionate with N-Methylmaleimide
A solution of N-methylmaleimide (25.0 mg, 2.23 × 10-4 mol, 10 eq.),
triethylamine (3.13 μL, 2.23 × 10-5 mol 1.0 eq.) and CH2Cl2 (10 μL, 1H NMR internal
standard) in DMSO-d6 (1.00 mL) was prepared in an NMR tube in the presence of air. An
initial 1H NMR spectrum was taken upon which ethyl 2-mercaptopropionate () was added
to the NMR tube and the solution mixed by inverting three times. Subsequent spectra
were taken at timed invervals and the fractional change in maleimide concentration
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measured by comparing the relative integrated peak areas of the maleimide olefin protons
(DMSO-d6, 7.02 ppm, 2H) to the CH2Cl2 protons (DMSO-d6, 5.76 ppm, 2H).
Synthesis of 3-Benzylsulfanyl-1-Methylmaleimide 43

An initially colorless solution of benzylmercaptan (2.64 g, 21.2 mmol) and Nmethylmaleimide (2.36 g, 21.2 mmol) in MeCN (50 mL) was first prepared at room
temperature followed by the addition of TEA (0.281 mL, 2.12 mmol) via syringe. The
resulting red solution was stirred at room temperature for 30 min followed by quenching
with acetic acid (1.0 mL) resulting in the solution becoming colorless. The solvent was
removed by rotary evaporation and the crude reaction mixture redissolved in diethyl ether
(100 mL) and washed with 0.1 M HCl (100 mL), H2O (100 mL), and saturated NaCl (100
mL). The product was further purified by column chromatography (65:35
hexanes:EtOAc, Rf = 0.35), yielding 43 (4.55 g, 91%) as a colorless viscous oil that
solidified into a waxy solid after 7 days; mp 47-52 °C. 1H NMR (600 MHz, DMSO-d6): δ
7.31 (m, 4H), 7.24 (m, 1H), 3.93 (dd, J = 62.3, 13.1 Hz, 2H), 3.76 (dd, J = 9.0, 3.9 Hz,
1H), 3.06 (dd, J = 18.5, 9.0 Hz, 1H), 2.78 (s, 3H), 2.45 (dd, J = 18.5, 3.9 Hz, 1H).
Reaction of 43 with N-Methylmaleimide.
A solution of N-methylmaleimide (25.0 mg, 2.23 × 10-4 mol, 10 eq.), 43 (5.29
mg, 2.23 × 10-5 mol, 1.0 eq.), and CH2Cl2 (10 μL, 1H NMR internal standard) in DMSOd6 (1.00 mL) was prepared in an NMR tube in the presence of air. An initial 1H NMR
spectrum was taken upon which TEA (3.13 μL, 2.23 × 10-5 mol, 1 eq) was added to the
NMR tube and the solution mixed by inverting three times. Subsequent spectra were
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taken at timed intervals and the fractional change in maleimide concentration measured
by comparing the relative integrated peak areas of the maleimide olefin protons (DMSOd6, 7.02 ppm, 2H) to the CH2Cl2 protons (DMSO-d6, 5.76 ppm, 2H).
Hydrogen-Deuterium Exchange Kinetics of 43
NMR Spectra were recorded with a Bruker Ascend™ 600 MHz spectrometer at
23 °C. Briefly, a solution of 7 (10.0 mg, 4.25 × 10-5, 1 eq) and D2O (100 μL, 5.54 mmol,
130 eq) in DMSO-d6 (0.600 mL) was prepared in an NMR tube in the presence of air and
an initial 1H NMR spectrum was acquired (t = 0 min). TEA (5.93 μL, 1 eq) was then
added to the NMR tube and the solution mixed by inverting three times. Subsequent
spectra were acquired at timed intervals and the fractional change in peak area (At/A0) of
protons Ha (3.80 – 3.75 ppm, 1H), Hb (3.10 – 3.00 ppm, 1H), and Hc (2.50 – 2.40 ppm,
1H) were measured relative to the peak area of the benzylsulfanyl aromatic protons (7.30
- 7.20 ppm, 5H).
2-cyano-2-propyl benzodithioate 44

A solution of bis(thiobenzoyl)disulfide 22 (1.00 g, 3.3 mmol) and AIBN (1.07 g,
6.6 mmol) in EtOAc (40 mL) was prepared in a 3-necked round bottomed flask equipped
with stir bar and condenser. The reaction was degassed by purging with N2 for 40 min
prior to heating to reflux (77 °C) for 18 h. The reaction was quenched by exposure to air
and freezing in liquid N2 followed by solvent removal via rotary evaporation. The crude
RAFT agent was purified by column chromatography (9:1 hexanes:EtOAc, Rf = 0.25) to
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give 44 as a dark red oil that solidified upon cooling to - 10 °C (0.87 g, 60%). 1H NMR
(200 MHz, CDCl3): δ 7.90 (d, 2H), 7.57 (t, 1H), 7.40 (t, 2H), 1.94 (s, 6H).
Synthesis of pDMA-CPDB 45

N,N-dimethylacrylamide (28.0 g, 282 mmol), 2-cyano-2-propyl benzodithioate 44
(298.0 mg, 1.34 mmol), AIBN (44.1 mg, 0.27 mmol), and benzene (100 mL) were
combined in a 250 mL round bottomed flask equipped with magnetic stir bar and sealed
with a rubber septum before purging with N2 for 45 mins. The reaction vessel was then
heated in an oil bath at 60 °C for 5 h, upon which the reaction was quenched via exposure
to air and freezing in liquid nitrogen. The solvent was removed by rotary evaporation and
the polymer precipitated 4 times into pentane, redissolving in a minimal amount of
CH2Cl2 between precipitations. The final product 45 was dried overnight in-vacuo before
characterizing via 1H NMR (D2O) and SEC-MALLS (DMF 20 mM LiBr). Mn(NMR) =
3220 g/mol, Mn(SEC) = 3360 g/mol, Ð = 1.06.
N-Benzylmaleimide 46

A solution of maleic anhydride (20.00 g, 204 mmoL) in anhydrous diethyl ether
(250 mL) was first prepared at room temperature in a 3-necked 1L round bottom flask
equipped with magnetic stir bar, condenser, and addition funnel. A solution of
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benzylamine (21.86 g, 204 mmol) in anhydrous diethyl ether (100 mL) was added
dropwise via addition funnel over 30 mins such that the exothermic reaction produced a
mild reflux of the solvent. The reaction mixture was stirred for 1 h at room temperature
before isolating the resulting solids by vacuum filtration followed by washing with
anhydrous diethyl ether (100 mL). The resulting N-benzylmaleamic acid intermediate
was dried in-vacuo and used without further purification (40.70 g, 97%).
N-benzylmaleamic acid (40.70 g, 198 mmol) was added as a solid to a stirred
solution of acetic anhydride (90.00 g, mmol) and anhydrous sodium acetate (13.00 g,
mmol) and the reaction heated at 100 °C for 30 min resulting in formation of a dark
brown homogenous solution. The reaction mixture was then poured into a vigorously
stirred solution of ice cold water (600 mL) and stirred for 30 min. The resulting brown
precipitate was isolated by vacuum filtration and washed with water (3 × 100 mL). The
solids were resuspended in water (500 mL) and stirred vigorously for 30 min before
isolation again by vacuum filtration. The crude compound was further purified by
recrystallization from EtOH:H2O (2:1, v:v) to afford 46 (27.02 g, 73%) as fine beige
crystals; mp 67-69 °C. 1H NMR (300 MHz, CDCl3): δ 7.22 (b, 5H), 6.64 (s, 2H), 4.61 (s,
2H). 13C NMR (CDCl3): δ 170.41, 136.17, 134.19, 128.69, 128.38, 127.86, 41.42.
Simultaneous “One-Pot” Aminolysis/Thiol-Maleimide End Group Modification of 45
with 46 (Method 1)
A representative procedure is as follows: 45 (100.0 mg, 3.10 × 10-5 mol, 1 eq) and
N-benzylmaleimide (29.0 mg, 1.55 × 10-4 mol, 5 eq) were measured into a 5 mL test tube
equipped with rubber septum and dissolved in 1.00 mL of DMSO. The reaction mixture
was degassed via three freeze-pump-thaw cycles and backfilled with argon. 100 μL of a
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solution of hexylamine in DMSO (102 μL/mL, 7.75 × 10-5 mol, 2.5 eq) and 100 μL of a
solution of DBU in DMSO (40.0 μL/mL, mol, 1 eq) were then added via gas tight syringe
and the reaction stirred for 12 h at room temperature (23 °C). End-modified pDMA was
purified by precipitation into diethyl ether (3 × 50 mL) and dried overnight in-vacuo. End
group analysis was performed using 1H NMR (D2O) by comparing the integrated peak
area of the benzyl aromatic protons (7.50 - 7.15 ppm, 5H) to the integrated peak area of
the pDMA N,N-dimethyl side chain and methyne backbone protons (3.30 – 2.20 ppm,
213.22H). NMR samples were filtered through a 0.20 μm Millex PTFE filter prior to
analysis.
Sequential “One-Pot” Aminolysis/Thiol-Maleimide End Group Modification of 45 with
46 (Method 2)
A representative procedure is as follows: 45 (100.0 mg, 3.10 × 10-5 mol, 1 eq) and
trimethylphosphite (18.3 μL, 1.55 × 10-4 mol, 5 eq) were measured into a 5 mL test tube
equipped with rubber septum and dissolved in 1.00 mL of DMSO. The reaction mixture
was degassed via three freeze-pump-thaw cycles and backfilled with argon. 100 μL of a
solution of hexylamine in DMSO (102 μL/mL, 7.75 × 10-5 mol, 2.5 eq) was then added
via gas tight syringe and the reaction stirred for 30 min at room temperature (23 °C) upon
which a previously degassed solution of 46 (29.0 mg, 1.55 × 10-4 mol, 5 eq) in DMSO
(0.5 mL) was added and the reaction stirred for 12 h at room temperature. End-modified
45 was purified by precipitation into diethyl ether (3 × 50 mL) and dried overnight invacuo. End group analysis was performed using 1H NMR (D2O) by comparing the
integrated peak area of the benzyl aromatic protons (7.50 - 7.15 ppm, 5H) to the
integrated peak area of the 45 N,N-dimethyl side chain and methyne backbone protons
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(3.30 – 2.20 ppm, 213.22H). NMR samples were filtered through a 0.20 μm Millex PTFE
filter prior to analysis.
Chapter IV Section 4 Experimental
tert-butyl 2-aminoethylcarbamate 47

To a 1 L flask equipped with a magnetic stir bar was added 1,2-diaminoethane
(7.7 mL, 114 mmol) and dichloromethane (450 mL). The solution was cooled using an
ice bath, upon which a solution of di-tert-butyl dicarbonate (5.00 g, 22.9 mmol) in
dichloromethane (50 mL) was added dropwise via addition funnel over 2 h. Following
complete addition, the ice bath was removed and the reaction stirred at room temperature
for 12 h, after which the solution was filtered of solids and the filtrate concentrated via
rotary evaporation to ~250 mL. The filtrate was then washed with half saturated brine (3
x 150 mL), brine (1 x 150 mL), dried using MgSO4, and the solvent removed via rotary
evaporation to yield the desired compound 47 as a colorless oil (3.25 g, 89%). 1H NMR
(300 MHz, CDCl3): δ 3.12 (dd, J = 11.6, 5.8 Hz, 2H), 2.75 (t, J = 5.9 Hz, 2H) 1.40 (s,
9H).
N-(methoxycarbonyl) maleimide 48

A solution of maleimide (7.00 g, 72.1 mmol) in dichloromethane (250 mL) was
prepared and cooled using an ice bath. A solution of N-methylmorpholine (7.92 mL, 72.1
mmol) in dichloromethane (50 mL) was added dropwise to the solution of maleimide
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over 10 min while stirring. Subsequently, a solution of methylchloroformate (6.69 mL,
86.5 mmol) in dichloromethane (50 mL) was added dropwise over 1 h, upon which the
ice bath was removed and the reaction stirred for 1 h at room temperature. The
heterogeneous solution was then poured into a separatory funnel and washed with 1 x 250
mL each of saturated NaHCO3, water, and brine, before drying over MgSO4. The solvent
was removed via rotary evaporation and the product further dried in vacuo to yield 48 as
an off white solid ( 10.26 g, 92%). 1H NMR (300 MHz, CDCl3): δ 6.80 (s, 2H), 3.88 (s,
3H).
tert-Butyl N-[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl]carbamate 49

A solution of 47 (3.25 g, 20.3 mmol) in saturated NaHCO3 (120 mL) was
prepared and stirred at room temperature for 10 min before vacuum filtering to remove
the resulting solids. The filtrate was subsequently cooled using an ice bath followed by
the solid addition of finely ground N-(methoxycarbonyl) maleimide 48 (3.15 g, 20.3
mmol). After 30 min, the ice bath was removed and the reaction stirred at room
temperature for an additional 30 min. The resulting precipitate was filtered, washed with
100 mL water, and dried overnight in vacuo to yield the desired compound 49 as a white
solid (3.87 g, 79%). 1H NMR (300 MHz, CDCl3): δ 6.69 (s, 2H), 3.78 – 3.53 (m, 2H),
3.31 (dd, J = 11.1, 5.8 Hz, 2H), 1.38 (s, 9H).
tert-Butyl N-{2-[(2R,6S)-3,5-dioxo-10-oxa-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl]ethyl}
carbamate 50
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A round bottomed flask equipped with a magnetic stir bar and condenser was
charged with 49 (3.87 g, 16.1 mmol), freshly distilled furan (20 mL, 275 mmol), and
benzene (80 mL) and heated to reflux for 12 h, upon which the reaction was concentrated
via rotary evaporation and further dried in vacuo resulting in isolation of 50 as a white
solid that required no further purification (4.65 g, mmol, 96%). 1H NMR (300 MHz,
CDCl3): δ 6.49 (s, 2H), 5.24 (s, 2H), 3.75 – 3.51 (m, 2H), 3.28 (dd, J = 11.1, 5.3 Hz, 2H),
2.83 (s, 2H), 1.40 (s, 9H).
2-[(2R,6S)-3,5-dioxo-10-oxa-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl]ethan-1-amonium
trifluoroacetate 51

N-bocethyl oxanorbornene 50 (4.60 g, 14.9 mmol) was dissolved in
dichloromethane (40 mL) and cooled using an ice bath. Trifluoroacetic acid (10 mL) was
then added via syringe over 10 min followed by stirring of the reaction overnight (12 h)
at room temperature. Diethyl ether (250 mL) was then added to the reaction and the
heterogeneous solution cooled using an ice bath for 30 min before isolating the resulting
precipitate by vacuum filtration. The isolated solids were further dried in vacuo, yielding
51 as a white solid (4.64 g, 97%). 1H NMR (300 MHz, D2O): δ 6.64 (s, 2H), 5.36 (s, 2H),
3.84 (t, J = 5.8 Hz, 2H), 3.23 (t, J = 5.9 Hz, 2H), 3.19 (s, 2H).
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(2R,6S)-4-[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl]-10-oxa-4
azatricyclo[5.2.1.02,6] dec-8- ene-3,5-dione 52

Oxanorbornene ethylamine TFA 51 (4.72 g, 14.6 mmol) was dissolved in
saturated NaHCO3 (200 mL) and cooled using an ice bath. The solution was stirred while
purging with N2 for 10 min at 0 °C to dispel any dissolved CO2. Subsequently, finely
ground N-(methoxycarbonyl) maleimide 48 (2.27 g, 14.6 mmol) was then added as a
solid to the solution of 51, followed by stirring for 30 min at 0 °C, upon which the ice
bath was removed and the reaction stirred for an additional 3 h at room temperature. The
resulting precipitate was isolated via vacuum filtration and the filtrand washed with water
(50 mL) before drying overnight in vacuo to yield the desired compound 52 as an offwhite solid (2.09 g, 48%). 1H NMR (300 MHz, CDCl3): δ 6.65 (s, 2H), 6.47 (d, J = 0.7
Hz, 2H), 5.19 (t, J = 0.8 Hz, 2H), 3.84 – 3.59 (m, 4H), 2.81 (s, 2H).
N-(3-bromopropyl)maleimide 53

3-Bromopropylamine hydrobromide (2.00 g, 9.1 mmol) was dissolved in
saturated NaHCO3 (100 mL) and cooled using an ice bath. The solution was allowed to
stir for 10 min at 0 °C while purging with N2 to dispel any dissolved CO2. Subsequently,
finely ground N-(methoxycarbonyl) maleimide 48 (1.42 g, 9.1 mmol) was added as a
solid to the solution of 3-bromopropylamine, followed by stirring for 30 min at 0 °C,
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upon which the ice bath was removed and the reaction stirred for an additional 1 h at
room temperature. The resulting precipitate was isolated via vacuum filtration and the
filtrand washed with water (50 mL) before drying overnight in vacuo to yield the desired
compound 53 as a white solid (1.23 g, 62%). Note: after ~1 hr, additional 53 formed in
the filtrate as colorless plate-like crystals. This additional product was isolated by
vacuum filtration followed by drying in-vacuo. 1H NMR (300 MHz, CDCl3): δ 6.70 (s,
2H), 3.65 (t, J = 6.9 Hz, 2H), 3.34 (t, J = 6.6 Hz, 2H), 2.15 (p, J = 6.7 Hz, 2H).
(2R,6S)-4-(3-bromopropyl)-10-oxa-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione 54

A round bottomed flask equipped with a magnetic stir bar and condenser was
charged with 3-bromopropyl maleimide 53 (5.16 g, 23.7 mmol), freshly distilled furan
(30 mL, 413 mmol), and benzene (150 mL) and heated to reflux for 12 h, upon which the
reaction was concentrated via rotary evaporation and further dried in vacuo resulting in
isolation of 54 as a white solid that required no further purification (6.16 g, 91%). 1H
NMR (300 MHz, CDCl3): δ 6.49 (s, 2H), 5.25 (s, 2H), 3.61 (t, J = 6.9 Hz, 2H), 3.31 (t, J
= 6.7 Hz, 2H), 2.83 (s, 2H), 2.12 (p, J = 6.8 Hz, 2H).
Sodium Methanethiosulfonate 55

Sodium methanesulfinate (5.00 g, 49 mmol) and elemental sulfur (1.57 g, 49
mmol) were combined in anhydrous methanol (500 mL) and heated to reflux. After 30
min, a homogenous solution was observed and the reaction cooled to room temperature,
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followed by solvent removal via rotary evaporation. The resulting crude solid was
triturated with absolute ethanol (2 x 30 mL) and further dried in vacuo yielding 55 as a
white crystalline solid (6.27 g, 95%) m.p. 271-272 °C (lit. 272-273 °C) 1H NMR (300
MHz, D2O): δ 3.36 (s, 3H).
(2R,6S)-4-[3-(methanesulfonylsulfanyl)propyl]-10-oxa-4-azatricyclo[5.2.1.02,6]dec-8ene-3,5-dione 56

Oxanorbornene propylbromide 54 (5.24 g, 18.3 mmol) and sodium
methanethiosulfonate 55 (3.69 g, 27.5 mmol) were dissolved in DMF (40 mL) and heated
at 50 °C for 18 h. Most of the solvent was removed via rotary evaporation and the crude
product was dissolved in EtOAc (100 mL) and washed with water (2 x 50 mL) and brine
(1 x 50 mL) before drying over MgSO4. The solvent was then removed in vacuo to yield
the product 56 as a yellow solid (5.00 g, 86%). 1H NMR (300 MHz, CDCl3): δ 6.50 (s,
2H), 5.25 (s, 2H), 3.61 (t, J = 6.5 Hz, 2H), 3.31 (s, 3H), 3.07 (t, J = 7.3 Hz, 2H), 2.84 (s,
2H), 2.15 – 1.99 (m, 2H).
Synthesis of 57

Styrene (15.00 g, 120 eq.), 44 (246.0 mg, 1 eq.), and AIBN (29.6 mg, 0.15 eq.)
were combined in a 25 mL Schlenk tube equipped with magnetic stir bar and sealed
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before degassing by three freeze-pump-thaw cycles and backfilled under argon. The
reaction vessel was then heated in an oil bath at 65 °C for 5.25 h, upon which the reaction
was quenched via exposure to air and freezing in liquid nitrogen. The polymer was
precipitated 3 times in to methanol, redissolving in a minimal amount of CH2Cl2 between
precipitations. The final product 57 was dried overnight in-vacuo before characterizing
via NMR and DMF SEC-MALLS. Mn(NMR) = 3090 g/mol, Mn(SEC) = 2980 g/mol, Ð =
1.03, dn/dc = 0.160 mL/g.
Synthesis of 58

N,N-dimethylacrylamide (28.0 g, 282 mmol), 44 (298.0 mg, 1.34 mmol), AIBN
(44.1 mg, 0.27 mmol), and benzene (100 mL) were combined in a 250 mL round
bottomed flask equipped with magnetic stir bar and sealed with a rubber septum before
purging with N2 for 45 mins. The reaction vessel was then heated in an oil bath at 60 °C
for 6 h, upon which the reaction was quenched via exposure to air and freezing in liquid
nitrogen. The solvent was removed by rotary evaporation and the polymer precipitated 4
times into pentane, redissolving in a minimal amount of CH2Cl2 between precipitations.
The final product 58 was dried overnight in-vacuo before characterizing via 1H NMR
(D2O) and SEC-MALLS (DMF 20 mM LiBr). Mn(NMR) = 3700 g/mol, Mn(SEC) = 3630
g/mol, Ð = 1.05, dn/dc = 0.086 mL/g.
End group functionalization of 57 with 52 (59)
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57 (600 mg, 1.94 × 10-4 mol, 1 eq), THF (2.00 mL) and trimethylphosphite (114.4
μL, 9.69 × 10-4 mol, 5 eq) were measured into a 10 mL test tube equipped magnetic stir
bar and sealed with a rubber septum. The reaction mixture was degassed via three freezepump-thaw cycles and backfilled with argon. Propylamine (39.9 μL, 4.85 × 10-4 mol, 2.5
eq) was then added via gas tight syringe and the reaction stirred for 60 min at room
temperature upon which a previously degassed solution of 52 (280.0 mg, 9.69 × 10-4 mol,
5 eq) in THF (4.0 mL) was added and the reaction stirred for 12 h at room temperature.
59 was purified by precipitation into MeOH (3 × 50 mL) and dried overnight in-vacuo.
End group analysis was performed using 1H NMR (acetone-d6) by comparing the
integrated peak area of the norbornene bridgehead methyne protons (5.25 – 4.95 ppm,
2H) to the integrated peak area of the polystyrene aromatic side chain protons (7.50 –
6.25 ppm, 137.92 H).
End group functionalization of 57 with 56 (60)

57 (500 mg, 1.6 × 10-4 mol, 1 eq), 56 (307 mg, 9.7 × 10-4 mol, 6 eq), and THF (2
mL) were combined in a 5 mL test tube equipped with magnetic stir bar and sealed with a
rubber septum. The reaction mixture was degassed via three freeze-pump-thaw cycles
and backfilled with argon. Propylamine (200 μL, 2.4 × 10-3 mol, 15 eq) was then added
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by gas-tight syringe and the reaction stirred for 12 h at room temperature. 60 was purified
by precipitation into MeOH (3 x 50 mL) and dried overnight in-vacuo. End group
analysis of 60 was performed in analogous fashion to that described for analysis of 58.
End group functionalization of 58 with 52 (61)

58 (500 mg, 1.35 × 10-4 mol, 1 eq), THF (2.00 mL) and trimethylphosphite (79.5
μL, 7.74 × 10-4 mol, 5 eq) were measured into a 10 mL test tube equipped magnetic stir
bar and sealed with a rubber septum. The reaction mixture was degassed via three freezepump-thaw cycles and backfilled with argon. Hexylamine (35.4 μL, 4.85 × 10-4 mol, 2.0
eq) was then added via gas tight syringe and the reaction stirred for 30 min at room
temperature upon which a previously degassed solution of 52 (194.0 mg, 7.74 × 10-4 mol,
5 eq) in THF (4.0 mL) was added and the reaction stirred for 12 h at room temperature.
The reaction mixture was then dialyzed against water (3 x 200 mL), changing the water
every hour. The aqueous solution was reclaimed from the dialysis bag and filtered
through a 0.2 uM Millipore filter and then further dialyzed against MeOH (5 x 100 mL),
changing the solvent every hour. 61 was subsequently isolated by rotary evaporation as a
colorless solid. End group analysis was performed using 1H NMR (D2O) by comparing
the integrated peak area of the norbornenyl olefin protons (6.65 – 6.55 ppm, 2H) to the
integrated peak area of the pDMA N,N-dimethyl side chain and methyne backbone
protons (3.30 – 2.20 ppm, 246.26H).
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End group functionalization of 58 with 56 (62)

58 (500 mg, 1.6 × 10-4 mol, 1 eq), 56 (307 mg, 9.7 × 10-4 mol, 6 eq), and THF (2
mL) were combined in a 5 mL test tube equipped with magnetic stir bar and sealed with a
rubber septum. The reaction mixture was degassed via three freeze-pump-thaw cycles
and backfilled with argon. Propylamine (200 μL, 2.4 × 10-3 mol, 15 eq) was then added
by gas-tight syringe and the reaction stirred for 12 h at room temperature. The reaction
mixture was then dialyzed against water (3 x 200 mL), changing the water every hour.
The aqueous solution was reclaimed from the dialysis bag and filtered through a 0.2 uM
Millipore filter and then further dialyzed against MeOH (5 x 100 mL), changing the
solvent every hour. 62 was isolated by rotary evaporation as an off-white solid. End
group analysis of 62 was performed in analogous fashion to that described for analysis of
61.

Synthesis of 3rd Generation Grubbs Catalyst 19

Grubbs 2nd generation catalyst (500 mg, 0.12 mmol) was weighed into a
scintillation vial containing a small magnetic stir bar followed by the addition of pyridine
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(0.474 mL, 5.88 mmol) in the presence of air. After 5 min, pentane (20 mL) was added to
the vial resulting in precipitation of a bright green solid. The vial was placed in the
refrigerator (5 °C) overnight upon which the green 3rd generation Grubbs catalyst 19 was
isolated by vacuum filtration and washed with pentane (20 mL) before drying in-vacuo.
19 was subsequently stored under argon in the dark at 5 °C. Yield: 400 mg, 93%.
ROMP of RAFT-Derived Macromonomers 58, 59, 60, or 61

A representative procedure is as follows: A stock solution of 19 (1 eq.) in CH2Cl2
(degassed by 4 x freeze-pump-thaw cycles and backfilled with argon) was measured into
a vial that was previously degassed with argon. A separate vial containing 59 (100.0 mg,
50 eq,) was evacuated and backfilled with argon. Degassed CH2Cl2 (200 uL) was added
to the vial of 59, upon which the solution was transferred by gas tight syrige to the vial of
19. The reaction was stirred for 6 h at room temperature before being terminated via the
addition of one drop of ethyl vinyl ether followed by precipitation in MeOH.
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CHAPTER IV
RESULTS AND DISCUSSION
Section 1. Tunable pH- and CO2-Responsive Sulfonamide-Containing
Polymers by RAFT Polymerization
Overview
Lately, extensive research efforts have been directed toward the synthesis of welldefined (co)polymers capable of rapid and reversible changes in solubility and/or
conformation in response to external stimuli including pH,144,228,229 temperature,230,231 or
ionic strength,232 among others.233–235 Of particular interest are “smart” nanocarriers for
drug and gene delivery that exploit discrete changes in physiological pH to elicit the
desired therapeutic effect.236–240 Designing such polymeric systems requires that the
morphological transitions occur over a very narrow designated pH range. Commonly, this
specificity is achieved by the selection of a monomer with a pKa at or near the target
transition pH; however, polymer design is accordingly restricted by the limited choice in
monomers and their respective pKa values. Consequently, a facile method of specifically
tuning polymer pH-responsiveness while maintaining a narrow transition range is needed.

Scheme 4.1. pH-dependent solubility of pMSAs.
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A number of attempts have been made to systematically vary the pHresponsiveness of polymers.57,241 One versatile approach towards modification of
polymer pKa was reported by Ringsdorf in seminal work in which a library of
sulfonamide-containing polymers derived from sulfa drugs was synthesized by classical
free radical or Michael-addition techniques.242 Variation of the sulfonamide R-group
afforded facile, tunable control over polymer pKa and subsequent pH-dependent
solubility (Scheme 4.1). Recently, Bae and coworkers further demonstrated this
versatility in pKa selection for a variety of polymer-based therapeutic applications.237,243–
245

However, until now the uncontrolled nature of the polymerization methods used to

prepare such polymers has limited the ability to attain well-defined polymer architectures
with the specific molecular weights and narrow molecular weight distributions required
for responsive nanotherapeutics.
Reversible-deactivation radical polymerization (RDRP) techniques such as
nitroxide-mediated polymerization (NMP), atom transfer radical polymerization (ATRP),
and reversible addition-fragmentation chain transfer (RAFT) polymerization have made
possible the synthesis of (co)polymers of a wide variety of architectures with predictable
molecular weights and narrow molecular weight distributions.76,246,247 In particular,
RAFT has been used to directly polymerize a variety of cationic, anionic, and other
functional monomers in organic or aqueous media without the necessity of protecting
group chemistries or post-polymerization modification.89,247 The facility of
polymerization and excellent functional group tolerance of RAFT polymerization have
driven our current objectives of synthesizing sulfonamide-containing polymers in a
controlled fashion.
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In this chapter we report, to our knowledge, the first controlled RAFT
polymerization of a library of methacryloyl sulfonamide (MSA) monomers possessing
pKa values in the biologically relevant regime (pH = 4.5-7.4). In this work we show that
temperature has a significant influence on the polymerization of MSAs, with lower
reaction temperatures affording improved molecular weight control and functional chain
end retention. Varying the sulfonamide R-group is shown to be an effective means of
adjusting monomer pKa and subsequently the pH-dependent solubility of the resulting
polymethacryloyl sulfonamides (pMSAs). During our study of the weakly acidic/basic
nature of the MSA derivatives chosen, we found a remarkably facile and reversible CO2induced solubility transition in aqueous solutions. The demonstrated control over RAFT
polymerization of MSAs now allows new routes for the synthesis of advanced polymer
architectures with tunable pH- and CO2-responsive properties for ultimate use in
biological and therapeutic applications.
RAFT Polymerization of Methacryloyl Sulfonamides (MSAs) at 70 °C
The MSA monomers 27-32 (R-groups shown in Scheme 4.2) were targeted for
this work based upon their respective pKa values (Table 4.3) that reside within the
biologically relevant pH range of 4.5-7.4. Utilizing a modified literature procedure,237
high monomer yields (>90%) were obtained from the reaction of methacryloyl chloride
and the appropriate sulfa drug precursor, as outlined in the experimental section.
Achieving controlled RAFT polymerization of a given monomer requires
appropriate choice of CTA and polymerization conditions. Previously, our group
successfully utilized the trithiocarbonate 4-cyano-4(ethylsulfanylthiocarbonylsulfanyl)pentanoic acid (26) and the dithioester 4-
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cyanopentanoic acid dithiobenzoate (23) to polymerize a wide variety of
(meth)acrylamide monomers in aqueous or organic media in a controlled fashion.153,248
Based on that work, we have investigated the RAFT polymerization of MSAs using 26
and 23 as outlined in Scheme 4.2. It is worth noting that although these monomers are
water soluble, polymerizations were conducted in DMF in order to avoid CTA hydrolysis
or aminolysis.119

Scheme 4.2. Synthetic pathway for the 23- or 26-mediated RAFT polymerization of
MSAs in DMF.
Initially, 26- and 23-mediated RAFT polymerizations of methacryloyl
sulfacetamide (27) were carried out at 70 °C in DMF using V-501 as the initiator at molar
ratios of [M]0:[CTA]0:[I]0 = 150:1:0.2. As illustrated in Figure 4.1, a near linear pseudofirst-order kinetic plot is observed for the polymerization of 27 with 26 at 70 °C. After an
initialization period of approximately 30 min, monomer conversion reached 81% after
600 min. The 23-mediated polymerization of 27 at 70 °C under analogous conditions was
significantly slower, reaching only 12% monomer conversion after 600 min. Retardation
in rate of dithiobenzoate-mediated polymerizations as compared to analogous reactions
mediated by trithiocarbonates has been observed previously for styrenics, acrylates, and
acrylamides with some monomers failing to polymerize in the presence of a
dithiobenzoate RAFT agent.107,249
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Figure 4.1. Kinetic plots for the 23- and 26-mediated RAFT polymerization of 27 at 70
°C in DMF ([M]0:[CTA]0:[I]0 = 150:1:0.2).
Despite near ideal linear pseudo-first-order kinetic behavior, the 26-mediated
polymerization of 27 at 70 °C produced polymers with Mw/Mn of 1.27 or higher (Table
4.1). Similarly, the polymerization of 27 with 23 yielded polymers with Mw/Mn >1.20.
The increased conversions achieved during the 26-mediated polymerization of 27
prompted our use of this CTA to polymerize each monomer derivative in order to
ascertain what influences the sulfonamide R-group might have on conversion, molar
mass, and molecular weight distribution (Table 4.1). As with the 26-mediated
polymerization of 27 at 70 °C, each substituted monomer derivative also yielded
moderately broad molecular weight distributions, typically increasing with conversion,
and indicative of limited polymerization control.
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Table 4.1
Conversion, molar mass, and molecular weight distribution data for the RAFT
polymerization of MSAs in DMF at 70 °C.a
entry

monomer

CTA

time
(min)

conv.b
(%)

[M]0
(mol/L)

Mntheoryc
(g/mol)

Mnexpd
(g/mol)

Mw/Mnd

1a

27

23

120

7

1.0

3200

4400

1.19

1b

27

23

360

10

4500

5800

1.18

1c

27

23

600

12

5400

6200

1.27

2a

27

26

120

22

9400

14 600

1.27

2b

27

26

360

67

28 500

26 400

1.41

2c

27

26

600

81

34 700

29 700

1.44

3a

28

26

120

13

7000

7400

1.27

3b

28

26

360

48

25 000

22 000

1.24

3c

28

26

600

66

34 200

28 100

1.26

4a

29

26

120

16

8800

13 900

1.22

4b

29

26

360

51

26 800

29 800

1.27

4c

29

26

600

69

36 300

35 500

1.29

5a

30

26

120

35

18 000

22 000

1.55

5b

30

26

420

79

40 600

34 900

1.78

5c

30

26

600

85

43 300

35 200

1.81

6a

31

26

120

12

6900

15 100

1.23

6b

31

26

360

47

26 800

34 600

1.20

6c

31

26

600

73

41 900

44 400

1.28

7a

32

26

120

15

8800

11 100

1.10

7b

32

26

420

62

35 500

25 900

1.45

7c

32

26

600

67

38 500

27 100

1.47

1.0

1.0

0.83

1.0

0.83

0.83
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a

Sulfonamide monomers were polymerized at 70 °C in DMF ([M] 0:[CTA]0:[I]0 = 150:1.0:0.2) using V-501 as the initiator.

b

Conversions were determined by 1H NMR (DMSO-d6) by comparing the relative integral areas of trimesic acid (internal standard)

aromatic protons (8.64 ppm, 3H) to the vinyl proton of the sulfonamide monomer (5.84 ppm, 1H). cTheoretical number average
molecular weights were calculated according to the following equation: Mn=(ρ·MWmon·[M]/[CTA]) + MWCTA where ρ is the
fractional monomer conversion, MWmon is the molecular weight of the monomer, and MWCTA is the molecular weight of the CTA.
d

As determined by SEC-MALLS (95:5 (v:v) DMF:CH3COOH 20 mM LiBr).

Chain Extension of P27 macroCTA at 70 °C
The degree of “living” chain end retention was investigated by synthesizing and
isolating a P27 macroCTA using 26 (P27-26) (Mn = 7 300 g/mol, Mw/Mn = 1.35),
followed by chain extension with 27 to yield the corresponding chain extended polymer
(P27-b-P27-26). Figure 4.2 shows the SEC traces of both the initial monomodal P27-26
macroCTA and the corresponding P27-b-P27-26 polymer after chain extension with 27.
The latter exhibits multimodality and broad molecular weight distribution, indicating
extensive loss of “living” polymer chain ends during the initial polymerization of the P27
macroCTA. Loss of “living” polymer chains is most often attributed to irreversible
radical termination, undesirable chain transfer events, or degradation of the
thiocarbonylthio chain ends. During the 23- and 26-mediated polymerizations of MSAs at
70 °C, we observed a loss of the characteristic color of 23 (pink) and 26 (yellow) after
extended polymerization times, qualitatively indicating degradation of the dithiobenzoate
and trithiocarbonate moieties, respectively.
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Figure 4.2. SEC traces of P27 macroCTA (Mn = 7300 g/mol, Mw/Mn = 1.35) and P27-bP27 after chain extension at 70 °C in DMF.
RAFT Polymerization of Methacryloyl Sulfonamides at 30 °C
Hypothesizing that a deleterious side reaction was competing with chain
extension during the CTA-mediated polymerization, we lowered the reaction
temperature. Such approaches have been previously successful in RAFT polymerizations,
yielding well-defined copolymers that maintained a high degree of chain end
functionality.158,250,251 Figure 4.3 shows the comparative SEC chromatograms of the 26mediated polymerizations of 27 at 70 °C and 30 °C under the polymerization conditions
outlined in Table 4.1. It should be noted that the 30 °C reaction utilized the low
decomposition temperature initiator 2,2’-azobis(4-methoxy-2-4-dimethyl valeronitrile)
(V-70). While both reactions produced polymers with similar number average molecular
weights, the resulting molecular weight distribution of the polymer synthesized at 30 °C
(58 % conversion, Mn = 29 700 g/mol, Mw/Mn = 1.05) was substantially lower than the
polymer prepared at 70 °C (67% conversion, Mn = 26 400 g/mol, Mw/Mn = 1.41).
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Figure 4.3. DMF SEC RI traces of P27 polymerized at 30 °C and 70 °C using V-70 and
V-501, respectively.
Figure 4.4a shows the kinetic plots for the respective 26- and 23-mediated
polymerizations of 27 at 30 °C. The former exhibited a longer pre-equilibrium
(initialization) period (~60 min) as compared to polymerization at 70 °C; however, linear
pseudo-first-order kinetic behavior was observed up to 600 min. Deviation from linearity
at longer times in this particular case is possibly due to the reduced radical flux observed
as the initiator concentration decreases substantially at prolonged reaction times, as we
have previously reported.95 Figure 4.4b shows the SEC chromatogram overlay at
specified times during the 30 °C polymerization of 27 with 26. The progression of the
polymer traces to lower elution volumes with corresponding increases in RI intensity,
without high molecular weight shouldering, is indicative of controlled polymerization
behavior and thus maintenance of thiocarbonylthio functionality. This is further indicated
by the narrow molecular weight distributions (Figure 4.4c) and linear progression of Mn
vs. monomer conversion (Figure 4.4d) observed for the 30 °C polymerization of 27.
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While Mn increases in a linear fashion during the RAFT polymerization of 27 at 30 °C,
experimentally determined molecular weights (Mnexp) are marginally higher than those
theoretically predicted (Mntheory) based upon monomer conversion. The higher than
expected molecular weights determined by MALLS directly of aliquots taken from the
polymerization could be indicative of irreversible coupling of CTA intermediate radicals
during the initialization stage.106,252,253
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Figure 4.4. a) Pseudo-first-order kinetic plots for the 26- and 23-mediated RAFT
polymerization of 27 at 30 °C in DMF ([M]0:[CTA]0:[I]0 = 150:1:0.2). b) SEC overlay
for 26-mediated polymerization of 27 at 30 °C in DMF. c) Mw/Mn versus conversion. d)
Mn versus conversion.
Table 4.2 summarizes the conversion, molar mass, and molecular weight
distribution data for the RAFT polymerization of each MSA derivative in DMF at 30 °C
using either 26 or 23 as the RAFT agent and V-70 as the initiator. Reducing the
polymerization temperature to 30 °C results in Mw/Mn values typically below 1.10 for all
monomer derivatives. Mn values determined by DMF SEC-MALLS are in reasonable
agreement with theoretical values calculated from monomer conversion; however, Mnexp
exceeds Mntheory in a similar manner to that discussed earlier. Furthermore, all
polymerizations conducted at 30 °C maintained the characteristic color of the parent
CTA, indicating limited degradation as compared to that at 70 °C.
The 23-mediated polymerization of 27 conducted at 30 °C resulted in 34%
monomer conversion after 710 min and narrow molecular weight distributions even after
1500 min of polymerization (53% conversion, Mn = 20 500 g/mol, Mw/Mn = 1.03) (Table
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4.2) with the Mn values determined by DMF SEC-MALLS agreeing well with the
theoretical values. The analogous reaction conducted at 70 °C yielded 12% monomer
conversion after 600 min and relatively broad molecular weight distributions (Mn = 6 200
g/mol, Mw/Mn = 1.27) (Table 4.1). The strikingly higher rate of polymerization observed
for the 23-mediated polymerization of 27 performed at 30 °C as compared to 70 °C is
consistent with effectively minimizing (though not completely eliminating) competing
dithioester degradation and limiting the accumulation of potentially rate-retarding
degradation byproducts.
Table 4.2
Conversion, molar mass, and molecular weight distribution data for the RAFT
polymerization of MSAs in DMF at 30 °C.a
entry

monomer

CTA

time
(min)

conv.b
(%)

[M]0
(mol/L)

Mntheoryc
(g/mol)

Mnexpd
(g/mol)

Mw/Mnd

1a

27

23

350

19

1.0

8300

9500

1.02

1b

27

23

710

34

14 700

16 700

1.01

1c

27

23

1500

53

22 700

20 500

1.03

2a

27

26

350

26

11 300

16 300

1.08

2b

27

26

710

58

24 800

29 700

1.05

2c

27

26

1500

81

34 600

37 500

1.03

3a

28

26

350

10

5600

8100

1.19

3b

28

26

710

30

15 900

14 500

1.12

3c

28

26

1500

69

36 000

28 600

1.02

4a

29

26

350

11

5700

10 300

1.12

4b

29

26

710

35

18 200

22 100

1.06

4c

29

26

1500

61

32 200

35 400

1.06

5a

30

26

240

8

4200

8100

1.16

1.0

1.0

0.83

1.0
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Table 4.2 (continued).

a

entry

monomer

CTA

time
(min)

conv.b
(%)

Mntheoryc
(g/mol)

Mnexpd
(g/mol)

Mw/Mnd

5b

30

26

360

14

7500

12 200

1.06

5c

30

26

780

54

28 200

33 200

1.05

6a

31

26

240

7

6300

10 800

1.11

6b

31

26

360

13

14 800

16 700

1.05

6c

31

26

780

44

35 500

43 800

1.04

7a

32

26

240

11

4200

8700

1.10

7b

32

26

360

26

7500

11 800

1.06

7c

32

26

780

62

25 000

30 100

1.07

[M]0
(mol/L)

0.83

0.83

Sulfonamide monomers were polymerized at 30 °C in DMF ([M] 0:[CTA]0:[I]0 = 150:1.0:0.2) using V-70 as the initiator.

b

Conversions were determined by 1H NMR (DMSO-d6) by comparing the relative integral areas of trimesic acid (internal standard)

aromatic protons (8.64 ppm, 3H) to the vinyl proton of the sulfonamide monomer (5.84 ppm, 1H). cTheoretical number average
molecular weights were calculated according to the following equation: Mn=(ρ·MWmon·[M]/[CTA]) + MWCTA where ρ is the
fractional monomer conversion, MWmon is the molecular weight of the monomer, and MWCTA is the molecular weight of the CTA.
d

As determined by SEC-MALLS (95:5 (v:v) DMF:CH3COOH 20 mM LiBr).

Chain Extension of P27macroCTA at 30 °C
To further demonstrate the controlled RAFT polymerization of MSAs at low
temperatures, a P27macroCTA was prepared at 30 °C using V-70 as the initiator and
isolated before chain extending with additional 27 at 30 °C. Figure 4.5 shows the SEC
chromatogram of the P27 macroCTA (Mn = 25 100 g/mol, Mw/Mn = 1.09) and a distinct
decrease in elution volume of the chain-extended polymer (P27-b-P27) (Mn = 49 600
g/mol, Mw/Mn = 1.07). The monomodal SEC chromatogram and absence of low
molecular weight tailing at higher elution volumes of the chain extended polymer is
additional evidence of improved chain end retention during the polymerization of MSAs
at 30 °C as compared to the analogous chain extension conducted at 70 °C (Figure 4.2).
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Figure 4.5. SEC traces of P27 macroCTA (Mn= 25 100 g/mol, Mw/Mn = 1.09) and P27b-P27 (Mn = 49 600 g/mol, Mw/Mn = 1.07) after chain extension in DMF. Both
polymerizations were conducted at 30 °C.
Methacryloyl Sulfonamide Monomer pKa Studies
MSA monomer titrations were performed to determine the pKa of each monomer
derivative after converting the respective sulfa drug precursors into the corresponding
methacrylamides. The pKa of the sulfonamide (SO2NH) group of each monomer
derivative was determined by equation 7 where pHEP1/2 is the pH corresponding to the
half equivalence point (EP1/2) of the titration curve. The volume of HCl titrant required to
reach the EP1/2 (VolEP1/2) was determined by equation 8 where VolEP is the volume of HCl
titrant required to reach the equivalence point of the titration curve, [SO2NH] is the
sulfonamide concentration, [HCl] is the concentration of HCl titrant used, and Volsol is
the initial volume of the monomer solution being titrated. Figure 4.6 shows the positions
of EP and EP1/2 on the titration curve for 27.
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𝑝𝐾𝑎 = 𝑝𝐻𝐸𝑃1/2

(7)

1 [𝑆𝑂2 𝑁𝐻]
(8)
𝑉𝑜𝑙𝑠𝑜𝑙
2 [𝐻𝐶𝑙]
Table 4.3 contains the pKa values for each monomer calculated using equation 1 along
𝑉𝑜𝑙𝐸𝑃1/2 = 𝑉𝑜𝑙𝐸𝑃 +

with the literature reported pKa values for the corresponding sulfa drug precursors. A
general trend is observed whereby the pKa of the MSA is lower than that of the sulfa drug
precursor which is consistent with the decrease in pKa observed upon acetylation of the
p-amino group of sulfa drugs.254

Figure 4.6. EP and EP1/2 locations on the titration curve of 27 (1 mM) titrated against
HCl (0.05 N) at 25 °C using a Metrohm 848 Titrino Plus autotitrator.
pH-dependent Solubility of Poly(methacryloyl sulfonamides)
The titration curves (Figure 4.7) demonstrate the facility by which the pHdependent solubility of pMSAs can be “tuned” by simply varying the sulfonamide Rgroup of the monomer. The changes in polymer solubility occur over a very narrow range
of typically 0.5 pH units. Table 4.3 summarizes the pH-dependent solubility of each
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MSA derivative. The critical onset of precipitation (pH*), is defined as the pH
corresponding to 90% light transmittance. For each of the MSA derivatives, pH* of the
polymer is greater than the pKa of the corresponding monomer. The pH* of a particular
pMSA is dependent upon the monomer pKa and the relative hydrophobicity of the
monomer derivative, both influenced by the sulfonamide R-group. The mutual influence
of these two parameters is readily apparent by comparing the pH* and pKa values for P27
and P28 (Table 4.3). While the pKa of 28 (4.51) is lower than that of 27 (4.88), the pH*
for P28 (5.3) is higher than that of P27 (5.1) due to the greater hydrophobicity of the
benzoyl R-group.
Table 4.3
MSA monomer and polymer titration data.

Mnexp
sulfadrug
Mw/Mn
(g/mol)
pKa

monomer
pKa

pH*

P27

31 400

1.04

5.38

4.88 ± 0.01

5.3

P28

27 500

1.03

4.57

4.51 ± 0.01

5.7

P29

32 000

1.05

5.29

5.19 ± 0.03

6.3

P30

24 400

1.03

6.16

5.44 ± 0.01

6.7

P31

43 800

1.04

6.70

5.75 ± 0.01

7.5

P32

34 400

1.08

7.49

7.33 ± 0.02

7.9

polymer
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Figure 4.7. Substituent effects on pH-dependent solubility transitions of sulfonamidecontaining polymers. Percent transmittance was measured using a UV-Vis
spectrophotometer (λ = 500 nm).
CO2-dependent Solubility of Poly(methacryloyl sulfonamides)
To date, CO2-responsive polymers rely almost exclusively upon protonation of
amine or amidine functional groups by carbonic acid (produced upon dissolution of CO2
in water) that alters polymer solubility and conformation in solution.235,255 However,
there are very few examples of CO2-responsive polymers based upon acidic functional
groups.256 In order for acid-functional polymers to exhibit CO2-induced changes in phase
or conformation, the pKa of the acidic functional group and more importantly the pH* of
the corresponding polymer, must be greater than the pH of the solution upon production
of carbonic acid via dissolution of CO2. Therefore, weakly acidic polyacids that exhibit
pH-responsive behaviors above pH = 4 (the pH of an aqueous solution in equilibrium
with 1 atm of CO2 at 25 °C) should also exhibit similar changes in properties upon CO2induced solution acidification.
The weakly acidic pMSA derivatives we report here exhibit pH* values above pH
= 5.0, making these ideal candidates as CO2-responsive polymers. To demonstrate the
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reversible CO2-responsiveness of pMSAs, polymethacryloyl sulfamethazine (P29) (Mn =
34 400 g/mol, Mw/Mn = 1.08) (1 eq sulfonamide functional group) was dissolved in 0.05
N NaOH (1.25 eq) and diluted with DI H2O to yield a final [SO2NH] = 6.7 mM and
[NaOH] = 8.4 mM. The solution was purged with CO2 (10 s) and then N2 (25 min) and
the % transmittance (λ = 500 nm) of the polymer solution measured before and after each
purge cycle using a UV-Vis spectrophotometer. Figure 4.8 shows % transmittance as a
function of purge cycle and illustrates the reversible CO2-triggered change in aqueous
solubility of P29.

Figure 4.8. Reversible solubility of P29 in response to presence or absence of CO2.
Solutions were purged with either CO2 for 10 s (shaded regions) or N2 for 25 min
(unshaded regions) and % transmittance measured using a UV-Vis spectrophotometer (λ
= 500 nm).
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Section 2. Mechanistic Insights into Temperature-Dependent Trithiocarbonate Chain-End
Degradation during the RAFT Polymerization of N-Arylmethacrylamides
Overview
The acknowledged utility of reversible-deactivation radical polymerization
(RDRP) is the facile synthesis of polymers with precise compositions, predetermined
molecular weights, and well-defined architectures while incorporating monomers
possessing a wide variety of functional groups.76,89,246,247 The success of any RDRP
technique depends greatly upon maintaining “living” chain end fidelity. In particular, the
reversible addition-fragmentation chain transfer (RAFT) process must retain
thiocarbonylthio end groups in order to maintain the active/dormant equilibrium
necessary for polymerization control. While thiocarbonylthio reactivity has often been
exploited as a facile means of post-polymerization end group modification of RAFT
polymers,257–263 a number of deleterious side reactions involving the thiocarbonylthio
moiety can occur including hydrolysis,119 aminolysis,95,119 thermolysis,264 oxidation,265,266
and irreversible coupling of intermediate radicals.252,267,268 It is therefore important to
fully understand the nature of any degradative reactions involving thiocarbonylthio end
groups in order to extend the current capabilities of RAFT polymerization.
Recently, we reported the RAFT polymerization of a library of pH-responsive
methacryloyl sulfonamide (MSA) monomers derived from sulfa drugs.97 Loss of chain
end functionality was observed during the polymerization of MSAs at the commonly
used temperature of 70 °C as evidenced, in part, by broad molecular weight distributions
(Mw/Mn > 1.3) and failure to successfully chain extend a poly(MSA) macro chain transfer
agent (macroCTA). However, narrow molecular weight distributions and controlled
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molecular weights were ultimately achieved by conducting the polymerizations at 30 °C.
The poor polymerization control of MSAs at 70 °C surprisingly contrasts numerous
literature reports of successful RAFT polymerizations of (meth)acrylamides in organic
and aqueous media at temperatures greater than 60 °C,91,95,100,269–271 thus prompting our
current investigation.
Since our initial report,97 we have conducted the RAFT polymerization of Nphenylmethacrylamide (33), an MSA analog lacking the sulfonamide functional group
(vide infra). Notably, the trithiocarbonate-mediated polymerization of 33 at 70 °C also
results in relatively broad molecular weight distributions (Mw/Mn = 1.30), indicating that
the sulfonamide functional group is not the primary cause for chain end degradation
during polymerization of MSAs. Previous reports regarding the atom transfer radical
polymerization (ATRP) of (meth)acrylamides attributed loss of “living” chain ends to
nucleophilic displacement of the terminal bromine by the penultimate amide unit.272–274
Similarly, oxazolone formation during peptide synthesis occurs by an amide “backbiting” reaction.275 There is also literature precedent for the effects of N-aryl substitution
on the cyclization of (thio)carbamoyl derivatives formed during sequencing of peptides
by Edman’s degradation276 as well as the cyclization of -bromobutyranilides.277 From
these observations, we have hypothesized that a similar reaction involving nucleophilic
attack on the ω-thiocarbonyl by the terminal methacrylamide unit may be responsible for
thiocarbonylthio degradation during the RAFT polymerization of Narylmethacrylamides.
In this contribution we report the influences of methacrylamide structure and
reaction temperature on trithiocarbonate degradation during the RAFT polymerization of
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N-substituted methacrylamides. A detailed study of the trithiocarbonate-mediated
polymerizations of 33 and N-benzylmethacrylamide (34) using SEC-MALLS and UV-vis
spectroscopy has now provided a clear understanding of the influence of methacrylamide
structure on CTA degradation. Furthermore, in situ 1H NMR analysis of RAFT polymer
small molecule analogs, prepared by single monomer unit insertion, affords additional
mechanistic insight into the specific degradation pathway.
33 and 34 Polymerization Kinetics
To our knowledge, there are no reports detailing the effects of N-aryl substitution
on RAFT-mediated polymerization control of (meth)acrylamides. To this end, we chose
to compare the RAFT polymerizations of 33 and 34 under analogous conditions (Scheme
4.3). 34 was chosen based upon its structural similarity to 33 while lacking direct N-aryl
substitution.

Scheme 4.3. Synthetic route for 37-mediated polymerization of 33 and 34 in DMF at 70
or 30 °C.
Table 4.4 summarizes the conversion, molar mass, and molecular weight
distribution data for the polymerizations of 33 and 34 in DMF at 70 and 30 °C, using the
RAFT agent 2-cyano-2-propyl dodecyl trithiocarbonate (37). The effect of
methacrylamide structure on polymerization control is initially apparent by comparing
the increase in molecular weight distribution of P33 (Mw/Mn = 1.30) relative to that of
P34 (Mw/Mn = 1.15) synthesized under identical reaction conditions. Limited molecular
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weight control during polymerization of 33 at 70 °C can also be seen in the Mn vs
conversion plot (Figure A1, Appendix A) which shows a decrease in Mn,exp relative to
Mn,th at higher conversions. By contrast, for the polymerization of 34 at 70 °C, Mn,exp
values mirror Mn,th values, indicating that the number of active/dormant chain ends
remain constant during polymerization (Figure A2, Appendix A).
Table 4.4
Conversion, Molar Mass, and Molecular Weight Distribution Data for the RAFT
Polymerizations of 33 and 34 in DMF at 70 and 30 °C.a
entry

monomer

temp.
(°C)

time
(min)

conv.b
(%)

Mn,thc
(g/mol)

Mn,expd
(g/mol)

Mw/Mnd

1a

33

70

240

37

12400

14800

1.09

1b

33

70

360

48

16000

17300

1.16

1c

33

70

480

55

18200

18100

1.24

1d

33

70

600

59

19500

18900

1.30

2a

34

70

240

24

8900

11700

1.06

2b

34

70

360

32

11500

13400

1.11

2c

34

70

480

37

13400

15000

1.15

2d

34

70

600

41

14600

16100

1.15

3a

33

30

300

9

3200

6000

1.07

3b

33

30

420

14

4900

7400

1.05

3c

33

30

600

23

7800

10500

1.02

3d

33

30

1380

50

16600

18800

1.02

4a

34

30

300

7

2700

3400

1.13

4b

34

30

420

10

3700

4100

1.07

4c

34

30

600

14

5100

5900

1.05

4d

34

30

1380

29

10400

11200

1.04
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a

Polymerizations were conducted at 70 or 30 °C in DMF ([M] 0:[CTA]0:[I]0 = 200:1.0:0.2) using V501 or V-70 as the initiators

respectively. bConversions were determined by 1H NMR (DMSO-d6) by comparing the relative integral areas of trimesic acid (internal
standard) aromatic protons (8.64 ppm, 3H) to the vinyl proton of 33 (5.86 ppm, 1H) or 34 (5.79 ppm, 1H). cTheoretical Mn values
were calculated according to the equation Mn,th=(ρMWmon[M]0/[CTA]0) + MWCTA where ρ is the fractional monomer conversion,
MWmon is the molecular weight of the monomer, and MWCTA is the molecular weight of the CTA. dExperimental Mn and Mw/Mn
values were determined by SEC-MALLS (DMF 20 mM LiBr).

Figure 4.9 shows the kinetic plots for the 70 °C polymerizations of 33 (black) and
34 (red); each plot shows an initialization period of approximately 30 min followed by
pseudo-first-order kinetic behavior up to 300 min with the differences in slope of the
curves indicative of the relative propagation rate coefficients (kp) for each monomer
derivative. Similar initialization periods were observed previously for the
trithiocarbonate-mediated polymerizations of N-aryl MSAs and are indicative of slow
fragmentation/reinitiation by the RAFT agent R-group.97,106 Interestingly, the first-order
kinetic plots for the homopolymerizations of 33 and 34 at 70 °C show similar minimal
decreases in slope beyond 300 min despite limited molecular weight control observed
during the same time period for the polymerization of 33. It might be expected that RAFT
agent degradation during polymerization of 33 would result in a decrease in the slope
(kp[Pn·]) of the pseudo-first-order kinetic plot due to chain transfer to thiol-containing
degradation byproducts. However, efficient chain transfer can take place without
influencing the rate of polymerization if the rate of reinitiation by thiyl radicals is greater
than the rate of propagation (i.e. kiT > kp).278 The decrease in Mn,exp relative to Mn,th
throughout the 70 °C polymerization of 33 (Figure A1, Appendix A) is evidence of an
increasing number of polymer chains resulting from efficient chain transfer.

95

Figure 4.9. Kinetic plot for the 37-mediated polymerization of 33 and 34 in DMF at 70
°C ([M]0 = 2.0 M, [M]0:[CTA]0:[I]0 = 200:1:0.2).
Recently we demonstrated that improved chain end retention and narrow
molecular weight distributions can be achieved during the RAFT polymerization of Naryl MSAs by reducing the reaction temperature.97 Likewise, as seen in Figure 4.10, the
molecular weight distribution of P33 synthesized at 30 °C (Mw/Mn = 1.02, Mn = 18800)
was markedly narrower than that of P33 synthesized under analogous conditions at 70 °C
(Mw/Mn = 1.30, Mn = 18900). Reduced polymerization temperature also afforded
improved molecular weight control during the polymerization of 33 as evidenced by the
linear progression of Mn,exp with conversion and good correlation between Mn,exp and
Mn,th values (Figure A3, Appendix A). As shown in Table 4.4, narrower molecular weight
distributions were also obtained during the polymerization of 34 at 30 °C (Mw/Mn < 1.10)
but the additional decrease was minimal due to already narrow Mw/Mn achieved during
polymerization at 70 °C.
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Figure 4.10. SEC RI chromatogram showing the effect of temperature on molecular
weight distribution for the 37-mediated RAFT polymerization of 33 at 70 and 30 °C.
The kinetic plots for the 37-mediated polymerizations of 33 and 34 at 30 °C
(Figure 4.11) exhibit initialization times of 100 min and 60 min respectively, while
demonstrating near pseudo-first-order kinetic behavior up to at least 1380 min. The
increase in initialization time with decreasing temperature for the RAFT polymerizations
of 33 and 34 is consistent with observations made by McLeary et al.106 The improved
linearity of the first-order kinetic plots is also consistent with previous low temperature
RAFT polymerizations of (meth)acrylamides and is generally attributed to increased
thiocarbonylthio chain end retention.158,250
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Figure 4.11. Kinetic plot for the 37-mediated polymerization of 33 and 34 in DMF at 30
°C ([M]0 = 2.0 M, [M]0:[CTA]0:[I]0 = 200:1:0.2).
Trithiocarbonate Degradation during the 37-mediated Polymerizations of 33 and 34
It is evident from the molecular weight data summarized in Table 4.4 that chain
end degradation is likely occurring during the 70 °C polymerization of 33. Meanwhile,
polymerization of 34 at the same temperature affords narrower molecular weight
distributions with good correlation between Mn,th and Mn,exp values. In order to ascertain
the influences of each polymerization component (i.e. solvent, monomer, and initiator) on
temperature-dependent trithiocarbonate degradation, reactions were performed in DMF
using combinations of 37, monomer (33 or 34), and initiator (V501) at relative
concentrations of [37]0:[M]0:[I]0 = 10:1.0:0.2 as illustrated in the figures of Figure 4.12.
The fractional change in total trithiocarbonate (TTC) concentration ([TTC]/[TTC]0) was
measured by comparing the absorbance (λ = 320 nm) of diluted aliquots taken at timed
intervals to that of an initial aliquot at t = 0. It is worth noting that only minimal change
in the molar extinction coefficient (ε) of 37 at λ = 320 nm occurs after covalent addition
of 33 or 34, allowing for accurate measurement of the total [TTC] during polymerization.
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Figure A5 in Appendix A shows the Beer-Lambert plots and ε values at λ = 320 nm for
37 (ε320 = 9380 M-1 cm-1) and the corresponding single monomer unit insertion (SMUI)
adducts of 37 and 33 (41) (ε320 = 9560 M-1 cm-1) and the SMUI adduct of 37 and 34 (42)
(ε320 = 10300 M-1 cm-1).
Examination of Figure 4.12a reveals no measureable influences of DMF (▼), 33
(▲), or V501 (●) independently on [TTC]/[TTC]0 at 70 °C. However, a 60 % decrease in
[TTC]/[TTC]0 is observed after 12 h when 37, 33, and V501 are combined at 70 °C (■)
such that monomer addition to 37 takes place. This result supports terminal monomer
unit-induced degradation in which the ultimate methacrylamide unit is in a favored
orientation for O-5 or N-5 nucleophilic attack on the terminal thiocarbonyl (Scheme 4.4).
In this case “5” denotes the number of atoms between the amide oxygen or nitrogen and
the thiocarbonyl carbon. By contrast, identical experiments performed with 34 showed
minimal trithiocarbonate degradation during polymerization with only a 3 % decrease in
[TTC]/[TTC]0 observed after 12 h (Figure 4.12b).
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Figure 4.12. Individual and combined influences of solvent, initiator, and monomer on
the time-dependent change in [TTC]/[TTC]0 as measured by UV-Vis spectroscopy
([M]0:[CTA]0:[I]0 = 10:1:0.2). Trithiocarbonate degradation experiments were performed
using (a) 33 or (b) 34 as the monomer.

Scheme 4.4. Proposed trithiocarbonate degradation by O-5 or N-5 nucleophilic attack by
the terminal methacrylamide unit.
Previously, we attributed the substantially improved polymerization control of
MSAs and 33 at 30 °C to increased chain end retention.97 As seen in Figure 4.13, the
effect of temperature on trithiocarbonate degradation was confirmed by measuring
[TTC]/[TTC]0 during polymerization of 33 at 30 °C under analogous conditions used for
experiments in Figure 4.12a. At 30 °C, only 8 % trithiocarbonate degradation was
observed after 720 min compared to 60 % degradation for the same time period at 70 °C.
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Figure 4.13. Trithiocarbonate degradation during the 37-mediated polymerization of 33
([M]0:[CTA]0:[I]0 = 10:1:0.2) at 70 and 30 °C using V501 and V-70 as initiators
respectively.
Small Molecule Analog Synthesis
In order to better study the mechanism and byproducts of N-arylmethacrylamidepromoted trithiocarbonate degradation, we attempted to synthesize a small molecule
analog of trithiocarbonate-terminated poly(N-phenylmethacrylamide). According to
Scheme 4.5, the desired product 40a should result from the SN1 reaction of sodium ethyl
trithiocarbonate (24) and 2-bromoisobutyrylanilide (39). Despite the reaction being
performed at room temperature (22 °C), isolation of 40a proved unsuccessful.
Recrystallization of the crude reaction mixture afforded 5,5-dimethyl-3-phenyl-2thioxothiazolidin-4-one (40), the N-5 cyclization product of 40a (Scheme 4.5). The
structure of 40 was confirmed in part by analysis of the 1H NMR spectrum (Figure 4.14)
which is absent of ethylsulfanyl –SCH2CH3 and amide -N-H 1H resonances. The 1H and
13

C chemical shifts of 40 also match those reported previously.227 1H NMR analysis of

aliquots sampled during the reaction (Scheme 4.5) showed rapid formation of 40,
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indicating that under these conditions, N-5 cyclization/elimination of the transient species
40a occurs even at temperatures below 30 °C.

Scheme 4.5. Synthetic route for small molecule analog 40a.

Figure 4.14. 1H NMR (300 MHz, CDCl3) spectrum of isolated N-5
cyclization/elimination product 40.
Small Molecule Analog Synthesis via Single Monomer Unit Insertion
Minimal degradation of 37 during the polymerization of 33 at 30 °C indicates that
covalent adducts of 33 and 37 are stable at low temperatures and can be formed by free
radical processes. Recently, single monomer unit insertion279,280 has become a facile
method for CTA synthesis, exploiting the “initialization” phenomenon previously
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described by McLeary, Klumperman, and coworkers.106 We found that the SMUI adduct
of 37 and 33 (41) could be marginally favored by stoichiometric control of monomer,
CTA, and initiator at 30 °C as outlined in Scheme 4.6. The SMUI adduct of 37 and 34
(42) was synthesized at 60 °C using AIBN as the initiator owing to the lower
nucleophilicity of the N-benzylamide at higher temperatures as previously demonstrated.
The labeled 1H NMR spectra of 41 and 42 are shown in Figures 4.15a and 4.15b
respectively.

Scheme 4.6. Synthesis of 41 and 42 by single monomer unit insertion.

Figure 4.15. 1H NMR (300 MHz, CDCl3) spectra of (a) 41 and (b) 42 SMUI adducts.
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In situ 1H NMR Analysis of 41 and 42 Degradation at 70 °C
In situ 1H NMR analysis was used to gain further insight into the mechanism and
kinetics of 41 and 42 degradation. The labeled 1H NMR spectra at select time points
during the degradation analysis of 41 at 70 °C in DMF-d7 are shown in Figure 4.16. After
5 min, only the 1H resonances 41 are observed. Subsequently, new signals in the aromatic
(7.4-7.7 ppm) and aliphatic (1.5-2.7 ppm) regions corresponding to degradation
byproducts appear and increase in intensity with time. Comparison of the 1H NMR
chemical shifts of the degradation byproducts (Figure 4.16) with those of 1-dodecanethiol
and 5,5-dimethyl-3-phenyl-2-thioxothiazolidin-4-one (40) (Figures A6, A7 and A8,
Appendix A) indicates that the byproducts of 41 degradation are those formed
exclusively by N-5 cyclization/elimination. Labeled resonances corresponding to N-5
cyclization/elimination degradation byproducts are given prime designation in the NMR
spectrum (Figure 4.16) obtained at 491 min.

Figure 4.16. 1H NMR (600 MHz, DMF-d7) overlay following the time-dependent
degradation of 41 at 70 °C.

104
Degradation of 42 at 70 °C (Figure 4.17) was also monitored using in situ 1H
NMR analysis. After 491 min, minimal degradation was observed as shown in the
expanded regions of the 1H NMR spectrum in Figure 4.17 corresponding to the 3-benzyl2-thioxothiazolidin-4-one methylene (peak i’) and the cyclized benzylmethacrylamide
methyl (peak e’). Also visible is the characteristic methylene of 1-dodecanethiol (peak d’)
which is additional evidence of degradation by N-5 cyclization/elimination.

Figure 4.17. 1H NMR (600 MHz, DMF-d7) overlay following the time-dependent
degradation of 42 at 70 °C.
Kinetic analysis of 41 degradation also provides additional evidence for exclusive
N-5 cyclization/elimination. As shown in Scheme 4.7, intramolecular N-5 nucleophilic
attack of the trithiocarbonate by adjacent methacrylamide can occur by either
cyclization/elimination (pathway A) or rearrangement (pathway B) depending upon
which C-S bond is cleaved. The total rate of degradation of 41 by pathways A and B is
equal to the rate of change in area of the phenyl 1H resonances (Figure 4.16, peaks i, j,
and k) as N-5 nucleophilic attack results in loss of the N-phenylamide. The exclusive rate
of N-5 cyclization/elimination (pathway A) is equal to the rate of change in area of the –

105
CH2-S- 1H resonance (Figure 4.16, peak d) as elimination of 1-dodecanethiol occurs. As
shown in Figure 4.18a, the fractional changes in area (At/A0) of peaks i (7.70 ppm) and d
(3.39 ppm) are essentially identical throughout the 491 min experiment indicating that
pathway A is responsible for the degradation of 41 at 70 °C.

Scheme 4.7. Possible N-5 nucleophilic attack degradation pathways.
Kinetic analysis of 42 degradation (Figure 4.18b) additionally supports the
proposed degradation pathway of N-5 cyclization/elimination as shown by the
comparable change in At/A0 of peaks i (4.42 ppm) and d (3.37 ppm) (Peak assignments in
Figure 4.17).
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Figure 4.18. Time-dependent fractional change in the area of select 1H chemical shifts
during the degradation of (a) 41 and (b) 42 in DMF-d7 at 70 °C.
As seen in Figure 4.19, excellent agreement is observed between the timedependent fractional changes in [TTC] measured during the 37-mediated polymerizations
of 33 and 34 by UV-Vis spectroscopy (open data points) and during 41 and 42
degradation measured by in situ 1H NMR analysis (solid data points). The half lives (t1/2)
of 41 and 42 at 70 °C in DMF were calculated to be t1/2 = 7.18 h and t1/2 = 78.5 h
respectively based upon the degradation rates measured using 1H NMR.
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Figure 4.19. Time-dependent change in [TTC]/[TTC]0 at 70 °C in DMF as measured by
UV-vis spectroscopy during polymerization (open circles) and as measured by in situ 1H
NMR during SMUI adduct degradation analysis (closed circles).
It is important to note that while we have determined that significant
trithiocarbonate degradation occurs by N-5 cyclization/elimination during the RAFT
polymerization of 33 at 70 °C, this work does not specifically address the influence of Nphenyl substitution on increased amide nucleophilicity and how this affects the observed
reaction mechanism. We are currently examining the influences of N-aryl substitution on
both reaction mechanism and rate of N-5 cyclization/elimination and will report this in a
future manuscript.
Influence of 3-phenyl-2-thioxothiazolidin-4-one Chain Ends on the RAFT Polymerization
of 33
Typically, RAFT agent degradation during polymerization results in the loss of
active thiocabonylthio chain ends affording “dead” polymer chains that can no longer
participate in the RAFT process. However, we have shown that trithiocarbonate
degradation by N-5 cyclization/elimination during the polymerization 33 results in
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formation of a new cyclic thiocarbonylthio end group. To date, there are few examples of
RAFT polymerizations mediated by cyclic thiocarbonylthio compounds.281–283 However,
Zhan and coworkers recently reported the RAFT polymerization of vinyl acetate using 40
as the RAFT agent, which resulted in incorporation of thiocarbonylthio functionality into
the polymer backbone.227 Similarly, it is plausible that the 3-phenyl-2-thioxothiazolidin4-one chain ends formed as a result of N-5 cyclization/elimination could participate
during the RAFT polymerization of 33 as shown in Scheme 4.8.

Scheme 4.8. Proposed mechanism for radical addition to 3-phenyl-2-thioxothiazolidin-4one chain ends during RAFT polymerization of 33 at 70 °C.
We investigated the possibility of 3-phenyl-2-thioxothiazolidin-4-one chain ends
participating in the RAFT process by conducting the polymerization of 33 at 70 °C in the
presence of 40, a small molecule analogue of N-5 cyclized poly(Nphenylmethacrylamide) chain ends. Figure 4.20a shows the kinetic plot for the 40mediated polymerization of 33 in DMF at 70 °C. Linear pseudo-first-order kinetic
behavior was observed up to 140 min with no initialization period. By contrast, the 37mediated polymerization of 33 under identical conditions exhibited a 30 min initialization
period, consistent with similar results first reported by Klumperman and coworkers.106
While the linear pseudo-first-order kinetic behavior indicates a constant kp[Pn·], the SEC
RI overlay shown in Figure 4.20b demonstrates that molecular weight control is not
achieved during the 40-mediated polymerization of 33 at 70 °C. The intensities of the
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SEC RI chromatograms shown in Figure 4.20b increase with conversion but the
unchanging peak elution volumes, which occur at the exclusion limit of the SEC system
(~11.0 mL), are representative of uncontrolled polymerization behavior where Mn does
not scale linearly with monomer conversion. While the polymers presented in Figure
4.20b were too large to characterize by our SEC-MALLS system, it is worth noting that a
polyvinylpyridine standard of Mn = 475,000 g/mol (Mw/Mn = 1.06) elutes at a volume of
11.5 mL. These results suggest that 3-phenyl-2-thioxothiazolidin-4-one-terminated
polymers do not participate in the normal CTA-mediated RAFT polymerization of 33 at
70 °C.
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Figure 4.20. (a) Kinetic plot and (b) SEC RI chromatogram overlay for the 40-mediated
polymerization of 33 in DMF at 70 °C ([33]0 = 2.0 M, [33]0:[40]0:[V501]0 = 200:1.0:0.2).
Section 3. “One-Pot” Aminolysis/Thiol-Maleimide End Group Functionalization of
RAFT Polymers: Identifying and Preventing Michael Addition Side Reactions
Overview
Reversible addition-fragmentation chain transfer (RAFT) polymerization has
made possible the synthesis of functionally-diverse polymers with predetermined
molecular weights and low dispersities (Ð) using a wide variety of monomer types and
polymerization conditions (e.g. aqueous and organic media).89,284,285 The versatility of
RAFT in synthesizing tailor-made polymers also stems from the fidelity by which
polymer end-functionality can be controlled. Such end-functionalized polymers have
been used to prepare advanced macromolecular architectures including block
copolymers,286 star copolymers,287 molecular brushes,202,213 and polymer
bioconjugates.172,288 Telechelic RAFT polymers can be synthesized directly by
controlling the RAFT agent R- and Z-group functionality263 or by post-polymerization
end group modification.289–291 The latter approach often exploits the inherent reactivity of
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the residual thiocarbonylthio moiety present on RAFT polymers, allowing for
simultaneous removal and replacement of the unstable RAFT agent with a benign or
functional end group.
In recent years, reduction or aminolysis of thiocarbonylthio-terminated RAFT
polymers to the corresponding polymeric thiol has afforded a myriad of thiol “click” end
group functionalization routes including thiol-isocyanate,292 thiol-epoxy,293 thiolhalogen,294 thiol-disulfide,295,296 and thiol-ene reactions.257,258,262,297–299 Particularly
advantageous are thiol-maleimide Michael addition reactions which proceed to near
quantitative conversions at room temperature in the presence of oxygen and water and
typically occur much more rapidly than analogous thiol-acrylate or thiol-acrylamide
reactions.260,300–305 Furthermore, thiol-maleimide end group modification of RAFT
polymers can be performed as “one-pot” reactions without isolation of the intermediate
polymeric thiol (Scheme 4.9).

Scheme 4.9. “One-pot” aminolysis/thiol-maleimide end group functionalization of RAFT
polymers.
To ensure quantitative polymer end group functionalization, an excess of
maleimide relative to polymeric thiol is required. It is therefore desirable to optimize the
reaction conditions to favor rapid and efficient polymer conjugation with minimal excess
of maleimide, especially when using costly biologic, therapeutic, or diagnostic agents.
One potential way to maximize end group functionalization efficiency while minimizing
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the required excess of maleimide is through the use of nucleophilic catalysts. ThiolMichael addition reactions typically employ a base catalyst (e.g. tertiary amine) to
generate the nucleophilic thiolate species.305 However, nucleophilic catalysts such as
phosphines, amines, and amidines have been used to initiate Michael addition reactions
and can increase reaction rates of these reactions by several orders of magnitude
compared to analogous base-catalyzed reactions.300,306–312 The proposed mechanism of
nucleophile-initiated thiol-maleimide Michael addition is illustrated in Scheme 4.10.312
Rather than direct deprotonation of thiol, conjugate addition of the nucleophile to the
maleimide double bond 60 forms the zwitterionic enolate 61, which in turn functions as a
strong base (pKa ≈ 25) capable of generating the nucleophilic thiolate species while also
forming a nucleophile-succinimide byproduct 62. In this regard, the nucleophile does not
function as a catalyst which would be regenerated during each catalytic cycle, but rather
serves as an initiator that generates the steady state enolate/thiolate concentration
necessary for the thiol-ene chain transfer mechanism to operate. Subsequent propagation
occurs by thiolate addition to maleimide forming the corresponding enolate 63, which
abstracts a proton from thiol, regenerating the thiolate along with the desired thiolmaleimide Michael addition product 64.

Scheme 4.10. Mechanism of nucleophile-initiated thiol-maleimide Michael addition.
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Recently, while investigating the use of nucleophilic initiators to improve the
efficiency of RAFT polymer end group functionalization with N-substituted maleimides,
we discovered that in certain instances, nucleophilic initiators reduced the degree of end
group functionalization compared to reactions performed using only a base catalyst.
Reagent order of addition and solvent-type were also determined to have marked effects
on end group functionalization efficiency (vide infra). These observations have prompted
this study aimed at understanding the influences of nucleophile type, solvent, and
reaction conditions on the efficacy of “one-pot” aminolysis/thiol-maleimide end group
functionalization of RAFT polymers. Furthermore, the results discussed herein offer
mechanistic insights into potentially detrimental side reactions that can occur during
thiol-maleimide Michael addition reactions.
Nucleophile-Promoted Michael Addition Side Reactions
Preliminary efforts in our lab to catalyze the “one-pot” aminolysis/thiolmaleimide end group modification of acrylamido RAFT polymers in DMSO using the
amidine 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) resulted in i) low end group
functionalization efficiencies compared to reactions performed in the absence of DBU, ii)
quantitative maleimide consumption, and iii) the formation of high molecular weight
impurities observable by SEC-MALLS. From these observations we hypothesize that a
low polymeric thiol concentration relative to maleimide concentration in the presence of
a strong nucleophile (DBU), results in anionic propagation of maleimide occuring faster
than the desired thiol-maleimide Michael addition. It is also possible that other
nucleophiles (e.g. amines and phosphines) commonly used during “one-pot”
aminolysis/thiol-maleimide modification of RAFT polymers could promote similar side
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reactions. Azechi et al. showed that 1°, 2°, and 3° amines can initiate the anionic
polymerization of N-substituted maleimides in highly polar aprotic solvents (DMSO and
DMF) whereas no polymerization was observed in less polar solvents (THF).313 Also,
phosphines have been used as initiators for the anionic polymerizations of methylene
malonic esters,314 cyanoacrylates,315 and N-substituted maleimides.316 It is therefore
plausible that during “one-pot” aminolysis/thiol-maleimide modification of RAFT
polymers, amine- and phosphine-initiated polymerization of maleimide could also
outcompete the desired thiol-maleimide Michael reaction and account for the poor end
group functionalization efficiencies observed under certain reaction conditions.
Reaction of N- and P-Based Nucleophiles with N-Methylmaleimide
A number of nucleophile types including amines (aminolysis), phosphines
(reducing agent), and amidines (nucleophilic initiator) can be present during “one-pot”
aminolysis/thiol-maleimide end group reactions of RAFT polymers. Accordingly, we
chose to first investigate the effect of solvent on the reactions of representative N- and Pbased nucleophiles with N-methylmaleimide (65) in the absence of thiol as outlined in
Figure 4.21. A stoichiometric excess of maleimide relative to nucleophile ([Nu]0:[Mal]0 =
1.0:10) was chosen to reflect the relative concentrations of these reagents used during
“one-pot” RAFT polymer aminolysis/thiol-maleimide reactions and to make apparent
whether or not maleimide polymerization is occurring. In situ 1H NMR analysis was used
to monitor the time-dependent fractional change in maleimide concentration
([Mal]/[Mal]0) by comparing the area of the maleimide olefin peak to the peak area of an
internal standard (CH2Cl2).
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Figure 4.21. Effect of solvent on the time-dependent fractional change in [Mal]/[Mal]0
upon reaction of 65 with representative nucleophiles a) hexylamine (HexAM), b) 1,8diazabicyclo[5.4.0]undec-7-ene (DBU), c) tributylphosphine (TBP), and d)
trimethylphosphite (TMP) as measured by in situ 1H NMR analysis.
Figure 4.21a shows the time-dependent [Mal]/[Mal]0 plots for the reactions of
hexylamine (HexAM) with 65 in different solvents with the dashed line ([Mal]/[Mal]0 =
0.9) representing the theoretical decrease in [Mal]/[Mal]0 predicted for the reaction of
HexAM and 65 via single aza-Michael addition. Reactions conducted in MeCN, EtOH,
and CH2Cl2 show decreases in [Mal]/[Mal]0 to a value of 0.9, beyond which no change in
[Mal]/[Mal]0 is observed up to 12 h, indicating exclusive aza-Michael addition takes
place in these solvents. Conversely, reaction of HexAM with 65 in DMSO results in rapid
maleimide consumption, corresponding to 7.5 maleimides consumed on average per
amine within the first 3 min. Subsequently, no change in [Mal]/[Mal]0 is observed up to
12 h. These results are consistent with those reported by Azechi et al.313 and confirm that
HexAM can initiate the anionic polymerization of 65 in polar solvents such as DMSO
whereas exclusive aza-Michael addition takes place in less polar solvents. Furthermore,
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the effect of solvent polarity on the reaction of HexAM with 65 is readily observed in
Figure 4.21a by noting the increase in reaction rate with increasing solvent polarity in the
order of CH2Cl2 (ε = 8.93) < EtOH (ε = 24.5) < MeCN (ε = 37.5) < DMSO (ε = 46.7).
The time-dependent [Mal]/[Mal]0 plots for the reactions of DBU and 65 are
shown in Figure 4.21b. Reaction rate increases with increasing solvent polarity with 100
% 65 conversion reached in < 10 min in DMSO. Quantitative consumption of 65 was
also observed for reactions performed in EtOH and MeCN while 71% maleimide
conversion was measured in CH2Cl2 after 12 h. Interestingly, the kinetic plots in Figure
4.21b do not rapidly reach a constant value of [Mal]/[Mal]0 as was observed during the
reaction of HexAM and 65 in Figure 4.21a. Unlike protic nucleophiles (e.g. 1°, 2°
amines, and thiols), aprotic nucleophiles such as DBU cannot undergo complete Michael
addition due to the lack of a transferable hydrogen from the nucleophile. Therefore, if an
active hydrogen-containing compound (e.g. thiol) is in low concentration or completely
absent, the nucleophile-derived zwitterionic enolate 61 can undergo reaction with
additional maleimide without enolate termination by proton transfer, allowing for a
“living-like” polymerization process to occur. Noteworthy is that precipitation was
observed during the reaction of DBU and 65 in CH2Cl2 after ~30 min. Limited solubility
of the propagating macro zwitterionic enolate in CH2Cl2 likely prevents the propagating
chain-end from reacting with 65 in solution, accounting for the non-quantitative
maleimide conversion obtained in this solvent. Nonetheless, these results indicate that
DBU-initiated polymerization of 65 occurs rapidly and extensively in both polar and
nonpolar solvents.
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Similarly, the aprotic nucleophile tributylphosphine (TBP) was shown to initiate
polymerization of 65 in all solvents tested (Figure 4.21c). Reaction rates increase with
solvent polarity with 95% maleimide conversion reached within 2.5 min in DMSO.
Precipitation was also observed during reactions performed in EtOH and CH2Cl2 after ~5
min following the addition of TBP. Poor solubility of the propagating phosphonium
zwitterionic enolate is again a likely explanation for the non-quantitative maleimide
conversions achieved in EtOH and CH2Cl2 during the time frame of these kinetic
experiments.
From these results it is apparent that maleimide polymerization initiated by DBU
or TBP is unavoidable, even in low polarity solvents. While DBU is optional during
“one-pot” aminolysis/thiol-maleimide modification of RAFT polymers, mild reducing
agents such as phosphines are generally required to prevent disulfide formation from
occurring between polymeric thiols during the RAFT agent aminolysis step.258,301
Initially, we explored triphenylphoshine as a more sterically hindered, and therefore less
nucleophilic phosphine, but maleimide polymerization was again observed in each of the
four solvents tested in this work (data not shown). Recently, Ho et al. reported on
trialkylphosphites as cheaper and less toxic alternatives to trialkylphosphines as reducing
agents during “one-pot” RAFT polymer aminolysis/thiol-ene reactions.317
Trialkylphosphites can undergo conjugate addition to electron deficient olefins but are
less nucleophilic than phosphines and typically require elevated temperatures (100 °C)
for reaction to take place.318,319 As seen in Figure 4.21d, the reaction of
trimethylphosphite (TMP) with 65 results in no measureable change in [Mal]/[Mal]0 in
MeCN, EtOH, and CH2Cl2. Only after prolonged reaction times (12 h) in DMSO is a 65
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% decrease in [Mal]/[Mal]0 observed. Consequently, TMP is a suitable alternative to
phosphines as a reducing agent during thiol-maleimide reactions when used in less polar
solvents. It should also be noted that trace amounts of water must be present for
trialkylphosphite (and phosphine) reduction of disulfides to occur.320 Therefore, rigorous
anhydrous conditions should be avoided during RAFT polymer aminolysis when using
trialkylphosphites as reducing agents.

Scheme 4.11. Proposed mechanisms of initiation, propagation, and termination for the
nucleophile-initiated anionic polymerization of N-substituted maleimides.
The proposed mechanisms of initiation, propagation, and termination for the
anionic polymerization of N-substituted maleimides initiated by protic or aprotic
nucleophiles are illustrated in Scheme 4.11. Conjugate addition of the nucleophile to the
maleimide double bond to form the zwitterionic enolate 61 in identical fashion to first
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step of nucleophile-initiated thiol-maleimide reactions. However, if the thiol
concentration is suitably low relative to maleimde concentration ([Mal] > [thiol]),
propagation can occur faster than proton transfer to the enolate 61, resulting in the
formation of the propagating macrozwitterionic species 66. For maleimide
polymerization initiated by protic nucleophiles (e.g. 1° or 2° amines), termination can
occur by proton transfer from the nucleophile to afford a terminated chain 67a.
Conversely, aprotic nucleophiles do not posess a transferable proton and consequently
can not under go “long range” Michael addition. However, termination by nucleophilic
displacement of the positively charged nucleophilic residue (66d) by the enolate terminus
of an adjacent chain (66c) could result in regeneration of the nucleophile while also
producing a new macrozwitterionic polymer chain (67cd) equal in mass to the sum of 66c
and 66d. These differences in termination mechanisms adequately describe the continued
decrease in [Mal]/[Mal]0 observed during reaction of aprotic nucleophiles with 65
whereas reaction of a protic nucleophile (HexAM) rapidly reach a constant value of
[Mal]/[Mal]0 owing to termination by proton transfer. Additional evidence of termination
by nucleophilic displacement was also obtained by noting that the solution viscosity of
the reaction of 65 with DBU continues to increase for several days after complete
maleimide consumption, eventually leading to complete vitrification. This continued
increase in solution viscosity would be expected if the macrozwitterions formed from the
reaction of DBU and 65 were functioning as macro A-B monomers capable of continued
step-growth polymerization resulting in a continued increase in molecular weight.
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Reaction of Thiols with N-Methylmaleimide (65)
It is evident from the kinetic plots shown in Figure 4.21 that strong N- and Pbased nucleophiles can react with maleimides to form either the Michael addition product
or polymaleimide depending upon the nucleophile type (protic or aprotic) and solvent
polarity. Therefore, it is plausible that other strong nucleophiles such as thiolates can
initiate the anionic polymerization of maleimides in polar solvents. To this end, we chose
to investigate the reaction of ethyl 2-mercaptopropionate (E2MP) with 65 under
conditions identical to those outlined in Figure 4.21, except with the addition of TEA to
generate the nucleophilic thiolate species. E2MP was chosen as a model thiol due to its
structural similarity to the polymeric thiol that would be produced upon aminolysis of a
polyacrylate RAFT polymer.

Figure 4.22. Effect of solvent on the time-dependent fractional change in [Mal]/[Mal]0
during the TEA-catalyzed reaction of E2MP with 65 as measured by in situ 1H NMR
analysis.
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As shown in Figure 4.22, only the reaction of E2MP and 65 in CH2Cl2 gives the
change in [Mal]/[Mal]0 expected for exclusive thiol-maleimide Michael addition
([Mal]/[Mal]0 = 0.9, dashed line). Meanwhile, the reactions conducted in more polar
solvents (DMSO, EtOH, and MeCN) show a continued decrease in [Mal]/[Mal]0 up to 12
h, with 100% maleimide conversion reached in 90 min in DMSO. Initially, we
anticipated the kinetic profiles for the reactions of E2MP and 65 (Figure 4.22) to rapidly
reach a constant [Mal]/[Mal]0 value due to rapid enolate termination by means of proton
transfer, as previously observed for the reactions of HexAM and 65 (Figure 4.21a).
However, a continued decrease in [Mal]/[Mal]0 up to 12 h is evidence of either slow
reaction of thiol or an additional reaction pathway.
Closer inspection of the kinetic profiles for reactions conducted in EtOH and
MeCN reveals an inflection point at the first time point (2.5 min) when [Mal]/[Mal]0 ≈
0.9, indicating that thiol-maleimide Michael addition likely occurs faster than subsequent
maleimide propagation in these solvents. Furthermore, in situ 1H NMR indicated 100%
thiol conversion prior to the first time point (2.5 min) for reactions conducted in DMSO,
MeCN, and CH2Cl2 (Figures A9-A11, Appendix A) whereas thiol conversion could not
be measured for the reaction performed in EtOH-d6 due to deuterium exchange between
the solvent and thiol proton. Quantitative thiol consumption early in each reaction
requires that proton transfer from thiol to enolate also occurs rapidly. Therefore, the
continued decrease in [Mal]/[Mal]0 observed at longer reaction times in more polar
solvents is not likely attributable to slow reaction of thiol and is suggestive of an alternate
maleimide reaction pathway.
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One plausible explanation for the continued decrease in [Mal]/[Mal]0 at longer
reaction times is TEA-initiated maleimide polymerization. The time-dependent change in
[Mal]/[Mal]0 plots (Figure A12, Appendix A) for the reactions of TEA with 65 in DMSO
and EtOH show a decrease in [Mal]/[Mal]0 of 0.07 and 0.04 respectively after 12 h.
Meanwhile, no change in [Mal]/[Mal]0 was observed in MeCN and CH2Cl2 after 12 h.
Accordingly, TEA-initiated maleimide polymerization is insufficient to account for the
significant decrease in [Mal]/[Mal]0 that occurs within the same time period during the
reactions of E2MP with 65 in these solvents.
Another potential explanation for the continued decrease in [Mal]/[Mal]0
observed in the kinetic plots of Figure 4.22 involves deprotonation of the thiol-maleimide
Michael adduct by TEA to regenerate the nucleophilic enolate species. Initially, this
seems unlikely since the pKa of TEA (10.75) is much lower than that of most
succinimide-derived enolates (~25). However, enolate formation of 2-aminosuccinimide
residues in peptides has been shown to occur under mildly basic conditions in aqueous
media (pH = 7.4), indicating that heteroatom-substitution of the succinimide -carbon
can reduce enolate pKa compared to unsubstituted succinimides.321
To test whether thiol-maleimide Michael addition products are capable of
reinitiating maleimide polymerization in the presence of TEA, the Michael adduct of
benzyl mercaptan and N-methylmaleimide (43) was synthesized and purified by column
chromatography. The Michael adduct of E2MP and 65 was not synthesized due to
potential complications arising from the presence of chemically distinct diastereomers
and the complexity in identifying the 1H NMR chemical shifts of the resulting four
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stereoisomers. Meanwhile, the synthesis of 43 from benzyl mercaptan and 65 affords a
racemic mixture of chemically indistinct enantiomers.

Figure 4.23. Effect of solvent on the time-dependent fractional change in [Mal]/[Mal]0
during the TEA-catalyzed reaction of 43 with 65 as measured by in situ 1H NMR
analysis.
Figure 4.23 shows that [Mal]/[Mal]0 decreases with time during the TEAcatalyzed reactions of 43 and 65 in DMSO, EtOH, and MeCN whereas no change in
[Mal]/[Mal]0 is observed in CH2Cl2 up to 12 h. The kinetic profiles obtained in each
solvent for the reactions of 43 and 65 in Figure 4.23 accurately reflect the kinetic profiles
observed below [Mal]/[Mal]0 = 0.9 (dashed line) for the analogous reactions of E2MP
and 65 shown in Figure 4.22. This is not a surprising result since the dashed line in
Figure 4.22 represents the change in [Mal]/[Mal]0 predicted for formation of the thiolmaleimide Michael adduct. Any decrease in [Mal]/[Ma]0 below a value of 0.9 in Figure
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4.22 would presumably occur as a result of TEA-promoted regeneration of the
nucleophilic enolate species and therefore resemble the kinetic profiles in Figure 4.23.
Also worth noting is that TEA has little influence on the time-dependent
[Mal]/[Mal]0 plots for the reaction of HexAM and 65 in DMSO as shown in Figure A13
in Appendix A. This indicates that the amine-maleimide adduct is not capable of
reinitiation of maleimide polymerization under these reaction conditions and that
reinitiation is likely unique to thiol-maleimide adducts.

Figure 4.24. a) Time-dependent fractional change in peak area (At/A0) for protons Ha, Hb,
and Hc during TEA-catalyzed H-D exchange of 43 in DMSO. b) 1H NMR spectral
overlay of select time points during H-D exchange experiments with 43.
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We next sought to provide direct evidence that TEA is a strong enough base to
generate the enolate of 43 in polar solvents. To this end, we used in situ 1H NMR analysis
to measure the relative rates of hydrogen-deuterium exchange (H-D) of 43 in a
DMSO/D2O mixture in the presence of TEA. Figure 4.24a shows the time-dependent
fractional change in peak area (At/A0) for the three chemically distinct protons of 43
which could be abstracted by TEA to form an enolate on either the -carbon (Ha) or the
-carbon (Hb and Hc) relative to the benzylsulfanyl group. For simplicity, only the
structure of the S enantiomer is shown in Figure 4.24a, whereas 43 is actually comprised
of a racemic mixture of enantiomers. The kinetic plot of Figure 4.24a reveals that H-D
exchange was only observed for proton Ha with a 97% decrease in At/A0 occurring by 35
min. Sigma withdrawing effects by the adjacent thioether are most likely responsible for
the increased acidity of Ha, leading to exclusive enolate formation at the -carbon. Figure
4.24b shows the 1H NMR spectral overlay of select time points during the H-D exchange
experiments with 43. The peak corresponding to Ha decreases in area with time while
maintaining the doublet of doublets (dd) splitting pattern that arises from spin-spin
coupling with Hb and Hc. Meanwhile, the peaks corresponding to the geminal protons Hb
and Hc do not change in area, but rather show changes in splitting pattern from dd to d as
spin-spin coupling of Hb and Hc with Ha are diminished through deuterium exchange.
Also apparent in Figure 4.24b is the significant downfield chemical shift of Ha (3.78
ppm) relative to Hb (3.07 ppm) and Hc (2.46 ppm) that arises from the deshielding (sigma
withdrawing) effects of the benzylsulfanyl group.
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Scheme 4.12. Proposed reaction pathways for the TEA-catalyzed thiol-maleimide
reaction in which reversible enolate formation is operational.
Scheme 4.12 shows the proposed reaction pathways for the TEA-catalyzed thiolmaleimide reaction when a stoichiometric excess of maleimide relative to thiol is
employed in polar solvents. Thiolate addition to maleimide forms the -enolate 63 which
can either abstract a proton from thiol or +NH(Et)3 to give the thiol-maleimide adduct 64,
or react directly with maleimide to form the propagating species 68 when conditions
favor propagation over termination (i.e. [Mal]>>[thiol]). Deprotonation of 64 by TEA
forms the -enolate 69 which can reversibly terminate by proton transfer or react with
maleimide to form the propagating species 70. The propagating species 68 and 70 derived
from - and -enolates respectively can continue to react with maleimide until
termination occurs by proton transfer. Also, the termination products of 68 can in theory
reinitiate maleimide polymerization by -enolate formation. These additional reaction
pathways can account for the continued decrease in [Mal]/[Mal]0 following initial
formation of the thiol-maleimide Michael adduct for the TEA-catalyzed reactions of
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E2MP with 65 shown in Figures 4.23. It should also be noted that exclusive enolate
formation at the -carbon rules out the possibility of TEA-catalyzed -elimination (retro
Michael addition) as a means of regenerating the nucleophilic thiolate species after
formation of the thiol-maleimide Michael adduct.
“One-pot” Aminolysis/Thiol-Maleimide End Group Functionalization of RAFT
Polymers
It is apparent that many of the reagents (e.g. amines and phosphines) commonly
used during “one-pot” RAFT polymer aminolysis/thiol-maleimide reactions can react
with maleimides to form polymaleimide or Michael addition byproducts and potentially
outcompete the desired polymeric thiol-maleimide Michael reaction. Also, we have
shown that intermediate strength bases such as TEA can deprotonate thiol-maleimide
Michael adducts in polar solvents to form a nucleophilic -enolate capable of subsequent
reaction with maleimide. However, the effects of these side reactions on RAFT polymer
end group functionalization efficiency are not yet well understood. Also not well
understood is the influence of aminolysis method on end group functionalization
efficiency. The simplest method involves simultaneous aminolysis of the RAFT polymer
in the presence of maleimide and does not require the use of a reducing agent to prevent
disulfide formation. However, the competing amine-maleimide aza-Michael addition
could prevent quantitative RAFT agent aminolysis and subsequently reduce the degree of
end group functionalization. Alternatively, the sequential method allows for complete
aminolysis of the RAFT agent to occur prior to the addition of maleimide in a second
step. This route limits side reactions between the amine and maleimide but necessitates
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the use of a reducing agent to prevent polymeric disulfide formation from occurring
during the aminolysis stage.

Scheme 4.13. “One-pot” aminolysis/thiol-maleimide modification of 45 with 46.
To investigate the effects of solvent, catalyst, reducing agent, and aminolysis
method on RAFT polymer end group functionalization efficiency, we first synthesized
the water soluble polymer poly(N,N-dimethylacrylamide) (45) using the RAFT agent 2cyano-2-propyl benzodithioate (44). Low dispersities (Ð = 1.06) and excellent agreement
between the number average molecular weights determined by size exclusion
chromatography (Mn(SEC) = 3360 g/mol) and by 1H NMR (Mn(NMR) = 3220 g/mol) are
evident of a controlled polymerization and high dithiobenzoate chain-end fidelity. “Onepot” reactions of 45 with N-benzylmaleimide (46) were conducted at room temperature
for 12 h using the initial molar ratios of [45]0:[HexAM]0:[46]0 = 1.0:2.5:5.0 as outlined in
Scheme 4.13. End group analysis by 1H NMR was performed in D2O by comparing the
integrated peak area of the benzyl aromatic protons (7.50 – 7.15 ppm) to the known
integrated peak area of the N,N-dimethyl side chain and methyne backbone protons (3.30
– 2.20 ppm) of 45 (Figures A14-A15, Appendix A). The poor solubility of 46 and its
nucleophile-initiated byproducts (i.e. poly(46)) in D2O allows for accurate quantification
of only 46 that is covalently attached to 45.
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Table 4.5
“One-pot” aminolysis/thiol-maleimide reactions of 45 with 46.a

a

entry

methodb

solvent

catalyst/
red agent

funct.e
(%)

CTAf
(%)

colorg
(12 h)

1a

1

CH2Cl2

DBUc

93

0

R

1b

1

MeCN

DBU

37

0

R

1c

1

EtOH

DBU

25

15

R

1d

1

DMSO

DBU

0

0

R

2a

1

CH2Cl2

-

89

0

Y

2b

1

MeCN

-

81

3

O

2c

1

EtOH

-

8

90

O

2d

1

DMSO

-

31

46

R

3a

2

CH2Cl2

-

95

0

Y

3b

2

MeCN

-

95

0

R

3c

2

EtOH

-

84

0

Y

3d

2

DMSO

-

72

0

R

4a

2

CH2Cl2

TBPd

89

0

R

4b

2

MeCN

TBP

86

0

R

4c

2

EtOH

TBP

84

0

R

4d

2

DMSO

TBP

72

0

R

5a

2

CH2Cl2

TMPd

98

0

Y

5b

2

MeCN

TMP

99

0

Y

5c

2

EtOH

TMP

86

0

Y

5d

2

DMSO

TMP

89

0

Y

[45]0:[HexAM]0:[46]0 = 1.0:2.5:5.0. bMethod 1: simultaneous aminolysis/thiol-maleimide; Method 2: sequential aminolysis/thiol-

maleimide. c[45]0:[DBU]0 = 1.0:1.0. d[45]0:[TBP or TMP]0 = 1.0:5.0. ePercent end group functionalization of 45 with 46 as measured
by 1H NMR. fPercent CTA remaining after reaction of 45 with 46 as measured by 1H NMR. gReaction color after 12 h: red (R), orange
(O), or yellow (Y).
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Table 4.5 summarizes the results of the “one-pot” aminolysis/thiol-maleimide
reactions of 45 with 46 with the last column indicating the color exhibited by each
reaction after 12 h. Entries 1a-d reflect our initial attempts to catalyze thiol-maleimide
end group functionalization reactions with DBU as a catalyst and were performed using
the simultaneous aminolysis method (method 1). A distinct trend of decreasing end group
functionalization efficiency with increasing solvent polarity was observed with 0%
functionalization achieved in DMSO. These results are relatable to the trend observed for
the reactions of DBU and 65 shown in Figure 4.21b, where the rate of DBU-initiated
maleimide polymerization increases with solvent polarity. From these results, we
conclude that in polar solvents, DBU-initiated maleimide polymerization is outcompeting
the desired polymeric thiol-maleimide reaction.
Table 4.5 entries 2a-d show the effect of simultaneous aminolysis/thiol-maleimide
Michael addition in the absence of DBU on end group functionalization efficiency.
Incomplete aminolysis was observed in all solvents except CH2Cl2 (2a) with reactions
performed in DMSO (2d) and EtOH (2c) retaining 46% and 90% respectively of the
original dithiobenzoate functionality. Accordingly, only 31% and 8% end group
functionalization was observed in DMSO EtOH respectively. These results show that the
amine-maleimide aza-Michael addition can occur faster than CTA aminolysis in more
polar solvents and are consistent with the effect of solvent polarity on the reaction rates
of HexAM with 65 shown in Figure 1a.
The reactions performed in Table 4.5 entries 3a-d were identical to those
performed in entries 2a-d except the HexAM was allowed to react with 45 for 30 min
prior to the addition of 46 (Method 2). CTA aminolysis was qualitatively confirmed to
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occur within 30 min by noting the change in color that takes place as the dithiobenzoate
end groups (orange) are aminolyzed to the corresponding N-hexylthiobenzamide
(yellow). Entries 3a-d show that 100% CTA aminolysis was acheived in all solvents
while end group functionalization efficiencies were significantly improved compared to
reactions conducted using the simultaneous aminolysis method (entries 2a-2d). High end
group functionalization (95%) was achieved in the less polar aprotic solvents CH2Cl2 (3a)
and MeCN (3b) while moderate degrees of functionalization were obtained in EtOH
(84%, 3c) and DMSO (72%, 3d). While these results are promising, it is well known that
disulfide coupling of polymeric thiols can occur during CTA aminolysis, resulting in both
reduced end group functionalization efficiencies and high molecular weight impurities,
thus necessitating the use of a reducing agent.258
Table 4.5 entries 4a-d show the use of TBP as a reducing agent results in
decreased end group functionalization efficiencies for reactions performed in CH2Cl2 (4a)
and MeCN (4b) compared to analogous reactions conducted without TBP (entries 3a and
3b respectively). Meanwhile, no effect of TBP was observed on the functionalization
efficiencies of reactions performed in EtOH and DMSO (entries 4c and 4d respectively).
From these results and the kinetic plots in Figure 4.21c, we conclude that
trialkylphosphines are not suitable reducing agents during thiol-maleimide end group
modification of RAFT polymers due to competing phosphine-initiated maleimide
polymerization. Alternatively, using the less nucleophilic TMP as a reducing agent
affords substantially increased degrees of end group functionalization in all solvents as
seen in Table 4.5 entries 5a-d with 98% and 99% end group functionalization acheived in
CH2Cl2 (5a) and MeCN (5b) respectively.
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Stoichiometric Considerations
Efficient and quantitative end group functionalization of RAFT polymers using
aminolysis/thiol-maleimide chemistry also requires consideration of the reactant feed
ratios. Ideally, minimal excess of maleimide should be used relative to polymeric thiol to
limit the waste of potentially costly maleimide compounds. However, inevitable side
reactions such as amine-maleimide aza-Michael addition must be taken into account
when choosing reactant stoichiometry such that [Mal]0 > [PnSH] + [amine]; [PnSH] and
[amine] are the polymeric thiol and unreacted amine concentrations respectively after
complete RAFT agent aminolysis has occurred. In this work, we found that aminolysis of
45 with HexAM using a molar ratio of [45]0:[HexAM]0 = 1.0:2.5 results in complete loss
of dithiobenzoate end groups within 30 min. However, other work conducted by our
group (not reported herein) has shown that dithiobenzoate-functional polystyrene
synthesized by RAFT requires several hours for complete aminolysis to occur using the
same dithiobenzoate to amine ratio. Therefore, the reactant feed ratios reported herein
should be considered as a starting point for stoichiometric optimization of different
RAFT polymer systems.
The type of RAFT agent being aminolyzed must also be considered when
choosing reactant stoichiometry. Dithiobenzoate-terminated polymers react with one
equivalent of amine to yield polymeric thiol and thiobenzamide byproducts in equimolar
amounts. Conversely, trithiocarbonate-terminated polymers can react with two
equivalents of amine to give the polymeric thiol, Z-group derived thiol, and thiourea
byproduct in equimolar amounts. In this case, the reactant stoichiometry must allow for
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[Mal]0 > [PnSH] + [amine] + [ZSH] where [ZSH] is the concentration of small molecule
Z-group derived thiol.
Section 4. Growth-Then-Coupling Method of Molecular Brush Synthesis from RAFT
Polymers and Thiol-Reactive Oxanorbornenes
Overview
In recent years, extensive efforts have been made towards developing synthetic
methodologies to prepare functionally diverse and structurally complex molecular brush
copolymers. Molecular brush or “bottle-brush” copolymers are comprised of polymeric
side-chains attached to a polymer backbone and exhibit highly branched spherical or
cylindrical morphologies with minimal intermolecular chain entanglement owing to the
volume-exclusion interactions between sterically crowded polymeric side-chains.322
Consequently, molecular brush (co)polymers have been used as polymer
nanotherapeutics,212 rheological modifiers,323 surfactants,324 and as discrete
nanostructures.325 The increased interest in molecular brushes has driven current efforts
towards developing facile and versatile synthetic routes.
Molecular brush copolymers can be synthesized using grafting-to, grafting-from,
grafting-through, or more recently by transfer-to routes.322,326 Of these approaches,
grafting-through ensures the highest grafting density with 100% of polymer backbone
repeat units bearing a polymeric side-chain. Lately, the strong thermodynamic driving
force of ring opening metathesis polymerization (ROMP) of norbornene-functional
macromonomers (MMs) has been demonstrated as an effective method of overcoming
the issues of steric hindrance and low concentration of polymerizable end groups
typically associated with grafting-through synthetic approaches.202,211
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Norbornene-functional macromonomers can be synthesized using either “directgrowth” (DG-MM) or “growth-then-coupling” (GC-MM) methods as reviewed recently
by Xia and coworkers.218 DG-MM synthesis has been accomplished using norbornenefunctional initiators during ring opening polymerization (ROP)189 and atom transfer
radical polymerization (ATRP).211 In addition, norbornene-functional chain transfer
agents have been used to prepare macromonomers using RAFT polymerization.201,212,213
Synthesizing MMs by RAFT is particularly advantageous due to the wide variety of vinyl
monomers available and ease of controlling end-group functionality. However, DG-MM
synthesis by RDRP techniques such as RAFT requires polymerization optimization for a
given monomer-type to minimize radical addition to the norbornene olefin during
polymerization.214 Furthermore Xia and coworkers have demonstrated that trace amounts
of difunctional macromonomer impurities resulting from radical-radical coupling of αnorbornene-functional polymers can result in undesired molecular brush branching and
broadened molecular weight distributions.218 Consequently, facile and efficient GC-MM
synthetic routes are desired.
New Synthetic Route Toward Norbornene-Functional RAFT Polymer Macromonomers
We envisioned a GC-MM synthetic route that exploits the latent reactivity of
thiocarbonylthio-terminated RAFT polymers. In Chapter IV Section III we demonstrated
the efficient and quantitative end group functionalization of RAFT polymers using “onepot” aminolysis/thiol-maleimide chemistry. Accordingly, norbornene end-functional
RAFT polymers should be accessible using thiocarbonylthio end-functional RAFT
polymers and a maleimide-functional oxanorbornene (52) as illustrated in Scheme 4.14.
Furthermore, it should be possible to end-functionalize RAFT polymers using a
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methanethiosulfonate (MTS)-functional oxanorbornene (56) to give the corresponding
disulfide-containing macromonomer. Molecular brushes comprised of side chains
attached by disulfide linkages are of particular interest for drug delivery applications
where selective intracellular reduction of disulfides would trigger molecular brush
disassembly and favor polymer clearance in vivo.

Scheme 4.14. “One-pot” end group functionalization of RAFT polymers with thiolreactive oxanorbornenes 52 and 56.
Synthesis of Thiol-Reactive oxaNorbornenes.
Maleimide-functional (52) and MTS-functional (56) oxanorborne derivatives
were synthesized according to Schemes 4.15 and 4.16 respectively. Substituted
oxanorbornedicarboximides are readily synthesized from the Diels-Alder reaction of
furan and N-substituted maleimides. However, subsequent chemical reactions of
oxanorbornene intermediates must be conducted at temperatures below 100 °C in order to
avoid the furan-maleimide retro Diels-Alder reaction.327 Consequently, low temperature
imide forming reactions were utilized for the synthesis of 52 and 56. Using the method
developed by Keller and Rudinger,328 reaction of N-methoxycarbonylmaleimide (48)
with primary amines in saturated NaHCO3 at 0-23 °C affords the corresponding Nsubstituted maleimides which precipitated out of the aqueous reaction mixture in
moderate to high yields and required no additional purification.
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Reaction of sodium methanethiosulfonate (55) with primary bromide-functional
oxanorbornenedicarboximide (54) affords in good yield the MTS-functional product 56.
In contrast to symmetric disulfides which undergo thiol-disulfide exchange to form a
mixture of mixed and homo disulfide products, reaction of MTS activated disulfides with
thiols gives exclusively the mixed disulfide owing to the excellent leaving group ability
and poor nucleophilicity of the methanesulfinic acid group. Consequently, this selectivity
has been extensively used to prepared disulfide end-functional RAFT polymers.296

Scheme 4.15. Synthetic route for 52.

Scheme 4.16. Synthetic route for 56.
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“One-pot” Synthesis of RAFT Polymer Macromonomers from Thiol-Reactive
oxaNorbornenes
We first synthesized dithiobenzoate-terminated poly(styrene) (57) and poly(N,Ndimethylacrylamide) (58) as representative RAFT polymers for end group
functionalization with thiol-reactive oxanorbornenes. Low dispersities and excellent
agreement between the molecular weights determined by NMR and SEC-MALLS for 57
(Mn(NMR) = 3090 g/mol, Mn(SEC) = 2980 g/mol, Ð = 1.03) and 58 (Mn(NMR) = 3710
g/mol, Mn(SEC) = 3630 g/mol, Ð = 1.05) are indicative of controlled RAFT
polymerization and high dithiobenzoate chain end fidelity.
The work in Chapter IV Section III of this dissertation shows that quantitative end
group functionalization of RAFT polymers using “one-pot” aminolysis/thiol-maleimide
chemistry is attainable using sequential aminolysis/maleimide addition, less polar
solvents (e.g. CH2Cl2), and mild reducing agents (e.g. trimethylphosphite) while avoiding
the use of aprotic nucleophilic catalysts such as amidines and phosphines. Similar
reaction conditions were used for the reactions of 57 or 58 with 52 as outlined in the
experimental section. Figure 4.25 shows the 1H NMR spectra of 57 before end group
modification (Figure 4.25c) and after reaction with 52 (Figure 4.25b). Complete
aminoylsis of the dithiobenzoate end groups of 57 is observed by noting the
disappearance of the aromatic protons at 8.0 – 7.3 ppm (Figure 4.25b). Ultimately, 98%
end functionalization of 57 is achieved with the characteristic oxanorbornene peaks a, b,
and c visible in Figure 4.25b. Similarly, reaction of the RAFT polymer 58 with 52 results
in complete dithiobenzoate aminolysis and near-quantitative (>99%) end group
functionalization efficiency as determined by 1H NMR (Figure 4.26). Minimal change in
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Mn(SEC) and Ð of end-modified polymers (59 and 61) compared to the starting RAFT
polymers (57 and 58) indicates little or no polymeric disulfide coupling (Table 4.6).

Figure 4.25. 1H NMR (300 MHz, acetone-d6) end group analysis of 57, 59, and 60.


Figure 4.26. 1H NMR (300 MHz, D2O) end group analysis of 58, 61, and 62.
End group functionalization of RAFT polymers 57 or 58 with 56 were also
performed as “one-pot” reactions. RAFT polymer aminolysis was conducted in the
presence of 56 using relative ratios of [57/58]0:[56]0:[amine]0 = 1.0:6.0:10. 1H NMR end
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group analysis of 56-modified RAFT polymers (60 and 62 respectively) confirms
quantitative aminolysis of dithiobenzoate end groups along with the appearance of the
characteristic oxanorbornene peaks. Reactions of 57 or 58 with 62 afforded moderately
high end group functionalization efficiencies (95% and 94% respectively) with no
significant change in Mn or Ð compared to the parent RAFT polymers indicating little or
no polymeric disulfide coupling (Table 4.6).
Table 4.6
Summary of end group functionalization of RAFT polymers 57 and 58 with thiol-reactive
oxanorbornenes 52a and 56.b
Mn(NMR)c
(g/mol)

entry

RAFT
polymer

1 (59)

57

3090

2 (60)

57

3 (61)
4 (62)
a

Mn(SEC)d
(g/mol)

funct.e Mn(SEC)f
(%)
(g/mol)

Ðd

norb.
deriv.

2980

1.03

52

98

3290 1.06

3090

2980

1.03

56

96

3360 1.05

58

3710

3630

1.05

52

>99

3950 1.07

58

3710

3630

1.05

56

94

3930 1.05

Ðf

[57/58]0:[52]0:[amine]0 = 1.0:5.0:2.5. b[57/58]0:[56]0:[amine]0 = 1.0:6.0:10. c Mn(NMR) was determined by comparing the integral

area of the dithibenzoate aromatic protons (5H) to either the aromatic protons of 57 or the N,N-dimethyl and methyne protons of 58.
Theoretical Mn values were calculated according to the equation Mn,th=(ρMWmon[M]0/[CTA]0) + MWCTA where ρ is the fractional

c

monomer conversion, MWmon is the molecular weight of the monomer, and MWCTA is the molecular weight of the CTA. dMn(SEC)
and Ð values of 57 and 58 were determined by SEC-MALLS (DMF 20 mM LiBr). eDetermined by 1H NMR. fMn(SEC) and Ð values
measured after end group modification.

Ring Opening Metathesis Polymerization of oxaNorbornene End-Functional RAFT
Polymers
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Scheme 4.17. ROMP of -oxanorbornenyl-functionalized macromonomers (59–62) into
the corresponding molecular brushes (P59–P62).
The -oxanorbornenyl-functionalized macromonomers (59-62) were next
polymerized by ROMP using the 3rd Generation Grubbs catalyst (19) (Scheme 4.17).
Polymerizations were conducted in CH2Cl2 using stoichiometric ratios of [MM]0:[19]0 =
50:1.0 and allowed to proceed for 6 h prior to termination via the addition of ethyl vinyl
ether. SEC-MALLS analysis of aliquots taken during preliminary experiments confirmed
that all reactions reached maximal MM conversion within 6 h. Figure 4.27a shows the RI
traces for dithiobenzoate-terminated poly(styrene) RAFT polymer before (57) and after
(59) end-functionalization with 52. 91% MM conversion was reached during the ROMP
of 59, affording the corresponding molecular brush (P59) of low dispersity and with
reasonable agreement between Mnth and Mnexp (Mnexp = 159,600 g/mol, Ð = 1.06) (Table
4.7). Similarly, ROMP of the disulfide-containing MM (60) resulted in 87% MM
conversion and produced the molecular brush P60 of low dispersity (Mn = 198,200
g/mol, Ð = 1.04) (Table 4.7). Worth noting is the bimodal shape of the residual MM peak
following ROMP of 59 and 60 as shown in Figures 4.27a and 4.27b respectively. The
residual MM peak appearing at longer elution volumes corresponds well with the peak
elution volume of the respective MM. Meanwhile, the peak exhibiting a lower elution
volume corresponds well with the high molecular weight shoulder exhibited by the RAFT
polymer 57 and the resulting MMs (59 and 60). Consequently, the higher elution volume
peak is likely due to coupled polymer resulting from termination by radical-radical
coupling during RAFT polymerization. Such coupled polymer would not retain the
RAFT agent end group and would not be functionalizable by 52 or 56. Nonetheless, these
results show that macromonomers derived from 57 and thiol-reactive oxanorbornene
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derivatives 52 and 56 can be polymerized by ROMP to give the corresponding molecular
brush of low dispersity and of relatively high MM conversion.

Figure 4.27. a) SEC RI traces of the parent RAFT polymer (▬ 57), 52-functional
macromonomer (▬ 59), and corresponding molecular brush (▬ P59). b) SEC RI traces
of the parent RAFT polymer (▬ 57), 56-functional macromonomer (▬ 60), and
corresponding molecular brush (▬ P61).


SEC RI traces of macromonomers (61 and 62) synthesized from the water soluble
RAFT polymer poly(N,N-dimethylacrylamide) (58) are shown in Figures 4.28a and
4.28b respectively. In contrast to the ROMP of poly(styrene)-based MMs (59 and 60),
ROMP of 61 and 62 exhibited limited MM conversion and yielded molecular brushes of
broad dispersities as shown in Table 4.7. Despite >99% oxanorbornenyl end group
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functionalization of 61 and 94% functionalization of 62, ROMP of 61 and 62 only
reached 57% and 76% conversion respectively in 6 h. Furthermore, extending the
reaction time beyond 6 h (data not shown) was determined to have no influence on MM
conversion for the ROMP of 61 or 62. From these observations we hypothesize that
catalyst 19 is likely degrading due to residual oxygen or as a result of some unforeseen
degradation reaction. It is well known that polar solvents and functional groups can
coordinate with Ru-based metathesis catalysts, consequently competing with monomer
for the catalyst binding site and slowing the rate of ROMP.329 Indeed, the rate of
polymerization measured during the ROMP of 61 and 62 is slower than that measured for
the ROMP of the poly(styrene)-based MMs 59 and 60 (data not shown). Therefore it is
plausible that the dimethylacrylamide side chains coordinate with 19 and slow the rate of
polymerization enough for degradation of 19 (e.g. oxidation) to occur before complete
consumption 61 or 62.
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Figure 4.28. a) SEC RI traces of the parent RAFT polymer (▬ 58), 52-functional
macromonomer (▬ 61), and corresponding molecular brush (▬ P61). b) SEC RI traces
of the parent RAFT polymer (▬ 58), 56-functional macromonomer (▬ 62), and
corresponding molecular brush (▬ P62).
Table 4.7
ROMP of RAFT-derived macromonomers summary.

a

entry

MM

MM conv.a
(%)

1

59

91

135,600

159,600

1.06

2

60

87

129,600

198,200

1.04

3

61

57

103,500

161,000

1.24

4

62

76

137,900

141,700

1.23

Mnthb
(g/mol)

Mnexpc
(g/mol)

Ðc

Macromonomer conversion was determined from the relative integral areas of the SEC RI traces at t = 0 min and t = 6 h. bTheoretical

Mn values were calculated according to the equation Mnth=(ρMWMM[MM]0/[19]0) where ρ is the fractional macromonomer conversion
and MWMM is the molecular weight of the macromonomer. cExperimental Mn and Mw/Mn values were determined by SEC-MALLS
(DMF 20 mM LiBr).

Reduction-Induced Molecular Brush Disassembly
Polymer therapetuics have made extensive use of disulfide reduction as an
intracellular specific bond-breaking reaction in order to trigger therapeutic agent release
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and polymer disassembly/degradation following cellular internalization.171 Similarly, we
envision the use of disulfide-containing molecular brushes as highly branched “delivery
vehicles” which would exhibit extended circulation times in vivo and undergo reductioninduced disassembly upon cellular internalization to promote subsequent polymer
clearance from the body. Accordingly, we investigated the reduction-induced
disassembly of P62, which is comprised of water soluble poly(N,N-dimethylacrylamide)
side chains attached to a poly(oxanorbornenedicarboximide) backbone via disulfide
linkages, under physiological conditions (pH = 7.4 PBS buffer) (Scheme 4.18). DLdithiothreitol (DTT) was used as a representative reducing agent at [DTT] = 5 mM in
accordance with the natural concentration range of glutathione found in mammalian cells
(1-10 mM). Residual macromonomer present after ROMP of 62 (Figure 4.28) was
removed by dialysis against water (MWCO = 15 kDa) followed by lyophilization. Figure
4.29 shows the monomodal SEC RI trace of P62 after dialysis (black trace).

Scheme 4.18. DTT reduction of P62 in pH = 7.4 PBS buffer (10 mM) at 23 °C.
DTT reduction of P62 was monitored by SEC-MALLS (DMF 20 mM LiBr) by
injecting aliquots at timed intervals using an autosampler. A solution of P62 in pH = 7.4
PBS was initially prepared in a GPC vial equipped with piercable cap to give a final
disulfide concentration of 1 mM. Subsequently, a stock solution of DTT in PBS was
added to the GPC vial to give a final [DTT] = 5 mM. The first aliquot, which was
injected 5 min after addition of DTT, is shown in Figure 4.29 (red trace). Remarkably,
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disappearance of the peak corresponding to P62 is observed by the first aliquot. The
appearance of a new peak at ~17.5 mL is nearly equivalent to the elution volume of 62
(elution volume = 17.4 mL). The second new peak with elution volume = 20.2 mL is that
of the PBS buffer salts. Also worth noting is that precipitation was observed in the GPC
vial following the addition of DTT and is likely due to the insolubility of the
poly(oxanorbornenedicarboximide) backbone (Scheme 4.18) in PBS.

Figure 4.29. SEC RI trace of the disulfide-containing molecular brush after purification
by dialysis (▬ P62) and SEC RI trace (▬) of P62 5 min after the addition of DTT (5
eq.). P62 molecular brush reduction reactions were performed in pH = 7.4 phosphate
buffered saline (10 mM) at 23 °C.
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CHAPTER V
CONCLUSIONS
Section 1. Tunable pH- and CO2-Responsive Sulfonamide-Containing
Polymers by RAFT Polymerization
A series of pMSA polymers with tunable, pH-dependent solubility in aqueous
media has been synthesized by RAFT polymerization. Initially, polymerizations
conducted in DMF at 70 °C gave polymers with broad molecular weight distributions,
but upon reducing the polymerization temperature to 30 °C and employing the low
decomposition temperature initiator V-70, polymers of narrow molecular weight
distribution and increased thiocarbonylthio chain end functionality were obtained.
Selection of the sulfonamide R-group of MSA monomers is a facile means of adjusting
pKa and ultimately the critical onset of precipitation pH (pH*) of the corresponding
pMSA. Thus it is possible to “fine tune” pH-dependent polymer solubility in the
biologically relevant regime (pH = 4.5-7.4). Additionally, we demonstrated, the
reversible CO2-responsiveness of pMSAs in aqueous media, further indicating the
potential of pMSAs in biological and nanotherapeutic applications.
Section 2. Mechanistic Insights into Temperature-Dependent Trithiocarbonate
Chain-End Degradation during the RAFT Polymerization of N-Arylmethacrylamides
Methacrylamide-induced trithiocarbonate degradation during RAFT
polymerization has been investigated. N-phenyl-promoted nucleophilic attack of the
terminal trithiocarbonate by the ultimate methacrylamide unit was shown to occur by N-5
cyclization/elimination, resulting in rapid loss of active chain ends in DMF at 70 °C. The
3-phenyl-2-thioxothiazolidin-4-one RAFT polymer chain ends resulting from N-5
cyclization/elimination were shown to have little direct influence on the RAFT process
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and thus function as “dead” chain ends. Suppression of methacrylamide-induced
trithiocarbonate degradation during the RAFT polymerization of N-arylmethacrylamides
can be achieved by reducing the reaction temperature to 30 °C. Work is currently
underway in our labs to study the influence of N-aryl amide substitution on both the
reaction mechanism and rate of N-5 cyclization/elimination.
Section 3. “One-Pot” Aminolysis/Thiol-Maleimide End Group Functionalization
of RAFT Polymers: Identifying and Preventing Michael Addition Side Reactions
In this work we have elucidated a number of deleterious nucleophile-promoted
side reactions that occur during the “one-pot” aminolysis/thiol-maleimide end group
modification of RAFT polymers. Nucleophilic thiol-ene Michael addition catalysts
including amines, amidines, and phosphines were shown to initiate the anionic
polymerization of N-methylmaleimide in a range of solvents with the rate of reaction
increasing with solvent polarity. We also demonstrated that in more polar solvents, thiols
can initiate the anionic polymerization of maleimides when [Mal] > [thiol]. Mechanistic
evidence of TEA-catalyzed enolate formation of the thiol-maleimide adduct was acquired
using proton-deuterium exchange experiments of thiol-maleimide adducts and used to
prove that thiol-maleimide adducts were capable of direct initiation of maleimide
polymerization in the presence of a weak base. Ultimately, optimal reaction conditions
for the selective and near quantitative “one-pot” end group modification of RAFT
polymers using thiol-maleimide chemistry was identified
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Section 4. Growth-Then-Coupling Method of Molecular Brush Synthesis from RAFT
Polymers and Thiol-Reactive Oxanorbornenes
This section details a new “grafting through” synthetic route towards molecular brushes
capable of intracellular-induced disassembly. RAFT polymer-derived macromonomers
were synthesized using “one-pot” aminolysis/thiol reactions with maleimide- or
methanethiosulfonate-functional oxanorbornenes. Subsequent ring opening metathesis
polymerization (ROMP) of the resulting macromonomers afforded molecular brushes
with RAFT polymer side chains attached to a polyoxanorbornene backbone via either
permanent thioether linkages or reversible disulfide linkages. Molecular brushes
comprised of disulfide linkages were shown to undergo reduction-induced disassembly
and show promise a new class of stimuli-responsive polymer therapeutics.
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APPENDIX A
SUPPORTING INFORMATION

Figure A1. Mn versus % conversion for 37-mediated polymerization of 33 at 70 °C.


Figure A2. Mn versus % conversion for 37-mediated polymerization of 34 at 70 °C.
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Figure A3. Mn versus % conversion for 37-mediated polymerization of 33 at 30 °C.


Figure A4. Mn versus % conversion for 37-mediated polymerization of 34 at 30 °C.
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Figure A5. Beer-Lambert plot and molar extinction coefficients (ε) for 37, 41, and 42 in
acetonitrile measured using a Lambda 35 UV-vis spectrometer (λ = 320 nm).
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Figure A6. (a) 1H NMR (600 MHz, DMF-d7) spectrum of 1-dodecanethiol, (b) 1H NMR
(600 MHz, DMF-d7) spectrum acquired at t = 491 min during the in situ degradation
analysis of 41 at 70 °C, (c) 1H NMR (600 MHz, DMF-d7) spectrum of 40. Peaks of
interest corresponding to degradation byproducts formed during in situ degradation
analysis (Figure A6b) are colored red and blue and correspond well with key peaks of
analogous compounds 1-dodecanethiol (red) and 40 (blue) (Figures A6a and A6c
respectively).
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Figure A7. Expanded region (3.00 - 0.5 ppm) of the 1H NMR (600 MHz, DMF-d7)
spectrum acquired at t = 5 min during in situ degradation analysis of 41 at 70 °C.


Figure A8. Expanded region (3.00 - 0.5 ppm) of the 1H NMR (600 MHz, DMF-d7)
spectrum acquired at t = 491 min during in situ degradation analysis of 41 at 70 °C.
Overlapping peaks are colored red or blue for improved visualization.
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Figure A9. a) 1H NMR spectrum of E2MP in DMSO-d6 at T = 0 min. b) 1H NMR
spectrum during the reaction of E2MP and 65 in DMSO-d6 at T = 3 min. Disappearance
of the thiyl (peak c) and methyne (peak d) protons of E2MP confirm quantitative thiol
conversion by 3.0 min.

Figure A10. a) 1H NMR spectrum of E2MP in MeCN-d3 at T = 0 min. b) 1H NMR
spectrum during the reaction of E2MP and 65 in MeCN-d3 at T = 2.3 min. Disappearance
of the thiyl (peak c) and methyne (peak d) protons of E2MP confirm quantitative thiol
conversion by 2.3 min
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Figure A11. a) 1H NMR spectrum of E2MP in CD2Cl2 at T = 0 min. b) 1H NMR
spectrum during the reaction of E2MP and 65 in CD2Cl2 at T = 2.5 min. Disappearance
of the thiyl (peak c) and methyne (peak d) protons of E2MP confirm quantitative thiol
conversion by 2.5 min.
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Figure A12. Effect of solvent on the time-dependent fractional change in [Mal]/[Mal]0
during the reaction of TEA with 65 as measured by in situ 1H NMR analysis.

Figure A13. Effect of solvent on the time-dependent fractional change in [Mal]/[Mal]0
during the TEA-catalyzed reaction of HexAM with 65 as measured by in situ 1H NMR
analysis.
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Figure A14. 1H NMR (300 MHz, D2O) spectrum of 45.

Figure A15. Representative 1H NMR (300 MHz, D2O) spectrum of 46-functionalized 45
(Table 4.5 entry 1a).
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Figure A16. 1H NMR spectrum (300 MHz, CDCl3) of 52.

Figure A17. 1H NMR spectrum (300 MHz, CDCl3) of 56.
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APPENDIX B
N-ARYLAMIDE NUCLEOPHILICITY
Overview
Previously, we described the unique influence of N-phenyl methacrylamide
substitution on the limited RAFT polymerization control of methacryloylsulfonamides
(27-32)97 and N-phenylmethacrylamide (33)330 at 70 °C in DMF. We showed that chain
end degradation during the trithiocarbonate-mediated polymerization of 33 at elevated
temperatures occurs by N-5 nucleophilic attack of the terminal thiocarbonyl moiety by
the ultimate methacrylamide unit. Although mechanistic insights were gained into the
specific degradation pathway (N-5 cyclization/elimination) as discussed in Chapter IV
Section II, the nature of the true nucleophilic species involved in N-5 cyclization and the
influence of N-phenyl amide substitution is still not understood. The purpose of this work
is to better understand the influences of N-phenyl substitution on amide nucleophilicty
and develop a fundamental understanding of how substituents influence the mechanism
of amide-based nucleophilic reactions.

Scheme A1. Influence of ionized (A2) or conjugate base (A4) resonance forms on amide
nucleophilicity.
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The structures and reactivity of neutral amides (A1) are greatly influenced by the
ionized resonance form (A2) whereby the lone pair on nitrogen is delocalized onto the
carbonyl oxygen, increasing the double bond character of the C-N bond and increasing
the electron density of the carbonyl oxygen atom (Scheme A1). Consequently, Nsubstituted amides exhibit planar structures due to restricted C-N bond rotation and react
with electrophiles via the oxygen atom to afford the O-substituted product (A3).
Alternatively, amide anions derived from protic amides and strong bases (e.g. NaH) (A4),
react with electrophiles almost exclusively via the nitrogen atom to give the N-substituted
product (A5). Selective reaction of amide anions at the nitrogen atom has been
rationalized using the “hard and soft Lewis acids and bases” (HSAB) theory which
attempts to predict/explain the outcomes of substitution reactions involving ambident
nucleophiles (i.e. nucleophiles with two potential nucleophilic sites). HSAB theory can
be applied to ambident nucleophiles such as amide anions by way of Kornblum’s rule
which states:
“… hard acids prefer hard bases and soft acids prefer soft bases. In an SN1
mechanism, the nucleophile attacks a carbocation, which is a hard acid. In
an SN2 mechanism, the nucleophile attacks the carbon atom of a molecule,
which is a softer acid. The more electronegative atom of an ambident
nucleophile is a harder base than the less electronegative atom. Therefore,
as the character of a given reaction changes from SN1 to SN2 like, an
ambident nucleophile becomes more likely to attack with its less
electronegative atom.”331
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In other words, SN2 reactions involving amide anions will proceed via the less
electronegative nitrogen atom ( = 3.0) rather than more electronegative oxygen atom (
= 3.5), where  is the Pauling electronegativity value. This adequately describes the
selectivity in forming the N-substituted product A5 upon reaction of amide anion A4 with
an electrophilic species by an SN2 mechanism as shown in Scheme A1. However,
according to these theories, the neutral amide of 41 should react via the oxygen atom to
give O-5 cyclization/elimination products (41B) rather than the observed N-5
cyclization/elimination products (41A) as shown in Scheme A2. The key to
understanding this mechanism and its products must therefore lie in the role of N-aryl
substitution on amide nucleophilicity.

Scheme A2. Proposed degradation of 41 by N-5 cyclization/elimination (pathway A).
In Chapter IV Section II we show that i) N-phenyl methacrylamide substitution
increases the observed rate of trithiocarbonate degradation of 41 compared to N-benzyl
substitution (42) and ii) degradation of 41 proceeds by N-5 cyclization/elimination. We
can rationalize these observations if N-phenyl substitution promotes amide N-H
dissociation to give the amide anion (and solvated proton) where the amide anion is the
true nucleophilic species. As shown in Scheme A3, dissociation of an N-arylamide (A6)
affords the corresponding amide anion with O- and N-based resonance structures A7 and
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A8 respectively. However, direct N-aryl substitution provides additional resonance forms
A9-A11 that can further stabilize the amide anion. These additional resonance forms
should reduce the pKa of A6 by stabilizing the conjugate base and consequently shift the
equilibrium towards the dissociated amide anion species ([CON¯Ph]) compared to an
analogous amide with N-alkyl substituents. Indeed, comparison of the literature pKa
values of N-methylacetamide (pKa = 25.9, DMSO)332 and N-phenylacetamide (pKa =
21.5, DMSO)333 confirms the influence of N-aryl substitution on increased amide acidity
in polar organic solvents. From these observations, we hypothesize that N-aryl
substitution decreases the pKa of 41 and consequently increases [CON¯Ph], accounting
for the increased rate of degradation by N-5 cyclization/elimination as compared to 42.

Scheme A3. Possible N-arylamide conjugate base resonance forms.
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To test this hypothesis, we have synthesized single monomer unit insertion
adducts A12 and A13 which possess either electron withdrawing p-chloro or electron
donating p-methoxy groups respectively (Figure A18). According to our theory, the
electron withdrawing p-chloro substituent of A12 should decrease the amide pKa and
consequently increase the amide anion concentration ([CON¯PhCl]) resulting in an
increased rate of degradation by N-5 cyclization/elimination as compared to 41.
Conversely, electron donating p-methoxy substitution should increase the amide pKa of
A13 relative to 41 and decrease the rate of degradation by N-5 cyclization/elimination as
compared to 41. Meanwhile we have already shown in Chapter IV Section II that 41
degrades significantly faster than 42 by N-5 cyclization/elimination. It should therefore
hold true that pKa41 < pKa42. Indirect evidence of the relative pKa values of 41 and 42 can
be inferred by noting the relative chemical shifts of the amide N-H protons in Figures
4.16 and 4.17 respectively (Chapter IV Section II). The N-H chemical shift (600 MHz,
DMF-d7) of 41 (9.64 ppm) is significantly downfield shifted compared to the N-H
chemical shift of 42 (8.34 ppm). Greater deshielding of the N-H proton of 41 relative to
42 is indicative of increased acidity (lower pKa).

Figure A18. Proposed inverse relationship between amide pKa and apparent amide
nucleophilicity.

164
In this work, we will study the influence of amide substituent, solvent polarity,
temperature, and acid/base catalysis on the kinetics of N-5 cyclization/elimination of the
SMUI adducts 41, 42, A12, and A13 in order to test our theory of N-arylamide
nucleophilicity. This work is currently on-going and therefore the following results and
conclusions are incomplete. However, the results reported herein thus far support our
current theory of N-arylamide nucleophilicity.
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Experimental
4-Chlorophenylmethacrylamide A14

Methacryloyl chloride (5.83 mL, 59.7 mmol) was added dropwise over 15 min to
a stirred solution of 4-chloroaniline (7.25 g, 56.8 mmol) and triethylamine (8.32 mL, 59.7
mmol) in CH2Cl2 (150 mL) that was previously cooled using an ice bath. Upon complete
addition of methacryloyl chloride, the reaction was stirred at 0 °C for 30 min followed by
stirring at room temperature for an additional 60 min. The reaction mixture was then
transferred to a separatory funnel and washed with 0.1 N HCl (1 × 150 mL), saturated
NaHCO3 (1 × 150 mL), and saturated NaCl (brine) (1 × 150 mL) before drying over
MgSO4. The solvent was removed via rotary evaporation and the isolated solids
recrystallized from hot hexanes:THF (90:10) to yield A14 (10.05 g, 90%) as colorless
needle-like crystals. 1H NMR (300 MHz, CDCl3): δ 7.52 (s, 1H), 7.43 (d, 2H), 7.23 (d,
2H), 5.72 (s, 1H), 5.40 (s, 1H), 1.98 (s, 3H).
4-Methoxyphenylmethacrylamide A15

Methacryloyl chloride (5.83 mL, 59.7 mmol) was added dropwise over 15 min to
a stirred solution of p-anisidine (7.00 g, 56.8 mmol) and triethylamine (8.32 mL, 59.7
mmol) in CH2Cl2 (150 mL) that was previously cooled using an ice bath. Upon complete
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addition of methacryloyl chloride, the reaction was stirred at 0 °C for 30 min followed by
stirring at room temperature for an additional 60 min. The reaction mixture was then
transferred to a separatory funnel and washed with 0.1 N HCl (1 × 150 mL), saturated
NaHCO3 (1 × 150 mL), and saturated NaCl (brine) (1 × 150 mL) before drying over
MgSO4. The solvent was removed via rotary evaporation and the isolated solids
recrystallized from hot hexanes:THF (90:10) to yield A15 (7.60 g, 70%) as colorless
needle-like crystals. 1H NMR (300 MHz, CDCl3): δ 7.38 (d, 3H), 6.79 (d, 2H), 5.71 (s,
1H), 5.37 (s, 1H), 3.73 (s, 2H), 1.99 (s, 3H).
Synthesis of A12

A solution of 27 (3.41 g, 9.9 mmol), A14 (1.93 g, 9.9 mmol), and V-70 (0.609 g,
2.0 mmol) in DMF (35 mL) was prepared in a round bottomed flask equipped with
magnetic stir bar and the reaction degassed via three freeze-pump-thaw cycles and
backfilled with argon. The reaction mixture was heated at 30 °C in an oil bath for 48 h,
followed by exposure to air and freezing in liquid N2. The reaction mixture was then
diluted with EtOAc (150 mL) and transferred to a separatory funnel and washed with
75% brine (1 × 150 mL), H2O (1 × 150 mL), brine (1 × 150 mL), and dried over MgSO4.
The crude product was then purified by column chromatography (85:15 Hexanes:EtOAc,
Rf = 0.20) yielding A12 (0.427 g, 8%) as a yellow solid. 1H NMR (300 MHz, CDCl3): δ
8.41 (s, 1H), 7.32 (d, 2H), 7.23 (d, 2H), 3.20 (t, 2H), 2.47 (s, 2H), 1.95 (s, 3H), 1.56 (b,
2H), 1.41 (d, 6H), 1.18 (b, 18H), 0.81 (t, 3H).
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Synthesis of A13

A solution of 27 (3.41 g, 9.9 mmol), A15 (1.89 g, 9.9 mmol), and V-70 (0.609 g,
2.0 mmol) in DMF (35 mL) was prepared in a round bottomed flask equipped with
magnetic stir bar and the reaction degassed via three freeze-pump-thaw cycles and
backfilled with argon. The reaction mixture was heated at 30 °C in an oil bath for 48 h,
followed by exposure to air and freezing in liquid N2. The reaction mixture was then
diluted with EtOAc (150 mL) and transferred to a separatory funnel and washed with
75% brine (1 × 150 mL), H2O (1 × 150 mL), brine (1 × 150 mL), and dried over MgSO4.
The crude product was then purified by column chromatography (75:25 Hexanes:EtOAc,
Rf = 0.28) yielding A13 (0.452 g, 9%) as a yellow solid. 1H NMR (300 MHz, CDCl3): δ
8.26 (s, 1H), 7.26 (d, 2H), 6.78 (d, 2H), 3.72 (s, 3H), 3.21 (t, 2H), 2.48 (s, 2H), 1.96 (s,
3H), 1.58 (b, 2H), 1.40 (d, 6H), 1.18 (b, 18H), 0.81 (t, 3H).
In situ 1H NMR Analysis
A representative procedure is as follows: A solution of 41 (2 × 10-2 M) in DMSOd6 (0.6 mL) was prepared in an NMR tube equipped with pierceable rubber septum and
the solvent degassed by two freeze-pump-thaw cycles followed by backfilling the NMR
tube with argon. 1H NMR spectra were acquired at predetermined temperatures using a
Bruker Ascend™ 600 MHz spectrometer.
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Results and Discussion
If the rate determining step of N-5 cyclization/elimination of 41 is dependent
upon [CON¯Ph], a non-nucleophilic base should catalyze the reaction by promoting the
formation of the nucleophilic CON¯Ph species. To this end, we examined the effect of
triethylamine (TEA) (pKa = 9.00, DMSO)334 as a base catalyst for N-5
cyclization/elimination of 41 in DMSO-d6 at room temperature (23 °C). As shown in
Figure A19, 100% degradation of 41 was observed within the time required to obtain the
first spectrum (5 min) with peaks corresponding to the degradation byproducts given
prime designation. In contrast, the half life of 41 in DMF-d7 at 70 °C in the absence of
TEA was measured to be t1/2 = 7.18 h (Chapter IV Section II).

Figure A19. 1H NMR (300 MHz, DMSO-d6) overlay following the TEA-catalyzed
degradation of 41 at room temperature.

Base-catalyzed degradation of 41 is evidence of the rate determining step of N-5
cyclization/elimination being dependent upon [CON¯Ph]. Consequently, we can develop
a kinetic theory based upon Scheme A2 where the rate of irreversible trithiocarbonate
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(TTC) degradation due to intramolecular nucleophilic attack by an adjacent amide can be
expressed as follows:
𝑅𝑎𝑡𝑒 = −

𝑑[𝑇𝑇𝐶]
= 𝑘𝑎𝑝𝑝 [𝐶𝑂𝑁𝐻𝑅]𝑡𝑜𝑡
𝑑𝑡

(A1)

where [TTC] is the concentration of 41, [CONHR]tot is the total concentration of
associated and dissociated amide, and kapp is the apparent rate constant for intramolecular
nucleophilic attack. Assuming that nucleophilic attack (pathway A and/or B, Scheme A2)
is the rate determining step, the total rate of trithiocarbonate degradation can be expressed
as the sum of the rates of degradation by both N-5 and O-5 intramolecular nucleophilic
attack:
−

𝑑[𝑇𝑇𝐶]
= 𝑘1 [𝐶𝑂𝑁¯𝑅] + 𝑘2 [𝐶𝑂𝑁𝐻𝑅]
𝑑𝑡

(A2)

where [CON¯R] is the concentration of amide anion, [CONHR] is the concentration of
neutral amide, and k1 and k2 are the first order rate constants for N-5 and O-5 nuclephilic
attack respectively. We have shown that degradation of 41 occurs exclusively by N-5
cyclization such that k2 = 0. This allows for simplification of Eq A2 to the following:
−

𝑑[𝑇𝑇𝐶]
= 𝑘1 [𝐶𝑂𝑁¯𝑅]
𝑑𝑡

(A3)

The quantity [CON¯R], which cannot be measured directly, can be determined from the
measurable quantity [CONHR] and the dissociation constant (Ka) according to the
equilibrium shown in Eq A4.
[𝐶𝑂𝑁𝐻𝑅] ⇆ [𝐶𝑂𝑁¯𝑅][𝐻 + ]

(A4)
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𝐾𝑎 =

[𝐶𝑂𝑁¯𝑅][𝐻 + ]
[𝐶𝑂𝑁𝐻𝑅]

(A5)

In the absence of external acid or base, [CON¯R] = [H+] such that:
1

1

[𝐶𝑂𝑁¯𝑅] = 𝐾𝑎2 [𝐶𝑂𝑁𝐻𝑅]2

(A6)

Substitution of Eq A6 into Eq A3 gives:
−

1
1
𝑑[𝑇𝑇𝐶]
= 𝑘1 𝐾𝑎2 [𝐶𝑂𝑁𝐻𝑅]2
𝑑𝑡

(A7)

The total trithiocarbonate concentration [TTC], which is equal to the total amide
concentration ([CONHR]tot) can be expressed as:
[𝑇𝑇𝐶] = [𝐶𝑂𝑁𝐻𝑅]𝑡𝑜𝑡 = [𝐶𝑂𝑁𝐻𝑅] + [𝐶𝑂𝑁¯𝑅]

(A8)

When Ka is small and [CONHR] >> [CON¯R], Eq A8 simplifies to [TTC] = [CONHR]
and can be substituted into Eq A7 to give:
−

1
1
𝑑[𝑇𝑇𝐶]
= 𝑘1 𝐾𝑎2 [𝑇𝑇𝐶]2
𝑑𝑡

(A9)

Integration of Eq. A9 using the integral form of an nth order rate equation (Eq A10) gives
the final integrated rate equation of trithiocarbonate degradation by N-5 cyclization (Eq.
A11).
1
1
=
+ (𝑛 − 1)𝑘𝑡
𝑛−1
[𝐴]
[𝐴]𝑛−1
0

(A10)
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𝟏
𝟏
𝟏
𝟏
[𝑻𝑻𝑪]𝟐 = [𝑻𝑻𝑪]𝟐𝟎 − 𝒌𝟏 𝑲𝟐𝒂 𝒕
𝟐

(A11)

According to Eq A11, plotting [TTC]1/2 versus time will give the y-intercept = [TTC]01/2
and slope = -(1/2)k1Ka1/2.

Figure A20. [TTC]1/2 vs time plots for the degradation of 41 and 42 in DMF-d7 at 70 °C
([TTC]0 = 0.0329 M).

We next used Eq A11 to replot the kinetic data obtained previously for the
degradation reactions of 41 and 42 from Figures 4.18a and 4.18b respectively (Chapter
IV Section II). As shown in Figure A20, the graph of [TTC]1/2 vs time yields linear plots
for the degradation of 41 and 42 in DMF-d7 at 70 °C. The k1Ka1/2 values for 41 and 42 in
DMF at 70 °C were calculated from the slopes of the linear plots in Figure A20 to be 2.22
× 10-4 M1/2 s-1 and 1.86 × 10-5 M1/2 s-1 respectively. However, in order for k1 to be
determined, Ka for the amide must be known.
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While Ka for the amides of interest in this study (41, 42, A12, A13) could be
measured by potentiometric or photometric titrations in DMSO using a strong base such
as sodium dimsyl,335 rapid trithiocarbonate degradation would likely occur due to
nucleophilic attack of the thiocarbonyl by the dimsyl anion and also as a result of basecatalyzed N-5 cyclization. Therefore an alternative method of determining Ka in situ is
desired. This can be accomplished by disturbing the amide dissociation equilibrium (Eq
4) via the addition of a known amount of strongly dissociating “super acid,” such as bis
trifluoromethanesulfonimide, and measuring the effect of [H+] on kapp (Eq 1) which is a
function of both k1 and Ka. If the dissociation constant of the acid (Ka,acid) is suitably large
compared to Ka of the amide, [H+]≈[HX] where [HX] is the concentration of externally
added acid. The relationship between [HX] and [CON¯R] can then be expressed as
follows:
[𝐶𝑂𝑁¯𝑅] =

𝐾𝑎 [𝐶𝑂𝑁𝐻𝑅]
[𝐻𝑋]

(A12)

Combination of Eq A1, Eq A3, and Eq A12 gives:
𝑘𝑎𝑝𝑝 [𝑇𝑇𝐶] =

𝑘1 𝐾𝑎 [𝐶𝑂𝑁𝐻𝑅]
[𝐻𝑋]

(A13)

Recalling that [TTC]≈[CONHR], Eq A13 can be simplified to:
𝒌𝒂𝒑𝒑 =

𝒌𝟏 𝑲𝒂
[𝑯𝑿]

Plotting kapp vs. [HX]-1 would yield a slope = k1Ka. Ka can then be determined by
combining the slopes from Eq A11 and Eq A14:

(A14)
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𝑘1 =

−2𝑠𝑙𝑜𝑝𝑒1
1
2

(from Eq 11)

(A15)

𝐾𝑎

𝑘1 =

𝑠𝑙𝑜𝑝𝑒2
(from Eq 14)
𝐾𝑎

𝟏 𝒔𝒍𝒐𝒑𝒆𝟐 𝟐
𝑲𝒂 = (
)
𝟒 𝒔𝒍𝒐𝒑𝒆𝟏

(A16)

(A17)

where slope1 is the slope of [TTC]1/2 vs. time plot (Eq A11) and slope2 is the slope of kapp
vs. [HX]-1 plot (Eq A14).
Despite not yet knowing the Ka values for the amides of interest in this study, we
can make the following predictions regarding the influence of amide substituents on the
values of k1 and Ka for uncatalyzed N-5 cyclization/elimination reactions.

1) Electron withdrawing substituents will increase the value of Ka.

Electron withdrawing substituents will stabilize the conjugate base of the amide and thus
shift the equilibrium towards the dissociated amide anion thus increasing the value of Ka.

2) Electron withdrawing substituents will reduce the value of k1.

At first this seems counterintuitive since we predict that electron withdrawing
substituents will increase the rate of degradation by N-5 cyclization/elimination.
However, k1 is a function of the relative nucleophilicity of the amide anion. Electron
withdrawing substituents will increase the stability of the amide anion relative to electron
donating substituents and consequently reduce the nucleophilicity (and reduce k1) of the
amide anion. Accordingly, we predict that electron withdrawing stubstituents will cause
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Ka1/2 to increase more than k1 will decrease, such that the product of k1Ka1/2, which is
directly proportional to the rate of degradation by N-5 cyclization, will increase. In other
words, the increase in concentration of the nucleophilic species [CON¯Ph] more than
compensates for the reduced nucleophilicity of that species.
We can initially evaluate these predictions if we assume the pKa values of 41 and
42 in DMF-d7 are similar to the pKa values of N-phenylacetamide (pKa = 21.5, DMSO)
and N-methylacetamide (pKa = 25.9, DMSO) respectively. Using these estimated pKa
values for 41 and 42 along with the k1Ka1/2 values determined previously from the slopes
of the kinetic plots in Figure A20, we calculated the k1 values for degradation by N-5
cyclization/elimination of 41 and 42 to be 1.25 × 107 M1/2 s-1 and 1.66 × 108 M1/2 s-1
respectively. As predicted, the k1 value of the more acidic amide (41) is lower (by ~1
order of magnitude) than the k1 value for the less acidic amide (42) despite the rate of N5 cyclization/elimination of 41 being greater than that of 42.
Conclusions
We have estabilised a mechanistic theory in order to explain the influence of Naryl substitution on the observed relative rates of N-5 cyclization/elimination of 41 and
42 at elevated temperatures. In addition, we have developed a kinetic model based upon
the “amide dissociation mechanism” which thus far fits the previously obtained kinetic
data. We also show that degradation by N-5 cyclization/elimination is base catalyzed and
we are currently investigating the influence of electron withdrawing/donating substituents
and solvent polarity on the N-5 cyclization/elimination rate constants (k1) and
dissociation constants (Ka) of select amides. Ultimately, this work has the potential to
provide greater insights into the nucleophilic character of amides.
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